Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Artificial Intelligence (AI) in Medical Education" in Advances in Medical Education and Practice.

Artificial Intelligence (AI) is rapidly transforming healthcare and educational systems worldwide. Within the domain of medical education, AI has emerged as a powerful tool with the potential to enhance learning, teaching, and assessment. The integration of AI technologies, such as machine learning, natural language processing, and intelligent tutoring systems, promises to reshape how medical students, clinicians, and educators interact with educational content and teaching strategies. AI has already shown promise in areas like personalized learning, simulation-based training, predictive analytics for performance evaluation, and administrative automation. As the future of medical practice becomes increasingly tech-driven, it is critical to explore how AI can both augment and redefine the landscape of medical education.

AI's integration into medical education is a timely and vital development. The global healthcare system is experiencing an urgent need for more skilled professionals, with a growing demand for more efficient, scalable, and personalized learning methods. AI offers an unprecedented opportunity to address these needs by facilitating adaptive learning environments that respond to individual learners' strengths and weaknesses. Furthermore, AI can help overcome challenges such as faculty shortages and time constraints, making high-quality medical education more accessible across diverse geographic regions. Additionally, AI can support more objective assessments, enhance the accuracy of feedback, and help educators make data-driven decisions that improve student outcomes. As AI continues to evolve, its potential to enrich medical education and improve healthcare delivery grows, making this an essential area of exploration for academic scholarship.

This Article Collection will focus on the application and potential of AI in medical education, with a particular emphasis on both theoretical and practical aspects. Subtopics include, but are not limited to:

• AI-driven Personalized Learning: Exploring how AI can tailor educational content to individual student needs, improving engagement and retention.
• Simulation and Virtual Reality: The role of AI in creating realistic, immersive environments for clinical training and skill development.
• AI in Assessment and Feedback: How AI can enhance formative and summative assessments, provide real-time feedback, and assist with competency tracking.
• Ethical and Practical Challenges: Examining issues such as data privacy, algorithmic bias, and the implications of AI on teaching roles.
• Future Trends and Innovations: Investigating upcoming AI technologies and their potential applications in evolving medical education paradigms.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code FEHJU for a 10% discount on the Article Processing Charge and to indicate that your article should be considered for this Collection. 

The manuscript submission deadline is 31 October 2025.

Guest advisors

Dr. Rasha A. Alamoush, The University of Jordan

[email protected]

Dr. Rasha A. Alamoush is an Associate Professor in the Department of Fixed and Removable Prosthodontics at the University of Jordan. She holds a Doctor of Dental Surgery (DDS) and a Master of Science (MSc), along with a Clinical PhD in Fixed and Removable prosthodontics. Her research focuses on fixed and removable prosthodontics, dental materials, CAD/CAM technology, and implantology, with numerous publications in reputable journals. Dr. Alamoush is also a consultant in her field, dedicated to improving patient care and advancing dental education and science.

Dr. Haider Julfikar, Manchester Metropolitan University

[email protected]

Dr. Julfikar Haider is a Senior Lecturer in Mechanical Engineering at Manchester Metropolitan University, specializing in surface engineering and advanced materials processing. He holds a PhD from Dublin City University and has published extensively, contributing to over 100 peer-reviewed journal articles. His research interests include composite materials, tribology, and applications of artificial intelligence in manufacturing systems.

Dr. Basima Ahmad Elshqeirat, The University of Jordan

[email protected]

Dr. Marwa M. Alnsour, The University of Jordan

[email protected]

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Future in Health Professions Education: Innovative Teaching Alternatives" in Advances in Medical Education and Practice.

The adoption of updated and innovative teaching methodologies, such as problem-based learning, 3D virtual simulations, augmented reality, and gamification, is increasingly recognized as essential for meeting the educational needs of today's students. These tools enable a pedagogical approach that supports the development of critical competencies - basic, transversal, and specific - required for the future careers of health professionals. In medicine and health sciences, the acquisition of these competencies spans knowledge, skills, values, and attitudes. These elements must be integrated and applied at various stages of medical education and practice to prepare students for the evolving demands of the healthcare field.

As higher education faces a rapidly changing world and a new generation of students with diverse learning preferences, health professions education must embrace innovative and adaptive approaches. The training of future healthcare professionals must move beyond traditional lecture-based methods, which, while valuable, may not fully equip students with the practical skills, critical thinking, and interpersonal competencies necessary for high-quality care. Novel pedagogical approaches, including gamification, game-based learning, simulations, and virtual reality, offer opportunities to foster active, collaborative learning environments that focus on comprehensive competency development.

This Article Collection aims to explore innovative teaching strategies in health professions education. Topics of interest include, but are not limited to:

• Assessment of knowledge, skills, and competencies in medicine and health sciences
• Quantitative and qualitative research on student and professional education in medical and health sciences
• The use and impact of educational technology and innovations on learning outcomes
• Applications of health sciences education in undergraduate, postgraduate, and continuing education, as well as clinical training

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code SMSJM for a 10% discount on the Article Processing Charge and to indicate that your article should be considered for this Collection. 

The manuscript submission deadline is 31 October 2025.

Guest advisors

Dr. Ana Isabel Cisneros-Gimeno, University of Zaragoza

[email protected]

Professor of Human Anatomy and Embryology at the Faculty of Medicine of Zaragoza, teaching since 1996.
Researcher in several consolidated and multidisciplinary groups of university teaching innovation.
President of the Technical Committee for Teaching Assessment and member of the Quality Assurance Committee for the Degree in Medicine. Mentor of students and scholarship holders.

Dr. Alberto Garcia-Barrios, University of Zaragoza

[email protected]

Professor of Human Anatomy and Embryology at the Faculty of Medicine of Zaragoza, teaching since 2016.
Lead researcher in the consolidated group of university teaching innovation (INNO_MED).
Mentor of students and scholarship holders.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Innovations and Impact: The Role of Ultrasound in Undergraduate Medical Education" in Advances in Medical Education and Practice.

Point-of-care ultrasound (POCUS) is transforming clinical practice across numerous medical specialties, and its integration into undergraduate medical education has gained increasing attention in recent years. Ultrasound offers a dynamic, visual, and interactive modality for teaching anatomy, physiology, clinical reasoning, and procedural skills. Medical schools worldwide are recognizing its pedagogical value and are piloting curricular innovations that bring ultrasound training to students early in their careers. This Article Collection aims to highlight current advances, practical implementations, and educational outcomes related to ultrasound-based teaching in undergraduate medical training.

Early exposure to ultrasound not only enhances the learning of foundational sciences but also supports competency-based education by fostering clinical decision-making, spatial reasoning, and diagnostic acumen. As educational institutions respond to technological advances and evolving healthcare demands, equipping students with ultrasound skills has become both feasible and essential. Moreover, the inclusion of ultrasound aligns with modern strategies for active, student-centered learning. Despite growing enthusiasm, challenges remain - including curricular integration, faculty training, resource availability, and assessment. Sharing successful strategies and rigorous evaluations is critical to advancing the field.

This Collection invites original research, systematic reviews, short reports, commentaries, and case studies that explore ultrasound in the context of undergraduate medical education. Potential subtopics include curriculum development, faculty development, interprofessional education, assessment strategies, student outcomes, and the role of simulation. Submissions may also address institutional frameworks, technology adoption, and longitudinal program evaluations. We especially welcome articles that demonstrate measurable educational impact, novel pedagogical models, or interdisciplinary collaboration. All contributions should be aligned with the journal’s mission to advance research and best practices in medical education.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code D7645 to indicate that your article should be considered for this Collection.

The manuscript submission deadline is 31 March 2026.

Guest advisor

Dr. Florian Recker, University Hospital Bonn

[email protected]

Dr. Florian Recker is a physician-scientist and medical educator based at the University Hospital Bonn, Germany. A specialist in obstetrics and prenatal medicine, he combines clinical expertise with a strong academic focus on medical education and ultrasound-based teaching. He holds a PhD, a Master of Medical Education from the University of Heidelberg, and completed his habilitation in the field of ultrasound education in obstetrics and gynecology.
Dr. Recker has received multiple national awards for excellence in university teaching and educational innovation, including the prestigious Ars Legendi Prize (2024) and multiple recognitions from the German Society for Medical Education (GMA). He is an active reviewer and editorial board member for several high-impact journals. 

Internationally engaged in professional organizations such as DEGUM, ISUOG, and SUSME, he is committed to advancing clinical skills training and interprofessional learning. Dr. Recker also has played key roles in national and European committees on medical education and ultrasound.

Dr. Johannes Matthias Weimer, Gutenberg University Mainz

[email protected]

Dr. med. Johannes Weimer is a physician and medical educator at the University Medical Center Mainz. As coordinator of the student ultrasound training program, he oversees the development and implementation of innovative teaching approaches, including peer-assisted learning and simulator-based instruction. His academic work centers on advancing ultrasound education and improving sonographic ergonomics, with a particular emphasis on embedding ultrasound training into medical curricula. Beyond his educational responsibilities, Dr. Weimer is actively involved in the clinical application of sonography, with a strong focus on the integration of cutting-edge ultrasound technologies into routine patient care. He is a member of DEGUM, EFSUMB, GMA and the Editorial Board of BMC Medical Education.

View all papers in this article collection

Dove Medical Press is pleased to invite you to the upcoming Article Collection “Biosimilars, Biobetters, and Bioparallels” led by Professor Ivo Abraham, Ms. Ansam Beddor, Dr. Nimer Alkhatib, and Dr. Karen MacDonald in Biologics: Targets and Therapy.

Looking back on almost three decades of biosimilars and despite their difficult start in Europe in 2015, biosimilars are solidly embedded in patient care and have become a mainstay in human therapeutics – at least in high income countries. Being equivalent in efficacy/effectiveness, safety and (mainly) priced lower than the originators they reference, biosimilars enable savings, expanded patient access, and greater patient equity. 

Furthermore, two recent developments have broadened the “later-in-class” biologics space beyond biosimilars. In October 2023, the United States Food and Drug Administration (FDA) approved Zymfentra, a subcutaneous (SC) formulation of Inflectra, an intravenous (IV) biosimilar referencing infliximab (Remicade). Rather peculiar but this SC formulation is approved in other jurisdictions as a biosimilar – along with its IV formulation – but in the US as a biological. Zymfentra is increasingly being referred to as a biobetter, in this case of a biosimilar (Inflectra) of originator infliximab (Remicade). Additional biobetters are on the horizon – as novel agents of biosimilar candidates that failed the upper bound of the equivalence margin. 

That same month, the FDA also approved toripalimab (Loqtorzi), the first Chinese PD-1 inhibitor based exclusively on Chinese clinical trials: not a biosimilar and neither a biobetter, but a bioparallel. It is a new biological molecule without the ambition of being an early-in-class innovator but instead a “later-in-class” entry, analogous (but not similar) in efficacy and safety, competing on price. There are more are on the horizon as well. 

While there can be clear benefits for adopting biosimilars, biobetters and bioparallels, many issues remain to be addressed: regulatory pathways; clinical evidence in support of regulatory approval; interchangeability; pricing and competition; commoditization of biological therapy; and the need for global access, especially in low, lower-middle and higher-middle income countries – among many others. 

To help address these issues, Biologics: Targets and Therapy invites authors to submit Original Research, Reviews, and Commentaries on relating to biosimilars, biobetters and bioparallels. Potential topics include but are not limited to:

• Clinical studies into the use of biosimilars, biobetters and bioparallels.
• Bioequivalence studies.
• Pharmacoeconomic analyses
• Research relating to the regulation, pricing, re-imbursement and market uptake of biosimilars, biobetters and bioparallels.

Keywords
Biosimilars, Biobetters, Bioparallels

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 31st December 2025. Please note normal Article Processing Charges apply.

Please submit your manuscript on our website, quoting the promo code DJZNQ for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to the upcoming Article Collection “Regulatory (FDA) Critical Clinical Initiative in Drug Research and Development” in Biologics: Targets and Therapy.

In recent years, the United States (US) Food and Drug Administration (FDA) has kicked off a number of critical clinical initiatives to assist the sponsors in pharmaceutical research and development. These critical clinical initiatives include, but are not limited to, (i) biosimilar drug development, (ii) cancer research, (iii) adaptive trial design, (iv) real-world data (RWD) and real-world evidence (RWE), (v) model-informed drug development (MIDD), (vi) AI for mobile individualized medicine, (vii) rare disease drug development, (viii) biomarker development, (ix) precision and personalized medicine, and (x) benefit-risk assessment. The purpose of these critical clinical initiatives is not only to provide regulatory flexibilities in drug development, but also to improve, shorten or speed up the review and approval process of drug development. 

In the past decade, it is aware that increasing spending of biomedical research does not reflect an increase of the success rate of pharmaceutical development. Woodcock (2004) performed a diagnosis and found out the following problems (i) a diminished margin for improvement that escalates the level of difficulty in proving drug benefits. (ii) genomics and other new science have not yet reached their full potential, (iii) easy targets are the focus as chronic diseases are harder to study, (iv) failure rates have not improved, (v) rapidly escalating costs and complexity decrease willingness/ability to bring many candidates forward into the clinic. To fix the problems, FDA kicked off these critical clinical initiatives to bridge the gap between the quick pace of new biomedical discoveries and the slower pace at which those discoveries are currently developed into therapies. These critical clinical initiatives are important to provide the sponsors the flexibility for identifying any signal, possible trend/pattern, and ideally optimal benefit regarding safety/efficacy of the test treatment under investigation. In addition, these critical initiatives can help in speeding up the development process in a more efficient way without undermining the scientific validity of the development. 

Potential topics include but are not limited to:

• Biosimilar drug development
• Rare disease drug development
• Hybrid adaptive trial design
• Real-world data (RWD) and real-world-world evidence (RWE) or alternative and confirmatory data/evidence (ACD/ACE)
• Novel design and analysis for cancer research
• Model-informed drug development (MIDD)
• AI technology for biomarker development of imaging data
• Benefit- risk assessment

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 31st December 2025. Please note normal Article Processing Charges apply.

Please submit your manuscript on our website, quoting the promo code WZJNO for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

View all papers in this article collection

Breast Cancer: Targets and Therapy is pleased to announce an upcoming Article Collection dedicated to the transformative role of antibody-drug conjugates in the treatment of breast cancer. 

Antibody-drug conjugates (ADCs) consist of monoclonal antibodies linked to cytotoxic drugs, allowing for selective delivery of the therapeutic agent directly to cancer cells and minimizing damage to healthy tissues. Advances in ADC research have led to numerous approvals for clinical use, with significant impact on breast cancer therapy, as ADCs can effectively reduce tumor size and improve progression-free survival. With the ongoing identification of novel targets and indications, ADCs are poised to become a leader in the era of targeted therapies for breast cancer. 

We welcome submissions of original research articles, reviews, and perspectives that contribute to the understanding and advancement of these therapies, including mechanisms of action, clinical efficacy, optimal combinations and ordering, and understanding and overcoming resistance. 

This Article Collection will be included in a wider Game Changer Series focused on breakthrough therapies across medicine. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor & Francis and Dove Medical Press, increasing the discoverability and visibility of your research.

The deadline for submissions is 1 April 2026. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website. Submitting authors are eligible for a 20% discount on the Article Publishing Charge. To apply this discount, enter the code NRLJP when prompted during submission. 

Please contact Commissioning Editor Cassie Houtz at [email protected] with any questions.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Breast Cancer in Young Women" in Breast Cancer: Targets and Therapy.

Breast cancer in young women is on the rise. Women diagnosed with breast cancer before the age of 45 often face more aggressive disease, higher mortality rates, and unique psychosocial issues, including fertility concerns and the impact on family life. This Article Collection seeks to highlight the latest advancements in research, treatment, and patient care to improve outcomes for this vulnerable group. 

We invite submissions on a wide range of topics, including but not limited to:

• Epidemiology and Risk Factors: Studies on genetic predispositions, lifestyle factors, and environmental influences specific to young women.
• Biological and Molecular Characteristics: Research on the unique tumor biology and molecular profiles of breast cancer in young women.
• Diagnosis and Screening: Innovations in early detection methods and the effectiveness of current screening protocols for younger populations.
• Treatment Strategies: Advances in surgical, chemotherapeutic, and radiotherapeutic approaches tailored to young patients.
• Psychosocial Impact: The psychological and social challenges faced by young women with breast cancer, including mental health, body image, and fertility issues.
• Survivorship and Quality of Life: Long-term outcomes, survivorship care plans, and quality of life assessments for young breast cancer survivors.
• Health Disparities: Examination of racial, socioeconomic, and geographic disparities in breast cancer incidence, treatment, and outcomes among young women.

The deadline for submissions is 5 September 2025. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code AWSGV for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Nanoparticles for Breast Cancer Treatment" in Breast Cancer: Targets and Therapy.

Nanotechnology is a driver of innovation in many different fields, including in the field of breast cancer treatment. Nanoparticles have shown potential to be innovative pharmaceutical products for the treatment of breast cancer. Because of their small size and high surface area, nanoparticles possess unique properties such as the ability to penetrate biofilms and influence intracellular mechanisms. Even so, nanoparticles for breast cancer treatment face many challenges including offsite accumulation, sufficient dosing, and toxicity concerns.

Breast cancer continues to be a significant worldwide health concern. The recent development of targeted treatments has transformed breast cancer therapy, providing more precise and successful strategies by tailoring interventions to the distinct genetic and molecular attributes of individual tumors. The application of nanoparticles for breast cancer treatment is similarly poised to bring about further breakthroughs in breast cancer treatments.

This Collection aims to bring together articles relating to the application of nanotechnology and nanoparticles for breast cancer treatment. This includes applications such as nanoparticles as a drug delivery vehicles for other therapeutics, nanoparticles for radiation and other treatments, and nanoparticles as a therapeutic. Nanoparticles could be of any material with a size on the nanometer scale including polymer nanoparticles, lipid nanoparticles, protein nanoparticles, metal nanoparticles, silica nanoparticles, or quantum dots. We invite submissions of original research articles, basic and translational research, clinical studies, detailed reviews, and expert opinions and commentaries that align with the journal's focus. This Collection will function as a resource for researchers, physicians, and healthcare professionals, advancing the future for the development of nanoparticles and nanotechnology for more effective, tailored treatment solutions for breast cancer.

The deadline for submissions is 13 October 2025. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code CSQWV for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisor

Kathleen McEnnis, New Jersey Institute of Technology, NJ, United States

[email protected]

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Rare Breast Cancer Subtypes" in Breast Cancer: Targets and Therapy.

Breast cancer remains one of the most prevalent and widely-researched cancers worldwide. While significant advancements have been made in understanding and treating common types of breast cancer, rare subtypes remain underexplored and underrepresented in research. Rare breast cancer subtypes generally exhibit distinct biological and molecular characteristics that differentiate them from more common subtypes. They are also frequently diagnosed at later stages, and there is often a lack of data on optimal treatment protocol and standardized therapeutic approaches. 

This Article Collection aims to highlight research on rare breast cancer subtypes, eg. metaplastic, micropapillary, neuroendocrine, adenoid cystic, pleomorphic, secretory, mucinous, and medullary breast cancers. We welcome contributions covering all stages of cancer research, from basic science to translational and clinical work, including but not limited to:

• Molecular biology of rare breast cancer subtypes
• Pathology of rare subtypes
• Transcriptomic profiling and other “omics” approaches
• Novel and emerging treatment strategies

The deadline for submissions is 1 July 2025. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code KMSSN for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest advisor

Pooja Advani, Department of Hematology and Oncology, Mayo Clinic

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Role of Stress in Breast Cancer" in Breast Cancer: Targets and Therapy.

Breast cancer is the most commonly diagnosed cancer in women and the leading cause of cancer death among women worldwide. Social determinants of health play a significant role in breast cancer outcomes, as there are well-documented disparities in breast cancer survival by socioeconomic status, education, race, and access to health insurance and preventive care. Research suggests that stress may be a mediator between social determinants of health and breast cancer risk and outcomes, through complex interactions of immune dysregulation, inflammation, and hormonal changes. More research is needed to better understand the mechanisms by which stress impacts breast cancer risk and prognosis, as well as to identify effective interventions that can reduce stress and improve outcomes. 

We invite original research articles, reviews, expert opinions, and commentaries – including basic and translational research and clinical and epidemiological studies – related to the role of stress in breast cancer, including but not limited to the following topics: 

• Role of neuropeptides and neurotransmitters (such as the adrenergic system) in breast cancer
• Role of glucocorticoids in cancer progression
• Impact of hormones in breast cancer prognosis
• Social determinants of health and breast cancer outcomes
• Stress and immunosuppression in breast cancer
• Anatomical relationship between the neural system and breast cancer behaviour – dormancy, metastasis, drug resistance, etc.

The deadline for submissions is 1 September 2025. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code SLSTU for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisor

Dr. Shipra Ghandi, Assistant Professor of Oncology, Roswell Park Comprehensive Cancer Center

[email protected]

View all papers in this article collection

Cancer Management and Research is pleased to announce an upcoming Article Collection dedicated to the transformative role of CAR-T therapy in the management of cancer.

Since the 2017 US FDA approval of the use of anti-CD19 CAR-T cell therapy for use against B-cell malignancies, CAR-T therapy has demonstrated significant clinical benefits in treating hematologic malignancies, showing clinical efficacy and durability even in patients who have been refractory to other treatments. Research is underway to develop and evaluate CAR-based therapies for application in solid tumors. 

Despite the remarkable impact of CAR-T therapies, challenges remain, including antigen escape, limited persistence, and overcoming the immunosuppressive microenvironment. Further, life-threatening toxicities, the high costs of manufacturing, and the need for a well-trained workforce currently limit the widespread use of CAR-T for cancer treatment.

Given the impact and continued importance of CAR-T cell therapies in cancer treatment, Cancer Management & Research welcomes submissions of original research articles, reviews, and perspectives on CAR-T, including basic science, translational research, clinical efficacy, and real-world implementation. 

This Article Collection is part of a wider Game Changer Series focused on breakthrough therapies across medicine. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor & Francis and Dove Medical Press, increasing the discoverability and visibility of your research. 

The deadline for submitting manuscripts is 1 April 2026. Please review the journal’s Aims and Scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website. Submitting authors are eligible for a 20% discount on the Article Publishing Charge. To apply this discount, enter the code TFRFH when prompted during submission.

Please contact Commissioning Editor Cassie Houtz at [email protected] with any questions.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Immune Effector Cells for Cancer Therapy – CAR-T and beyond" in Cancer Management and Research.

Cellular therapies for both malignant and non-malignant disease have substantially grown in the past decade. Genetically engineered immune effector cells (IEC) have provided hope for patients with primary refractory malignancies and have received multiple regulatory approvals in B-cell lymphomas, acute lymphoblastic leukemia, and myelomas. Now the investigational portfolio of such promising treatment has grown substantially to include other cellular types (natural killer cells, and tumor infiltrating lymphocytes) and other malignancies including solid tumors. 

IEC were shown to be able to overcome resistance of malignant cells to treatment and have shown durable remissions in otherwise advanced malignancies with poor outcomes. The explosion of novel technologies beyond chimeric antigen receptor T-cells (CAR-T) to include T-cell receptor (TCR) engineered cells as well as other non-T cell therapy platforms like natural killer cells and tumor infiltrating lymphocytes expanded the application of such curative therapies beyond B-cell lymphomas and leukemias to other disease indications. 

This Article Collection welcomes submissions on topics including but not limited to:

• Optimization of already-approved IEC to improve outcomes and minimize toxicities
• Novel investigational cell therapy platforms and technologies in development
• Combination treatment with other agents like checkpoint inhibitors
• Expanding applications of IEC in solid tumors
• Strategies to modulate immunosuppressive tumor microenvironment,
• Expanding access to IEC through on site manufacturing,
• Methods to foster national and international collaborations to develop therapies for rare diseases
• Developing robust quality and regulatory infrastructures to ensure the safety of such promising therapies

The deadline for submitting manuscripts is 30 October 2025. Please review the journal’s Aims and Scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code VBJGE for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection. Please contact commissioning editor Cassie Houtz at [email protected] with any inquiries.

Guest Advisor

Basem M. William, MD, MRCP(UK), FACP

[email protected]

Professor Basem William is an internationally recognized expert in lymphoma, blood and marrow transplant, cellular therapy, and drug development. He is the inaugural Clinical Director of OhioHealth Blood and Marrow Transplant Program, Medical Director of Immune Effector Cell Program and Cell Therapy Laboratory, and John P. McConnell Endowed Chair for Cancer Research.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Self Screening for Cancer: Promises and Pitfalls" in Cancer Management and Research.

Cancer is a leading cause of death worldwide, and early detection can significantly improve prognosis. However, many individuals are not screened or are inadequately screened for cancer. Self-screening for cancer has the potential to lead to earlier detection, which in turn enables earlier treatment and better survival rates. It has also been touted as a way to reduce disparities in cancer outcomes, as self-screening kits could be made available to individuals without access to high-quality in-office screening. 

Self-collection methods have been implemented in several countries, and at-home collection kits for colorectal cancer screening and HPV testing have recently been approved in the United States. 

However, challenges remain for implementing self-screening and ensuring that this method of testing is accurate and accessible. 

We invite submissions on a range of subtopics related to self-screening for cancer, including but not limited to:

• Technological advancements in self-screening tools
• Accuracy and reliability of self-screening methods
• Regulation of self-screening tools
• Educational strategies for promoting accurate and effective self-screening
• Self-screening and overcoming disparities in cancer care
• Best practices for physicians (eg. de-escalate screening to primary HPV testing)
• Health systems implementation for successful screening

The deadline for submitting manuscripts is 31 July 2025. Please review the journal’s Aims and Scope of the journal and author submission instructions prior to submitting a manuscript. 

Please submit your manuscript on our website, quoting the promo code BJOFF for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisor

Diane M. Harper, University of Michigan School of Medicine

Diane M. Harper is an internationally recognized family physician and clinical research expert in HPV-associated diseases, their prevention, early detection, and treatment for the prevention of cancer. She has been a consultant for the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to advise on global guidelines and to set up screening and prevention operations in low and middle-income countries to prevent cervical cancer. She also has received the Distinguished Scientist Award from the European Research Organization on Genital Infection and Neoplasia for her scientific work as well as the Femmes de l'Année Prix Monte Carlo, which honors influential changemakers working to better women's lives around the world. As a physician-researcher, Dr. Harper has a strong interest in public health, epidemiology, and health behaviors, all fields in which she has published over her 30-year career. She has over 300 publications and tens of thousands of citations, has contributed to multiple textbooks, and has shaped global guidelines and policies related to cervical cancer screening and prevention efforts in the U.S., Europe, and for the WHO Elimination of Cervical Cancer Initiative.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advancements in pharmacological, surgical and adjunct therapeutic modalities for inflammatory bowel disease", organized by Guest Advisor Dr Syed Hassan in Clinical and Experimental Gastroenterology.

Advancements in experimental platforms have enhanced our understanding of disease-pertinent pathophysiology for inflammatory bowel diseases (IBD). This has fueled identification of novel molecular targets, thus revolutionizing treatment aspirations from symptomatic control to well-defined objective aspirations by implementation of the treat-to-target approach. Despite these rapid advances, a significant subset of patients (40%) fail to respond to therapy. A further 30% of patients in remission lose response, necessitating the need for cycling through numerous therapeutic options. Subsequently, this increases the risk of adverse events and imposes a significant financial burden. More importantly, long term unabated inflammation also increases the risk of disease-associated long-term complications including strictures, fistulas, perforations and colorectal cancer. The rapid introduction of novel agents into treatment algorithms coupled with lack of comparative data has complicated the management of IBD. While landmark clinical trials have delineated the efficacy and safety of novel biologics and small molecules, a collective analysis of data reveals a perceived therapeutic ceiling due to a plateau in the attainment of disease remission. The clinical and symptomatic heterogeneity of IBD is known to complicate patient management. This is attributed to varying disease location, disease behavior, age at disease onset, treatment status, presence of perianal disease and extra-intestinal manifestations. Modern transcriptomics have established the notion of heterogeneity in IBD pathogenic responses based on disease characteristics. Together this indicates a critical unmet need in the management of IBD. 

This Article Collection will aim to highlight cutting edge clinical research to optimize therapeutic and alternative adjunct modalities to improve clinical outcomes and quality of life for IBD patients. We encourage original research that focuses on the following:

• Comparing efficacy and safety in a variety of clinical situations to aid decision making in the therapeutic ladder.
• Comparing short-term and long-term outcomes associated with monotherapy and advanced combination therapy.
• Real world studies in refractory IBD cohorts.
• Ascertaining therapeutic outcomes and safety in the inpatient management of IBD.
• Studies informing therapeutic de-escalation strategies.
• Inform treatment strategies for patients with limited proctitis, ostomies, J-pouch and small bowel disease.
• Studies aiding surgical treatment selection with a focus on positioning of surgical therapy.
• Illustrating outcomes and safety associated with newer surgical techniques.
• Identifying optimal timing for surgery.
• Evaluating the role of dietary therapy as an adjunct measure for IBD.
• Assessing the impact of nutritional status on overall outcomes.
• Role of physical and psychological factors and disease flares to improve holistic treatment of IBD patients.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 30 June 2025.

Please submit your manuscript on our website, quoting the promo code SZAGF for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection. 

Guest advisor

Dr. Syed Adeel Hassan, University of Kentucky, USA

[email protected]

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Hormone Replacement Therapy in Aging - Benefits, Risks, and Clinical Considerations for Older Adults" in Clinical Interventions in Aging.

We are pleased to announce a new Article Collection in Clinical Interventions in Aging, dedicated to the game-changing role of hormone replacement therapy (HRT) in healthy aging and the management of age-related disorders.

For eligible patients, HRT has revolutionized aging-related healthcare, offering significant benefits in restoring hormonal balance, alleviating menopause and andropause symptoms, reducing osteoporosis and cardiovascular risks, and ultimately enhancing health span and quality of life for older adults.

Given the importance of HRT in aging medicine, Clinical Interventions in Aging invites submissions of original research articles, reviews, and perspectives exploring the mechanisms of action, clinical efficacy, safety, and real-world application of these transformative therapies.

The collection, edited by the Editor-In-Chief Prof. Nandu Goswami, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

While the call is open to receive manuscripts across the broad spectrum of HRT in aging medicine, the Editors are particularly interested in manuscripts highlighting the role of HRT for older adults in the following area, including but not limited to:

• Osteoporosis and sarcopenia – HRT’s impact on bone density, fall prevention, and frailty
• Cardiovascular and metabolic effects – HRT’s role in heart disease, diabetes, and inflammation
• Cognitive and neurological effects– HRT’s potential in Alzheimer’s disease and cognitive aging
• Long-term risks and monitoring – HRT’s potential risks in cancer and thromboembolism
• Mental health and quality of life – HRT’s impact on mood, depression, sleep, and sexual health
• Efficacy and safety – considerations in late initiation of HRT in older adults

Please submit your manuscript on our website. Submitting authors will be eligible for a 20% discount of the Article Publishing Charge by applying the following code at the point of submission RFPTL. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Sam Zhang at [email protected].

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submissions is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Innovative Care Models for Older Adults: The Role of Telehealth and Emerging Technologies" in Clinical Interventions in Aging.

The rapid growth in the older adult population is driving health care systems to adopt a wide range of technology-enabled solutions to deliver care to this segment of the population. This approach has transformed how older adults receive care by offering diverse benefits, including greater accessibility, improved chronic disease management, and enhanced satisfaction for both patients and caregivers. Timely interventions and reduced travel demands are especially valuable for individuals with mobility limitations or those residing in rural areas. However, despite these benefits, widespread adoption of digital solutions remains challenging. Overcoming hurdles and tailoring interventions to meet the unique needs of older adults are crucial. This Article Collection will highlight evidence-based research and innovative strategies that advance person-centered and high-quality care for older adults.

Older adults are increasingly using digital health technologies, such as telehealth, mobile health, patient portals, and wearable devices.¹ However, some older adults still face barriers in adopting technology-enabled care that can lead to inequities. Barriers include challenges in learning or accessing new technologies, age-related biases, and difficulty using technologies that are not designed to support patients with age-related issues such as cognitive decline or sensory impairments.²

To address these gaps, health care providers and health systems must ensure that technology-enabled care meets the needs of older adults and addresses the barriers they face. The Principles and Guidelines for Telehealth and Aging offer a roadmap for delivering telehealth in ways that are person-centered, equitable, accessible, integrated, and coordinated.³ Beyond telehealth, the same principles can guide broader technology-enabled care strategies to ensure solutions are tailored to the unique needs of older adults, leading to improved care delivery and outcomes.

This Article Collection for Clinical Interventions in Aging seeks submissions that explore how technology-enabled care can be delivered to older adults in ways that meet their needs and that are person-centered, equitable, accessible, integrated, and coordinated. We welcome evidence-based research, interventions, and insights highlighting solutions that overcome barriers to technology adoption and improve clinical outcomes in aging populations. Potential topics include:

• Evidence-based virtual and hybrid care models that expand health care access for older adults in underserved areas
• Innovative digital health tools designed to address age-related health challenges
• Advanced technologies that facilitate data exchange across electronic health records, improving care coordination for older adults with complex needs
• Caregiver integration tools that enhance support for older adults, particularly those experiencing cognitive decline

The goal of this Article Collection is to provide actionable insights that advance effective, equitable care practices to improve health and quality of life for older adults.

Sources

1. James CA, Basu T, Nallamothu BK, Kullgren JT. Use of digital health technologies by older US adults. JAMA Network Open. 2025;8(1).

2. Leff B, Ritchie CS, Rising KL, Cannon K, Wardlow L. Addressing barriers to equitable telehealth for older adults. Frontiers in Medicine. 2025;12.

3. Wardlow L, Leff B, Biese K, et al. Development of telehealth principles and guidelines for older adults: A modified Delphi Approach. Journal of the American Geriatrics Society. 2022;71(2):371-382.

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 30 November 2025.

Please submit your manuscript on our website, quoting the promo code ENBIV for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Sam Zhang at [email protected] with any queries.

Guest Advisors

Dr. Liane Wardlow, PhD, West Health Institute

[email protected]

Liane Wardlow, PhD, is the Senior Director of Clinical Research and Telehealth at the West Health Institute. With 20 years of experience in research across various disciplines, industries, and organizations, Dr. Wardlow has contributed to initiatives at the U.S. Department of Education’s Institute of Education Sciences, the University of California, San Diego’s Alzheimer’s Disease Research Center, Pearson Education, and now the West Health Institute. Her current research focuses on improving health service delivery to enhance the lives of older adults. This includes optimizing care-in-place models, such as telehealth, home-based primary care, home-based palliative care, and Programs of All-Inclusive Care for the Elderly (PACE). These healthcare delivery models aim to improve health outcomes, quality of life, and care experiences while reducing costs and enabling older adults to age in place with dignity.

Dr. Laurie Archbald-Pannone, MD, MPH, University of Virginia

[email protected]

Laurie Archbald-Pannone, MD, MPH, serves as the Claude Moore Associate Professor of Geriatrics, as well as in Infectious Diseases, at the University of Virginia School Of Medicine. As a geriatrician and infectious disease specialist with extensive experience in geriatric medicine and facility-based infection control and prevention, Dr. Archbald-Pannone has over 15 years of clinical and research expertise in the post-acute and long-term care setting (PALTC). She serves as an invited member of the Virginia Department of Health's Long-Term Care Advisory Task Force and, with funding support from VDH, serves as the medical director of the Virginia IMPACT. She is actively involved in medical education, currently serving as College Dean for Student Affairs at the University Of Virginia School Of Medicine.

Dr Suzanne M. Gillespie, MD, University of Rochester School of Medicine and Dentistry

[email protected]

Suzanne Gillespie, MD, is a geriatrician and Certified Medical Director. She is an Associate Professor of Medicine in the Division of Geriatrics and Aging at the University of Rochester School of Medicine and Dentistry and the past president of the Society for Post-Acute and Long-Term Care Medicine.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Perioperative Management and Integrated Surgical Care for Older Adults" in Clinical Interventions in Aging.

Global populations are aging. With this, comes increasing incidence of neoplastic and degenerative disease, as well as traumatic injuries sustained because of falls from standing height. Surgical management is the mainstay of management for these conditions. However, this is complicated by such multimorbidity and frailty in older populations. This can contribute to high complications rates and adverse outcomes, including mortality. Frailty has been shown to be associated with such outcomes across a whole host of surgical specialties and settings. However, interventions to influence adverse outcomes in frail older surgical patients have not been widely studied. Evidence is needed to inform best practice, permit guideline development, and improve health and social outcomes for older people with surgical pathologies.

Health economies globally are facing substantial financial crises in the current climate; there is therefore an absolute need to deliver efficient and cost-effective care, that minimizes bed occupancy and healthcare consumption. There is insufficient research to currently guide best practice in several surgical specialties and pathologies. Although examples have been set in the field of orthopedics, there is a clear need to research whether similar models of care and interventions have efficacy in other surgical arenas.

The sustainability of healthcare in the context of an aging population is absolutely dependent on maximizing safety and efficiency, minimizing harm, whilst still providing equal access for older people, who should not be discriminated against on the basis of age alone. This Article Collection calls for papers that contribute to global knowledge in this field. We welcome any submissions relating to the perioperative and surgical care of older people, which show clinical or socioeconomic benefit over conventional practice.

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 1 August 2025. 

Please submit your manuscript on our website, quoting the promo code LAJJN for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisors

Dr. Frances Rickard, Southmead Hospital, North Bristol NHS, Bristol, United Kingdom

[email protected]

Dr. Rickard is a Consultant Physician and Perioperative Geriatrician at Southmead Hospital in Bristol

Dr. David Shipway, Southmead Hospital, North Bristol NHS, Bristol, United Kingdom

[email protected]

Dr. Shipway is a Consultant Physician and Perioperative Geriatrician at Southmead Hospital in Bristol. He is also a Senior Clinical Lecturer with the University of Bristol. 

Dr. Margot Lodge, Alfred Health/Monash University

[email protected]

Dr. Lodge is a consultant geriatrician at Alfred Health. She is an adjunct research fellow at Monash University.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Understanding Physical Functioning in Older Adults – New Approaches and Novel Interventions" in Clinical Interventions in Aging.

As older adults age, physical function declines. However, age-related decline happens at different rates for different individuals. Understanding risk factors for physical decline and mechanisms underlying this age-related decline is critical so that targeted interventions can be developed to prevent mobility disability. There is interest in understanding the biologic factors related to mobility decline, and how those relate to other functional capacities, especially cognitive. The contribution of sensory information to mobility function is increasingly appreciated. Multimorbidity and frailty are also significant factors influencing physical function in older adults. Systems-level factors, such as social determinants of health, can also impact risk for mobility disability.

Maintaining physical function is an important component of healthy aging that impacts older adults’ quality of life, their ability to remain independent, and their overall health. New approaches are needed to examine the multifactorial mechanisms influencing age-related physical decline on both an individual and systems-level. Novel interventions to prevent mobility disability or improve physical functioning can make a significant impact on not only physical health but overall well-being.

This Collection will accept original research, review articles, short reports, expert opinion, and clinical trial reports that cover a range of topics on physical function in older adults. Articles can discuss individual level and systems-level factors that increase risk for physical dysfunction or mobility disability, explore the geroscience hypothesis as it relates to mobility decline, and identify biochemical pathways and novel targets to prevent sarcopenia. The connection of mobility with other systems, such as sensory or cognitive, in older adults is of interest. In addition, both clinical trials and small pilots that test new interventions are welcome.

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 31 July 2025.

Please submit your manuscript on our website, quoting the promo code XSMQJ for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Sam Zhang at [email protected] with any queries.

Guest Advisor

Dr. Atalie C. Thompson, MD, MPH, Wake Forest Baptist University School of Medicine

[email protected]

Atalie C. Thompson, MD, MPH is a clinician scientist and board certified ophthalmologist with fellowship training in glaucoma whose research focuses on the relationship of the visual system to aging and novel methods for early detection of age-related eye diseases. She completed her undergraduate studies at Harvard College, received a fellowship to complete a masters degree in public health from University of California, Berkeley, and received her medical degree from Stanford Medical School. She finished her residency, clinical fellowship in glaucoma and a research fellowship at Duke University Eye Center. She has received funding from the National Insitutes of Health, American Glaucoma Society, the Doris Duke Charitable Foundation and the OAIC Pepper Center. She currently serves as the Vice Chair of Research for the Department of Ophthalmology at Atrium Health Wake Forest Baptist and has a co-appointment in Gerontology and Geriatric Medicine.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advances in Intraocular Lenses" in Clinical Ophthalmology.

We recently celebrated 75 years of intraocular lenses (IOLs), which were first implanted by Sir Harold Ridley in 1949. Refractive cataract surgery continues to evolve rapidly, with new surgical technologies constantly emerging. The advanced optics of premium IOLs not only enhance the patient's quality of vision but also their overall quality of life and independence from glasses. 

Artificial intelligence has introduced a new generation of formulas that provide exceptionally accurate IOL power calculations. By understanding the design philosophies and clinical performances of newer IOLs, we can better guide patients toward achieving optimal visual outcomes tailored to their specific vision needs. 

Recent advancements have led to significant improvements in intermediate vision through the use of trifocal IOLs, extended depth of focus (EDOF) IOLs, monofocal-plus IOLs, light adjustable lenses (LAL), and toric IOLs. These options have improved visual acuity for many patients and resulted in a high level of satisfaction. 

Despite the many articles published on IOLs, important challenges remain in synthesizing clinical evidence. Common issues include meta-analyses comparing lens categories with only one or a few lenses per category, inconsistent publication of results, a lack of secondary analyses segmented by biometric data that could enhance selection criteria, and insufficient long-term results. Moreover, new IOLs and variations of existing IOLs are launched each year, which require clinical evidence to develop evidence-based recommendations for their use. 

This Article Collection aims to provide readers with the latest advancements and current knowledge in IOLs. We welcome original research and review articles (including meta-analyses and systematic reviews) related to the suggested topics, though submissions are not limited to these areas:

• Outcomes of newer IOLs, focusing on secondary endpoints such as defocus curves, contrast sensitivity, and patient-reported outcomes
• Advanced IOLs, including trifocal IOLs, EDOF IOLs, monofocal-plus IOLs, LAL, toric IOLs, and any emerging options
• Design features related to IOL construction and fixation sites; materials used for optics, filters, and haptics
• Outcomes of supplementary (piggyback) IOLs, customized IOLs, and secondary IOLs
• Considerations for IOLs used in the pediatric population
• Advancements in IOL power calculation
• Innovations in the field of refractive cataract surgery and IOLs

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code DXQSW for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

The manuscript submission deadline is 1 November 2025. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest adviser

Dr. Mithun Thulasidas, Trinity Eye Hospital, Kerala, India

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Emerging Trends in Digital Ophthalmology and Social Media" in Clinical Ophthalmology.

The prevalence of social media use globally has resulted in a profound shift in how patients access and interact with health information. Studies show that 75% of patients turn to social media as their first resource for health-related inquiries. This trend has led many to use online information as a substitute for professional consultations. 

New digital and AI-based technologies have also broadened patients' understanding of and access to eye health screening and treatment modalities. Increased digital access to health information can have a significant influence on patients' health-related behaviors, whether positively or negatively. All of this underscores a concerning gap in the professional oversight of health-related content obtained via these platforms. 

More research is needed to evaluate digital platforms and the type of ophthalmology content trending online (including the prevalence of misinformation) in order to optimize patient education and encourage practices that promote eye health. 

Misinformation amongst ophthalmology-related content on social media is rampant. The medical community has been slow to leverage social media as a tool for health education. Although 70% of physicians are active on social media, only a small fraction—around 10%—are involved in content creation. This disparity highlights a missed opportunity for clinicians to provide evidence-based, reliable health information to a vast audience, especially in the face of widespread misinformation online. 

Given these dynamics, it is important for ophthalmologists to better understand emerging digital technologies, social media usage, and trending online topics in the eyecare space to improve patient education and guide patients toward more informed decision-making. 

This Article Collection will explore the intersection between digital platforms and eye care. Key areas include the impact of social media on public awareness of eye health, the role of online communities in supporting patients with ocular diseases, and the effectiveness of social media campaigns in promoting preventive eye care. 

This Article Collection will also focus on the accuracy of health information shared online, as well as misinformation and its effects on patient behavior and treatment outcomes. 

Subtopics may include, but are not limited to: 

• The use of telemedicine and virtual consultations in ophthalmology.
• The engagement of ophthalmologists in social media content creation.
• Ethical considerations regarding patient privacy and professional conduct in digital spaces.
• The influence of social media on medical education.
• The adoption of new digital technologies within the field of ophthalmology. 

Both original research and review articles are welcome.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code EOQPN for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

The manuscript submission deadline is 1 November 2025. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest adviser

Dagny Zhu, MD, NVISION Eye Centers, Rowland Heights, California, USA

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Femtosecond Laser in Lens Surgery: Contribution to Emmetropia" in Clinical Ophthalmology.

The achievement of emmetropia has been one of the oldest dreams in ophthalmology. This goal involves the correction of any refractive error, and by extension, age-related presbyopia. It is also presently established that lens surgery holds the title of the best available and definitive technique to address presbyopia correction, whether in the presence of a cataract or a transparent crystalline lens. In this quest, femtosecond laser technology arose, enabling competing indexes of reproducibility, precision, efficacy, and customization regarding the several steps involved in lens surgery. The present Article Collection will serve the purpose of providing further illumination on the role of femtosecond laser in lens surgery and stimulating new developments of this technology. 

The advent of premium IOLs in the context of refractive lens exchange has triggered demands for a higher standard of surgical procedure; hence the concept of premium lens surgery. Cataract surgery itself has shifted goals in the direction of the best refractive correction. Independency of spectacles by means of surgical intervention has become the desire of an increasingly significant part of the population. The high levels of reproducibility and customization of femtosecond laser-assisted technology are liable to open new horizons in the domain of refractive lens surgery. 

Topics of interest include: 

• Approaches to the different types of femtosecond laser (fs) pulse energy pattern (low or high) reporting their similarities and differences in all kinds of outcomes.
• Reviews (preferably systematic) and/or meta-analyses on the subject with well-defined references to the studied fs platform(s).
• Emphasis on the refractive outcomes of femtosecond laser-assisted lens surgery, either in the context of cataract or, preferably, refractive lens exchange.
• New incomes to premium lens surgery, in the context of femtosecond laser lens surgery, such as Artificial Intelligence (AI).
• Further developments on fs technology as to permit “zero” phaco, i. e., the feasibility of femtosecond machine’s full autonomy.
• Improvements on fs platforms (portability) and cost-effectiveness strategies.
• The birth of new premium IOLs, as thrusted by fs technology.

We welcome original research articles, reviews, editorials, commentaries, clinical trial reports, and protocols. Please note that all meta-analyses require a pre-submission check. Complete the pre-submission check form before submitting.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code PCKXI for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

The manuscript submission deadline is 1 November 2025. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest advisers

Dr. Ramiro Salgado, NewClinics, Porto, Portugal 

Prof. Antonio A. P. Marinho, Hospital Luz Arrabida, Portugal 

Prof. Dr. Alireza Mirshahi, Dardenne Eye Hospital, Bonn, Germany

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Translating Science to Practice in Uveitis: A Step-by-Step Clinical Guide Across the Disease" in Clinical Ophthalmology.

Uveitis represents a diverse group of intraocular inflammatory diseases affecting both children and adults. It remains a leading cause of preventable vision loss worldwide, with varied presentations, etiologies, and systemic associations that pose significant clinical challenges. This Article Collection aims to serve as a comprehensive, step-by-step guide for clinicians managing uveitis across its full spectrum—from diagnosis to long-term care. As diagnostic technologies and therapeutic options evolve, there is a growing need for practical, evidence-based frameworks that support real-world clinical decision-making. The increasing use of multimodal imaging, laboratory investigations, systemic screening, and artificial intelligence (AI) tools has transformed the approach to uveitis. Pediatric uveitis, in particular, demands special attention due to its unique disease patterns, treatment challenges, and impact on long-term visual outcomes. This Collection seeks to translate emerging science into accessible clinical practice, enabling better patient care across various healthcare settings. 

This Article Collection is developed in partnership with Clinical Ophthalmology and the PROTON (Program for Ocular Inflammation and Infection Translational Research) Group, a global network dedicated to advancing ocular inflammation research and implementation. PROTON connects clinician-scientists and researchers to promote multidisciplinary, translational approaches. We invite submissions including original research, clinical reviews, diagnostic and treatment algorithms, expert consensus guidelines, pediatric-focused studies, and innovations in digital health and AI. Contributions spanning infectious and non-infectious uveitis, anterior to posterior involvement, systemic associations, imaging, therapeutics, and multidisciplinary care models are encouraged. 

Topics may include, but are not limited to: 

• Infectious and non-infectious uveitis
• Anterior to posterior disease
• Pediatric uveitis
• Multimodal imaging
• Systemic workup strategies
• Biologics and small molecules
• Long-term monitoring tools

Contributions from ophthalmologists, rheumatologists, immunologists, pediatric specialists, and data scientists are especially welcome. Together, we aim to curate a pragmatic, high-impact, and forward-looking resource that enhances clinical practice and patient care in uveitis across all age groups and disease severities.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code 790D1 to indicate that your submission is for consideration in this Article Collection. Please note that normal Article Processing Charges will apply.

The manuscript submission deadline is 15 February 2026. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest advisers

Prof. Rupesh Agrawal, Tan Tock Seng Hospital, Singapore

Prof. Vishali Gupta, Post Graduate Institution for Medical Education and Research, Chandigarh, India

Prof. Alejandra de-la-Torre, School of Medicine and Health Sciences Universidad Del Rosario, Bogota, Colombia

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Metabolic Syndrome and Cardiovascular Disease", organized by Guest Advisors Dr. Constantine E. Kosmas and Dr. Christina Kostara in Clinical Pharmacology: Advances and Applications. 

Metabolic syndrome (MetS) is characterized by a constellation of metabolic abnormalities, including obesity (especially central obesity), insulin resistance, hypertension, hypertriglyceridemia, and low levels of high-density lipoprotein cholesterol (HDL-C). Each of these metabolic abnormalities represents an independent risk factor for cardiovascular disease (CVD), and their combination significantly increases the risk of a spectrum of cardiovascular conditions, including microvascular dysfunction, coronary atherosclerosis and calcification, cardiac dysfunction, myocardial infarction, and heart failure. 

MetS is strongly associated with cardiovascular morbidity and mortality. Patients with MetS have a higher risk of developing CVD compared with those without MetS in the next 5–10 years, and the long-term CVD risk is even higher. While advances in understanding the etiology and consequences of MetS have been made, the underlying pathophysiologic mechanisms that conspire into the full spectrum of the observed MetS-associated cardiovascular pathologies remain insufficiently explained. 

This Article Collection aims to highlight current knowledge pertaining to the pathophysiological mechanisms underlying MetS-associated cardiovascular entities and the clinical phenotyping of metabolic syndrome, as well as the advanced research in drug development based on experimental or clinical research studies and the therapeutic interventions to reduce the cardiovascular burden of metabolic syndrome. We welcome submissions (original articles, reviews, or short communications) from clinical, translational, and basic research. 

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal's Aims and Scope and author submission instructions prior to submitting a manuscript. 

Keywords

• Metabolic Syndrome
• Cardiovascular Disease
• Therapeutic interventions
• Atherosclerosis
• Cardiovascular Risk factors

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 31 December 2025.

Please submit your manuscript on our website, quoting the promo code WPKNP for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisors

Dr. Constantine E. Kosmas, 2nd Department of Cardiology, National & Kapodistrian University of Athens, Greece

[email protected]

Constantine E. Kosmas, M.D., Ph.D., FACC, FACP is a Clinical/Academic/Non-Invasive Cardiologist and Clinical Lipidologist, currently serving as a Scientific Associate of the Lipid Clinic at the 2nd Department of Cardiology of the National and Kapodistrian University of Athens at the University General Hospital “ATTIKON”. 

He has served for a long time (2014-2023) as Director of Nuclear Cardiology and Lipid Clinic at a large private practice in New York (Cardiology Unlimited, P.C.). He has also served as Assistant Professor of Medicine at Icahn School of Medicine at Mount Sinai and Medical Director of Mount Sinai Advanced Cardiovascular Group, as well as Clinical Assistant Professor of Medicine at the Medical School of the University of Pennsylvania and at the Weill Medical College of Cornell University. Dr. Kosmas has also served as Director of Clinical Services and Associate Director of Nuclear Cardiology at Episcopal Hospital, Philadelphia, PA, as well as Acting Director of Coronary Care Unit at New York Hospital Queens, Flushing, New York. 

Dr. Kosmas holds Board Certifications in Internal Medicine and Cardiovascular Disease in the USA and Greece, as well as Board Certifications in Nuclear Cardiology and Clinical Lipidology in the United States. He has been extensively involved in teaching mid-level providers, students, medical residents, and cardiology fellows at several academic institutions in New York and Pennsylvania. He has also been extensively involved in cardiovascular clinical research with several publications in the medical literature and numerous lectures in academic institutions and national conferences, especially on lipid-related subjects. Dr. Kosmas has also served as a member of the American Board of Internal Medicine (ABIM)’s Cardiovascular Disease Item-Writing Task Force. In addition, he has served as a member of many Speaker Bureaus and Advisory Boards of several large international pharmaceutical companies. Dr. Kosmas is an active member of the Editorial Board as well as a Reviewer in several prestigious peer-reviewed medical journals.

Dr. Christina Kostara, Laboratory of Clinical Chemistry, Faculty of Medicine, School of Health Sciences, University of Ioannina, Greece

[email protected]

Christina Kostara is a Post-Doctoral Researcher in the Faculty of Medicine at the University of Ioannina, Greece.

Dr. Kostara’s main research interest focuses on the investigation of lipid profiling (Lipidomics) as a novel approach for the analysis of biological matrixes using high resolution nuclear magnetic resonance spectroscopy (NMR) combined with high throughput “omics” technologies.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection on “Laser Treatment of Benign Pigmented Lesions and Facial Rejuvenation” in Clinical, Cosmetic and Investigational Dermatology.

Benign pigmented lesions and facial rejuvenation are among the highest growing demands of patients in the field of cosmetic and aesthetic dermatology. Laser treatment uses light energy to improve facial flaws, including melasma, uneven pigmentation, and blemishes by stimulating collagen production. Although there are numerous options for treatment of both benign pigmented lesions as well as facial rejuvenation, the outcome is not always satisfactory for patients. 

Differentiating between the laser procedures that are backed by science from those derived by marketing is a very important mission to ensure patients have the best outcome. Collecting evidence-based materials from key opinion leaders and presenting it to practitioners is one way that we can complete this mission. 

Through this Collection of publications focusing on the available literature about laser treatment of benign pigmented lesions and facial rejuvenation, we aim to provide practitioners with an open access volume of work that will aid patient care and satisfaction. 

Review articles, clinical studies, and randomized control studies covering any topic related to laser treatment of benign pigmented lesions or laser assisted facial rejuvenation are welcomed to this Collection.

Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 01 December 2025.

Please submit your manuscript on our website, quoting the promo code 73CB8 to indicate that your submission is for consideration in this Article Collection. Please note that normal Article Processing Charges will apply.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "From Type 1 to Type 2 Diabetes and Obesity: The Impact of Continuous Glucose Monitoring (CGM) and Emerging Diabetes Management Technologies on Metabolic Health" in Diabetes, Metabolic Syndrome and Obesity.

Continuous glucose monitoring (CGM) is widely used in type 1 diabetes (T1D) to improve management and prevent dangerous fluctuations in blood glucose levels. While CGMs have long been a cornerstone of T1D care, their use is rapidly expanding beyond T1D into Type 2 diabetes (T2D) and obesity management, offering exciting possibilities for the future of diabetes care. In T2D, CGMs provide critical real-time insights into glucose fluctuations, helping patients make informed decisions about their diet, physical activity, and medication. This allows for more personalized, data-driven management, which has been shown to improve overall glycemic control and reduce the risk of complications. The true promise of CGMs, however, lies in their potential to reshape the way patients approach their health, particularly in T2D and obesity care. By offering continuous glucose feedback, CGMs help individuals better understand how their lifestyle choices - such as food intake, exercise, and stress—impact their glucose levels. This increased awareness encourages patients to make more mindful decisions and adapt their behaviors, fostering long-term, sustainable changes in their lifestyle. As individuals begin to see the direct impact of their habits on their metabolic health, they are empowered to take greater control over their condition, leading to better weight management and improved overall health outcomes. 

Looking ahead, CGMs and other emerging technologies hold the potential to revolutionize diabetes and obesity care. By providing real-time, actionable data, these technologies enable a more integrated and personalized approach to managing these conditions. This Article Collection gathers articles that explore the evolving role of CGMs and emerging diabetes management technologies in shaping the future of care for diabetes and obesity, highlighting their ability to improve patient outcomes through personalized, lifestyle-driven, and pharmacology-based interventions.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

Please submit your manuscript on our website. Submitting authors will be eligible for a 10% discount on the Article Publishing charge by entering the code B91B1.

The deadline for submitting manuscripts is 31 January 2026.

Guest Advisors

Dr. Emir Muzurovic, University of Montenegro, Montenegro

[email protected]

Emir Muzurovic (MD,PhD), a physician and researcher at the Department of Internal Medicine, Endocrinology Section, Clinical Centre of Montenegro, and the Faculty of Medicine, University of Montenegro, Podgorica, Montenegro. He works on advancing the management of diabetes and metabolic health, with a focus on integrating innovative medical technologies into clinical practice. His expertise spans endocrinology, metabolic disorders, and personalized patient care.

Prof. Manfredi Rizzo, University of Palermo, Italy

[email protected]

Prof. Manfredi Rizzo, MD, PhD, a physician and researcher specializing in internal medicine, diabetes, and cardiovascular prevention. He is Associate Professor at the University of Palermo and Head of both the Unit of Diabetes and Cardiovascular Prevention and the Cardiometabolic Research Laboratory. He is an active member of various scientific societies and has authored over 250 peer-reviewed publications, with a notable H-Index of 47.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Global Trends and Innovations in Type 1 Diabetes: Incidence, Management, and Beta-Cell Preservation" in Diabetes, Metabolic Syndrome and Obesity.

Concerns about the ongoing rise in Type 1 Diabetes (T1D) have been buoyed recently by exciting developments in approaches to easier, more effective management through automated insulin delivery and smart devices, as well as medication to delay T1D progression and use cell-based treatments—culminating in a true shift in the disease horizon. 

Given the importance of these shifts for the trajectory of the field of T1D and future management, Diabetes and Metabolic Syndrome invites submissions of original research articles, reviews, and perspectives exploring global shifts in epidemiology, pathophysiology, and transformative technology and cell-based management. 

This Collection focuses on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading improvements in patient outcomes. 

While the call is open to receive manuscripts across the broad spectrum of changes in T1D incidence and treatment, we are particularly interested in manuscripts relating to the following areas:

• Global incidence
• Technology-based management
• Treatment to prolong beta cell survival
• Cell-based treatments

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

Please submit your manuscript on our website, entering the promo code 2A26C to indicate that the paper is for consideration in this Article Collection. The deadline for submitting manuscripts is 28 February 2026.

Guest Advisor

Prof. Mark D. DeBoer, University of Virginia, USA

[email protected]

View all papers in this article collection

We are pleased to announce a new hot-topic Article Collection in Diabetes, Metabolic Syndrome and Obesity dedicated to the game-changing role of GLP-1 receptor agonists in type 2 diabetes and obesity. Since their clinical introduction, GLP-1 receptor agonists have revolutionized patient care, offering significant benefits in glycemic control, weight loss and management, and cardiovascular and renal diseases for eligible patients. 

Given the recognized importance of GLP-1 agonists in managing type 2 diabetes and obesity, and the accumulating new evidence showing several pleiotropic effects, Diabetes, Metabolic Syndrome and Obesity invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these transformative therapies. 

The Collection, edited by the Editor-In-Chief Professor Rebecca Conway and the Section Editor Professor Ernesto Maddaloni, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. 

While the call is open to receive manuscripts across the broad spectrum of GLP-1 agonists in managing type 2 diabetes and obesity, the Editors are particularly interested in manuscripts relating to the following areas:

• Obesity
• Diabetes complications, particularly cardiovascular disease, nephropathy, diabetic bone disease
• The brain (reduction in cognitive decline, addition) in diabetes
• Pediatric obesity and diabetes or type 1 diabetes

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

Please submit your manuscript on our website. Submitting authors will be eligible for a 20% discount on the Article Publishing charge by entering the code BOUZT.

The deadline for submitting manuscripts is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advances in design and development of ophthalmic drugs", organized by Guest Advisors Dr. Georgios D. Panos in Drug Design, Development and Therapy.

This Article Collection will focus on the latest advances in drug design and development for the treatment of various ophthalmic diseases and conditions.

Ophthalmic diseases, including glaucoma, age-related macular degeneration, diabetic retinopathy, and dry eye disease, are a significant public health concern, affecting millions of people worldwide. Despite the increasing availability of some effective treatments, there is still an unmet need for safe and even more effective drugs that can treat these conditions.

This Article Collection will bring together leading researchers and clinicians in the field to present their latest research on the design and development of ophthalmic drugs. Topics that will be covered in this special issue include but are not limited to:

- New drug delivery systems for ophthalmic drugs
- Advances in small molecule drug design and development for ophthalmic conditions
- Nanotechnology-based approaches for ocular drug delivery
- Pharmacokinetics and pharmacodynamics of ophthalmic drugs
- Design and development of sustained-release ophthalmic drug delivery systems
- Gene Therapy and novel biological therapies for the treatment of ocular diseases

We welcome submissions of original research articles and review articles that address any aspect of drug design and development for ophthalmic diseases. All submitted manuscripts will undergo a rigorous peer-review process to ensure the highest quality of the published papers.

This Article Collection will provide a valuable resource for researchers, clinicians, and pharmaceutical companies working in the field of ophthalmic drug design and development and will further advance the understanding of the current state of the art in ophthalmic drug research and help pave the way for the development of safe and effective treatments for ophthalmic diseases.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 30 June 2025.

Please submit your manuscript on our website, quoting the promo code CBTYJ for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Drug Design, Development and Therapy on "Advances in p53 Drug Discovery", organized by Dr. Andreas Joerger (Goethe University, Germany), Dr. Alexander Dömling (Palacky University in Olomouc, Czech Republic) and Editor-In-Chief Dr. Frank M. Böckler (Eberhard Karls University Tübingen, Germany).

Often referred to as the "guardian of the genome", p53 plays an important role in maintaining cellular homeostasis by regulating and orchestrating cell cycle arrest, DNA repair, apoptosis, and senescence. Mutations in the TP53 gene which encodes p53, are found in a broad range of human cancers, leading to loss of its tumor-suppressive functions and contributing to cancer progression and metastasis. In addition, some gain-of-function (GOF) p53 mutants can acquire new oncogenic activities affecting genomic instability, metabolic reprogramming, and the tumor microenvironment, while promoting invasion, metastasis, and cancer cell proliferation. The complexity of p53's structure and function, particularly its role as a transcription factor and its interactions with a large number of cellular signaling pathways, has made it a challenging target for drug discovery. However, recent advances in structural biology, computational methods, and medicinal chemistry have opened new avenues for the development of drugs that can restore or enhance p53 function, offering hope for more effective cancer therapies. Furthermore, additional targets, such as MDM2/X, HAUSP, Cop-1, Pirh-2, Wip-1, PTEN, AKT, and Siah-1, could become points of therapeutic intervention, influencing p53 and its signaling and regulation network.

Playing a core role in tumor suppression, the ability to modulate p53 activity holds the potential to transform cancer treatment. The development of drugs that can restore the function of mutant p53 or enhance the activity of wild-type p53 is a critical area of research with significant implications for improving patient outcomes and survival rates in cancer.

To help raise the profile of this important area of research, Drug Design, Development and Therapy is publishing a timely Article Collection on p53 drug discovery. The Collection is led by Dr. Andreas Joerger, Prof. Dr. Alexander Dömling, and the Editor in Chief, Prof. Dr. Frank Böckler. 

Potential topics include, but are not limited to, the following:

• Structural and Molecular Biology of p53 Elucidating its Therapeutic Value
• Small Molecule Modulators of Targets Involved in p53 Signalling and Regulation
• Rescue of Loss-of-function Mutant p53 or Restraint of Gain-of-function Mutant p53
• p53-targeted Gene / Immune Therapies
• Clinical Translation of p53-based Therapies
• Challenges and Future Directions

Please submit your manuscript on our website, using the promo code XITLT for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Advances in p53 Drug Discovery” Collection. We will be welcoming relevant papers up until the 31st of March 2026. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection. 

Guest Advisors

Dr. Andreas Joerger, Goethe University

[email protected]

Andreas C. Joerger obtained his doctoral degree from the University of Freiburg, Germany in 2000. He then assumed a postdoc position in the group of Prof. Sir Alan Fersht at the Medical Research Council (MRC) Centre for Protein Engineering in Cambridge, United Kingdom, initially working on protein design. He stayed on as a senior scientist in structural biology until 2010, before moving to the MRC Laboratory of Molecular Biology in Cambridge (2010-2015). During his long spell at the MRC, he made key contributions towards unraveling the complex structural biology of the tumor suppressor p53 and related proteins. He determined the first crystal structures of p53 cancer mutants, which led to the Y220C mutant being used as a paradigm for the development of mutant p53 rescue drugs based on protein stabilization. In 2016, Dr. Joerger joined the group of Prof. Stefan Knapp at the Institute of Pharmaceutical Chemistry at Goethe University, Frankfurt am Main. Since 2018, he is Principal Investigator on p53 drug discovery and transcriptional regulation at the Structural Genomics Consortium (SGC) Frankfurt. His other research interests include the evolutionary history of the p53 pathway, protein design, epigenetic targets and E3 ubiquitin ligases. 

Dr. Alexander Dömling, Palacky University in Olomouc

[email protected]

Alex Dömling studied Chemistry & Biology at the Technische Universitat Munchen (TUM). He performed his Ph.D. with Ivar Ugi and his postdoc – funded by a Feodor Lynen stipend from the Alexander von Humboldt Foundation – with double Nobel Laureate Barry Sharpless. After his habilitation at TUM, he became a professor at the University of Pittsburgh, then chair of the Department of Drug Design at the University of Groningen, and most recently ERA Chair at Palacky University. He also started several biotech companies. He is the author of over 300 publications and over 70 patent applications. His current lab works according to the mantra ‘Automation + Miniaturization = Acceleration’ on the ERC-funded project of engineering an autonomous drug discovery platform called AMADEUS.

Alexander Dömling is a world-renowned researcher in the area of miniaturization, automation of synthetic chemistry, and multicomponent reaction chemistry. Professor Dömling applies multicomponent reaction chemistry to solve problems in drug discovery and related areas. Notably, he introduced the Acoustic Droplet Ejection technology platform to perform precise high throughput synthetic chemistry and demonstrated its applicability to multiple different chemistries and chemical biology projects.

Dr. Frank M. Böckler, Eberhard Karls University Tübingen

[email protected]

At the Institute of Pharmaceutical Sciences, Frank Böckler heads the laboratory of Molecular Design & Pharmaceutical Biophysics, which combines Chemical Biology, Molecular and Structural Biology and Biophysics, as well as Computational Chemistry, Machine Learning and Molecular Design. In addition, he is a member of the Institute for Bioinformatics and Medical Informatics (IBMI). In 2004, he received his Ph.D. in Medicinal Chemistry with summa cum laude at Friedrich-Alexander University in Erlangen (Germany). Joining Prof. Sir Alan R. Fersht as a postdoc at the MRC Center for Protein Engineering in Cambridge/UK, he discovered p53 mutant stabilizers as potential new cancer therapeutics. In 2008, he was appointed Professor (W2tt) for Bioanalytics at Ludwig-Maximilians University (LMU) Munich, before moving to Tübingen in 2010 as a full professor. His work is dedicated to understanding molecular interactions, such as halogen and chalcogen bonds, as the foundation for chemical biology and drug discovery and to apply theoretical, fragment-based, biophysical, and structural methods to cancer research, particularly involving the human kinome and the network of the tumor suppressor p53.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Drug Design, Development and Therapy on "Exploring Fragment-Based Approaches in Drug Discovery", organized by Prof. Anna K. H. Hirsch (Saarland University, Germany), Dr. Walid A. M. Elgaher (Saarland University, Germany), Prof. Oliver Koch (Universität Münster, Germany) and Editor-In-Chief, Prof. Frank M. Böckler (Eberhard Karls University Tübingen, Germany).

With the emergence of fragment-based drug discovery (FBDD), the field of drug discovery has undergone significant changes. Unlike traditional high-throughput screening techniques, FBDD is based on identifying low molecular weight compounds (fragments) with a low affinity to the biological target. These initial fragment hits are then developed into drug-like molecules through a range of techniques, including fragment merging, growing, and linking, to produce a lead with a higher affinity.

FBDD has the capacity to streamline the drug discovery process by initiating a bottom-up process of combining fragments with high ligand efficiencies. Structural insights from X-ray crystallography have fostered hopes that fragments with strong local interaction networks could be extended to target a wider binding site, often boosting the affinity substantially. The method not only increases the probability of identifying active compounds compared to random screening but also allows an in-depth exploration of the chemical and biological space surrounding these fragments. In 2024, 52 fragment-derived candidates had made it to different phases of clinical studies (phase 1–3), while seven drugs (Asciminib, Capivasertib, Erdafitinib, Pexidartinib, Sotorasib, Vemurafenib, and Venetoclax) have already been approved. This highlights the great relevance and potential of this approach for drug discovery.

To help raise the profile of this important area of research, Drug Design, Development and Therapy is publishing a timely Article Collection on fragment-based drug discovery. The Collection is led by Prof. Anna K. H. Hirsch, Dr. Walid A. M. Elgaher, Prof. Oliver Koch, and Editor in Chief, Prof. Frank M. Boeckler.

Potential topics include, but are not limited to, the following:

• Advancements in Fragment Screening Techniques
• Specialized Fragment-Libraries and Library Design
• Structural Biology and Fragment-Based Design
• Chemical Biology and Fragment Evolution
• Case Studies and Success Stories
• Challenges and Future Directions

Please submit your manuscript on our website, using the promo code SODHO for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Advances in p53 Drug Discovery” Collection. We will be welcoming relevant papers up until the 30th of April 2026. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Prof. Dr. Anna K. H. Hirsch, Saarland University, Germany

[email protected]

Anna Hirsch read Natural Sciences with a focus on Chemistry at the University of Cambridge and spent her third year at the Massachusetts Institute of Technology, doing a research project with Prof. Timothy Jamison. She carried out her Master’s research project in the group of Prof. Steven V. Ley at the University of Cambridge. She received her Ph.D. from the ETH Zurich in 2008 and worked on the de novo structure-based design and synthesis of inhibitors for an anti-infective target enzyme in the group of Prof. François Diederich. Subsequently, she joined the group of Prof. Jean-Marie Lehn at the Institut de Science et d’Ingénierie Supramoléculaires (ISIS) in Strasbourg as an HFSP postdoctoral fellow, before taking up a position as assistant professor at the Stratingh Institute for Chemistry at the University of Groningen in 2010 where she was promoted to associate professor in 2015. In 2017, she moved to the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), where she heads the department for drug design and optimization. Her work focuses on anti-infective drug design by adopting rational approaches such as structure- and fragment-based drug design in combination with the target-guided strategies dynamic combinatorial chemistry and kinetic target-guided synthesis. 

Dr. Walid A. M. Elgaher, Saarland University, Germany

[email protected]

Dr. Walid A. M. Elgaher studied Pharmacy at Assiut University (Egypt). He was awarded a scholarship from the German academic exchange service (DAAD) for doctorate study in Germany. In 2016, he got his Ph.D. in Medicinal Chemistry under the supervision of Prof. Rolf W. Hartmann, Saarland University. He then returned to Egypt and was appointed as a Lecturer of Pharmaceutical Organic Chemistry at the Faculty of Pharmacy, Assiut University. In 2017, he joined the group of Prof. Anna K. H. Hirsch as a postdoctoral fellow at HIPS, and since 2024 has been a habilitand at Saarland University. His work focuses on the application of modern drug design approaches tackling un(der)exploited therapeutic targets and the use of biophysical and computational techniques for drug discovery and optimization. 

Prof. Dr. Oliver Koch, Universität Münster, Germany

[email protected]

Oliver Koch is Heisenberg-Professor of Computational Drug Discovery at the Institute of Pharmaceutical and Medicinal Chemistry, University of Münster. His interests lie in the development and application of computational methods in rational drug design with focus on ‘big data’ driven decisions and artificial intelligence combined with fragment- and structure-based design. The methods are applied to develop bioactive molecules and to understand selectivity, promiscuity and polypharmacology of protein-ligand interactions. In an interdisciplinary way, the in-silico work is combined with biochemical evaluation, x-ray crystallography and preparative organic synthesis. He received his Ph.D. in Pharmaceutical Chemistry in 2007 at Philipps-University Marburg in the group of Gerhard Klebe and also completed a postgraduate program computer science with focus on machine learning and data science. He worked as a postdoc at CCDC in Cambridge/UK and afterwards for MSD Animal Health Innovation GmbH, Schwabenheim, Germany. In 2012, he became an Independent Junior Group Leader of „In-silico Medicinal Chemistry“ at Technical University Dortmund, Germany. From 2019-22 he was Independent Group Leader for “Computational Medicinal Chemistry and Molecular Design” at University of Münster, where he became a Heisenberg-Professor for Computational Drug Discovery in 2022. 

Prof. Dr. Frank M. Böckler, Eberhard Karls University Tübingen

[email protected]

At the Institute of Pharmaceutical Sciences, Frank Böckler heads the laboratory of Molecular Design & Pharmaceutical Biophysics, which combines Chemical Biology, Molecular and Structural Biology and Biophysics, as well as Computational Chemistry, Machine Learning and Molecular Design. In addition, he is a member of the Institute for Bioinformatics and Medical Informatics (IBMI). In 2004, he received his Ph.D. in Medicinal Chemistry with summa cum laude at Friedrich-Alexander University in Erlangen (Germany). Joining Prof. Sir Alan R. Fersht as a postdoc at the MRC Center for Protein Engineering in Cambridge/UK, he discovered p53 mutant stabilizers as potential new cancer therapeutics. In 2008, he was appointed Professor (W2tt) for Bioanalytics at Ludwig-Maximilians University (LMU) Munich, before moving to Tübingen in 2010 as a full professor. His work is dedicated to understanding molecular interactions, such as halogen and chalcogen bonds, as the foundation for chemical biology and drug discovery and to apply theoretical, fragment-based, biophysical, and structural methods to cancer research, particularly involving the human kinome and the network of the tumor suppressor p53.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Drug Design, Development and Therapy on "Modern Computational Approaches for Drug Design and Discovery", organized by Dr. Tamer M Ibrahim Abdelrehim (Kafrelsheikh University, Egypt), Dr. Muzammal Hussain (New York University, USA), Dr. Ahmed Elkerdawy (University of Lincoln, UK) and Editor-In-Chief Dr. Frank M. Böckler (Eberhard Karls University Tübingen, Germany).

Computer-aided drug design (CADD) is a fundamental component of contemporary drug discovery. CADD methods are generally divided into two main categories: Structure-Based Drug Design (SBDD) and Ligand-Based Drug Design (LBDD). The swift advancements in crystallography and homology modeling have greatly improved structure-based virtual screening, facilitating the effective identification of potential drug candidates in the initial stages of drug discovery. Furthermore, the rise in accessible computational power has enhanced the implementation of traditional in silico drug design and discovery methods, allowing for the rapid screening of extensive chemical libraries. CADD methods have garnered significant attention due to their ability to expedite drug discovery while reducing time, labor, and costs. They have emerged as a crucial driving force in drug discovery across both academic and industrial sectors.

Recently, this field has experienced remarkable advancements, largely fueled by the progress of artificial intelligence (AI) including both machine learning and/or deep learning in drug discovery initiatives. The increasing availability of experimental data has facilitated the creation of highly precise AI models, which have a wide range of applications, including predicting the pharmacological activities of molecules, conducting ADME/T profiling, and forecasting molecular properties.

This Collection seeks to gather the most recent advancements in the development and application of computational methods for drug design and discovery, along with their application in preclinical research. We invite submissions from all relevant fields of study, including but not limited to:

• de novo drug design

• lead optimization

• virtual screening methodologies

• AI models to predict molecular activities/properties

• ADME/T property prediction

The collection is primarily open to original research articles, as well as reviews and perspectives.

The deadline for submissions is 31 October 2025. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code EPTVR for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection. Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest advisors

Dr. Tamer M Ibrahim Abdelrehim, Kafrelsheikh University

[email protected]

Tamer M. Ibrahim Abdelrehim is an Associate Professor of Pharmaceutical Chemistry in the Faculty of Pharmacy, Kafrelsheikh University, Egypt. Prof. Abdelrehim’s research interest includes enhancing the performance of Structure-Based Virtual Screening workflows and fighting infectious diseases using Computer-Aided Drug Design (CADD) methodologies, and Medicinal Chemistry synthesis approaches. 

Dr. Muzammal Hussain, New York University

[email protected]

Muzammal Hussain is currently a Postdoctoral Fellow at the New York University Grossman School of Medicine, where his research focuses on targeted protein degradation and drug discovery aimed at addressing challenging disease targets. His interests include structure-based drug design, modeling and analysis of ligand-protein interactions, phenotypic and virtual drug screening, and investigating drug mechanisms and signaling pathways. 

Dr. Ahmed Elkerdawy, University of Lincoln

[email protected]

Dr. Ahmed Elkerdawy earned his doctoral degree from the University of Erlangen–Nuremberg - Germany with a specialization in Computer-aided Drug Design (CADD) in the Computer-Chemistry-Centre (CCC) research group. Dr. Elkerdawy has a unique blend of experiences in synthetic chemistry and CADD. He published more than 70 papers dealing with using computer-aided drug design approaches for lead discovery and lead optimization for new targets in the treatment of serious health problems like cancer, Alzheimer’s, and inflammation. 

Dr. Frank M. Böckler, Eberhard Karls University Tübingen

[email protected]

At the Institute of Pharmaceutical Sciences, Frank Böckler heads the laboratory of Molecular Design & Pharmaceutical Biophysics, which combines Chemical Biology, Molecular and Structural Biology and Biophysics, as well as Computational Chemistry, Machine Learning and Molecular Design. In addition, he is a member of the Institute for Bioinformatics and Medical Informatics (IBMI). His work is dedicated to understanding molecular interactions, such as halogen and chalcogen bonds, as the foundation for chemical biology and drug discovery and to apply theoretical, fragment-based, biophysical and structural methods to cancer research, particularly involving the human kinome and the network of the tumor suppressor p53.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Drug, Healthcare and Patient Safety on "Medication Safety in Geriatric Populations". The Collection is led by the Editor-in-Chief, Professor Rajender Aparasu.

With the increase in older adults globally, there is a greater need to understand medication safety issues, as older adults are often excluded in randomized trials. In addition, the complexity of chronic care for older adults often leads to polypharmacy and potentially inappropriate medication use, which can result in drug-induced diseases, adverse drug reactions, drug interactions, cognitive impairment, falls, hospitalization, and mortality. This Article Collection aims to address these challenges by bringing together the latest research and clinical insights to improve medication safety in geriatric populations.

Medication safety is crucial in geriatric populations due to the increased susceptibility of older adults to adverse drug reactions and the potential for drug interactions. The aging process can alter pharmacokinetics and pharmacodynamics, making older adults more prone to medication-related problems. Ensuring medication safety in this vulnerable population is essential to prevent medication-related morbidity and mortality and associated healthcare burden such as hospitalization, healthcare costs, and health-related quality of life for older adults.

To help raise the profile of this important area of research, Drug Healthcare and Patient Safety is publishing a timely Article Collection on medication safety in geriatric populations.

Potential topics include, but are not limited to, the following:

1. Medicated-related problems in older adults

2. Polypharmacy and Medication Management

3. Inappropriate Medication Use

4. Drug-drug and Drug-disease Interactions

5. Prescribing Cascade and Deprescribin

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 31 December 2025.

Please submit your manuscript on our website, quoting the promo code IXNYV for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

We are pleased to announce a new Article Collection in HIV/AIDS - Research and Palliative Care, dedicated to the transformative role of pre-exposure prophylaxis (PrEP) in HIV prevention. Since its clinical introduction, PrEP has revolutionized HIV care, providing significant benefits in preventing transmission, enhancing prevention confidence, and reducing anxiety for at-risk populations.

Given the global importance of PrEP, HIV/AIDS - Research and Palliative Care invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of this transformative strategy.

The collection, edited by Editor-In-Chief Professor Olubunmi Akindele Ogunrin, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of PrEP in HIV prevention, the Editors are particularly interested in manuscripts relating to the following areas:

• Agents in PrEP strategy
• Delivery models
• Target populations
• Barriers and support
• Education, acceptability, adoption, adherence and retention

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 1 April 2026.

Please submit your manuscript on our website. Submitting authors are eligible for a 20% discount on the Article Publishing charge by applying the following code at the point of submission F4375. 

If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor at [email protected].

Guest Advisors

Olubunmi Akindele Ogunrin, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Stigma and discrimination in HIV prevention and care" in HIV/AIDS - Research and Palliative Care.

Despite the biomedical advancements in HIV prevention and treatment, and evolving public discourse on sexuality, HIV-related stigma persists, posing a significant challenge to the quality of life and mental health of people living with HIV (PLHIV). In the current context, marked by new prevention methods, innovative treatments, and a complex interplay with conservative political landscapes, novel forms of stigma and discrimination emerge, impacting both prevention and treatment efforts.

This Article Collection aims to examine the complex effects of HIV-related stigma, encompassing a myriad of forms, on the treatment and care of PLHIV. This Collection invites contributions from a variety of perspectives, including but not limited to, examinations of the effects of stigma and discrimination on PLHIV, particularly in terms of health outcomes, barriers to treatment, and strategies to overcome them. We welcome studies exploring how gender identity, sexual orientation, ethnicity, socioeconomic status, and other socioeconomic variables, modulate HIV-stigma experience and both mental and physical health outcomes among different populations and contexts. We are also interested in research on interventions and policies that aim to reduce HIV-related stigma and discrimination, and improve the mental health and well-being of PLHIV through capacity building and social inclusion. Additionally, we welcome articles that develop instruments to assess HIV-related variables, including stigma, adherence to treatment, knowledge, and attitudes.

In line with this publication's commitment to high standards and a global approach, we will seek to ensure that published articles represent diversity in international contexts, disciplinary approaches, and contributors, with particular focus on the Global South and underrepresented populations. Our objective is to promote a worldwide discussion regarding the effects of stigmatization of individuals living with HIV, enabling readers to understand the intricacies of health inequalities that emerge in diverse settings and populations.

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 31 January 2026.

Please submit your manuscript on our website, quoting the promo code WKFVI for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Zhiyuan Zhang at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Angelo Brandelli Costa, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Brazil; John Cabot University, Italy
Psychologist. Professor at the Pontifical Catholic University of Rio Grande do Sul (PUCRS), Brazil and John Cabot University, Rome. Researches and publishes extensively on social psychology, particularly in areas like prejudice, discrimination, and LGBTQ+ psychology. Has a strong academic presence and is recognized for his work in these fields.

Guilherme W Wendt, Federal University of Rio Grande do Sul (UFRGS), Brazil
Psychologist. Professor at the Federal University of Rio Grande do Sul (UFRGS), Brazil. Researches and publishes in the areas of clinical psychology, psychoanalysis, and gender studies. Has a strong academic background, and is known for his work related to gender and sexuality.

Henrique Pereira, University of Beira Interior, Portugal
Clinical Psychologist, specialist in Clinical and Health Psychology and Sexology, and Full Professor of Clinical Psychology and Sexuality at the University of Beira Interior - UBI, Covilhã (Portugal), Department of Psychology and Education. Holds a doctorate in Clinical Psychology, and a Master’s degree in Health Psychology. Develops work and research in the fields of Psychology, Sexuality, Health, Human Development and Aging.

Felipe Alckmin-Carvalho, University of Beira Interior, Portugal
Clinical Psychologist. Holds a Doctorate in Clinical Psychology (University of São Paulo, Brazil). Currently a Visiting Assistant Professor in the Department of Psychology and Education at the University of Beira Interior, Covilhã, Portugal, where he is also a post-doctoral researcher. Develops work and research in the fields of Health Psychology, HIV/AIDS, Stigma and Sexuality.

View all papers in this article collection

Immunotargets and Therapy is pleased to invite you to submit your research to its latest Article Collection on "Autoimmune Disease.” The Collection, led by Editor-In-Chief Professor Michael Shurin, welcomes relevant Reviews, Original Research and Editorials up until the 1st July 2025. The Collection promises to be a valuable resource for years to come, with articles published alongside some of our finest hot-topic reviews.

Please submit your manuscript on our website, using the promo code ZFWRR for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Autoimmune Diseases” Collection.

Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

While the call is open to receive manuscripts across the broad spectrum of autoimmune diseases, the Editors are particularly interested in manuscripts relating to these key areas:

• Natural Autoantibodies
• Autoimmune disorders: New epidemiological data
• Pathophysiology of autoimmune diseases
• Novel diagnostic and therapeutic approaches for autoimmune disorders
• Therapeutic targeting of autoantibodies
• Clinical utilization of autoantibodies
• Regulatory immune cells for the treatment of autoimmune diseases
• Autoantigenomics
• AI in autoimmunity

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Pathogenesis and Therapy of CNS Immune-Mediated Diseases" in ImmunoTargets and Therapy.

Central nervous system (CNS) immune-related diseases include a broad range of conditions whereby the immune system abnormally targets the brain, spinal cord, or other neuronal tissues. The origin of these diseases can be autoimmune, inflammatory, infectious, or paraneoplastic. Autoimmune conditions include epilepsy, multiple sclerosis (MS), myelin oligodendrocytes antibodies associated disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), autoimmune encephalitides, and acute disseminated encephalomyelitis (ADEM). Inflammatory conditions can include epilepsy, primary angiitis of the CNS and secondary CNS vasculitis. Paraneoplastic neurological syndromes comprise of limbic encephalitis and cerebellar ataxia. Infectious or post-infectious diseases consist of cerebellitis and progressive multifocal leukoencephalopathy The underlying mechanisms of the these conditions include T-cell-mediated damage, antibody-mediated injury, microglial activation and blood-brain barrier (BBB) disruption Therapies for these conditions include immunosuppressants (steroids, rituximab, cyclophosphamide), plasma exchange, intravenous immunoglobulin as well as disease-modifying therapies such as ocrelizumab, tociluzumab and natalizumab. 

Studying CNS immune-related diseases is critically important for several reasons. These diseases have high disease burden and poor outcomes; they cause severe disability, chronic pain, cognitive decline and even death. They affect children, young and middle-aged adults mostly, leading to significant socioeconomic impacts due to loss of work force and long-term dependency. These conditions have complex and poorly understood mechanisms. Understanding the underlying mechanisms can reveal new therapeutic targets. There is a limited treatment options and the available ones are expensive. Most of the available therapies such as steroids, immunosuppressants and monoclonal antibodies have serious side effects. Of concern, some patients are treatment-resistant, underscoring the need for exploring precision medicine approaches. Exploring CNS immunity can reveal how the brain interacts with peripheral immune cells, which can be applied to other conditions. In a nutshell, this topic is essential to pave the way for the development of the safer therapies and uncover fundamental brain-immune interactions that could transform treatment for neurological diseases. 

Although the Collection is open to receiving manuscripts across the broad spectrum of central nervous system (CNS) immune-related diseases, the Editors are principally interested in manuscripts relating to the mechanisms and/or treatment of these conditions:

• Autoimmune- and inflammatory- related epilepsy including new-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES).
• Multiple sclerosis (MS).
• Myelin oligodendrocytes antibodies associated disease (MOGAD).
• Neuromyelitis optica spectrum disorder (NMOSD).
• Autoimmune encephalitides (AE).
• Acute disseminated encephalomyelitis (ADEM).
• Primary angiitis of the CNS.
• Secondary CNS vasculitis.
• Limbic encephalitis.
• Cerebellar ataxia.
• Progressive multifocal leukoencephalopathy.
• Acute necrotizing encephalopathy,
• Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids(CLIPPERS).

This Collection, led by Prof Lifen Yang, welcomes relevant original research papers, reviews (critical reviews and systematic reviews), and case series until the 31st January 2026. The Collection promises to be a valuable resource for years to come, with articles published alongside some of our finest hot-topic reviews.

Please submit your manuscript via our website. Upon submission, please use the promo code CDCFE to indicate that your manuscript will be considered for the “Molecular and Cellular Mechanisms of Hypersensitivity” Collection. Please note that normal Article Processing Charges will apply.

Guest advisers

Prof. Lifen Yang, Xiangya Hospital, Central South University

Dr. Miriam Kessi, Xiangya Hospital, Central South University

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Role of Natural Killer Cells in Disease" in ImmunoTargets and Therapy.

Natural killer (NK) cells were first identified by Dr. Ronald B. Herberman, who unfortunately passed away several years ago. Since their first identification, it was clear that these cells expressed anti-tumor activity and were initially named natural cytotoxicity (NC) cells, and later as NK cells. Although they respond to danger whilst circulating in the peripheral blood, they can rapidly migrate into sites of immune reactions in peripheral tissues. It is also apparent that whilst responsible for killing tumor cells, they additionally display an immunoregulatory function. Consequently, they react to microbes, particularly virally-infected cells, as well as protecting the immune system by depleting unwanted antigen-presenting cells - which can sometimes be detrimental due to provoking autoimmunity.

Although the therapeutic potentials of NK cells in cancer and to some extent in autoimmune diseases are well established, these cells also play important roles in other diseases which will constitute an important aspect of this Article Collection. This Article Collection aims to explore the involvement and/or therapeutic potentials of NK cells in various diseases. Reviews and original articles from worldwide experts dealing with the role of NK cells in any of the below mentioned fields are highly encouraged to submit their valuable work.

1. Cancers
2. Autoimmune diseases
3. Neurodegenerative diseases
4. Stroke and heart diseases
5. Virus infection, including COVID
6. Other microbial infections
7. Pulmonary diseases
8. Gastrointestinal diseases
9. Musculoskeletal diseases
10. Hematological disorders
11. Skin diseases

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code SIYCD for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 1 July 2025.

Please contact Ashley Ambros at [email protected] with any queries regarding this Article Collection.

Guest advisors

Dr. Azzam A. Maghazachi, Research Department, ImmunoProfiling and Boosting, Oslo, Norway

[email protected]

Dr. Azzam A Maghazachi received a masters degree from New York University Medical School (USA), and a PhD degree in Immunology from the University of Manitoba Medical School (Canada). He completed post-doctoral fellowships at NYU Medical School (USA) and then worked under the supervision of the late Dr. Ronald B. Herberman at the Pittsburgh Cancer Institute. Between 1988-2007, he held several senior positions in various institutes and universities in the USA, Canada and Norway. He was a Professor of Physiology in the faculty of Medicine at the University of Oslo, Norway, and later a professor of Immunology in the college of Medicine, University of Sharjah. Dr. Maghazachi research interests include cancer immunology, autoimmune diseases, chemokines, and drug mechanisms of action. Dr. Maghazachi is an editor or editor-in-chief for more than 10 scientific journals in the fields of Immunology, Oncology and Neuroscience. He has published more than 120 scientific papers as well as book chapters and ebooks.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Emerging Trends in Multidrug-Resistant Infections" in Infection and Drug Resistance.

Multidrug-resistant infections represent a critical global health crisis, posing significant threats to public health, economics, and patient safety. As resistance to antibiotics increases, healthcare providers face a diminishing arsenal of effective treatments, complicating the management of infections and leading to higher morbidity and mortality rates. This situation results in longer hospital stays and increased medical costs, imposing a substantial economic burden on healthcare systems. Vulnerable populations, such as the elderly and immunocompromised individuals, are particularly at risk, underscoring the urgency to confront this challenge. Moreover, the global nature of infectious diseases means that resistance can lead to widespread outbreaks that transcend national borders, necessitating coordinated global responses and enhanced surveillance efforts.

Addressing multidrug resistance is essential to protect public health, preserve modern medical achievements, and ensure that effective treatment options remain available for future generations. It becomes imperative to understand the epidemiology, mechanisms, and clinical implications of these infections.

This Article Collection aims to unite innovative research that examines the numerous facets of multidrug resistance, including the mechanisms of antibiotic resistance, the epidemiology of multidrug resistance pathogens, outbreaks by multidrug resistance, the role of novel therapeutic strategies such as phage therapy and antimicrobial peptides, public health implications, and effects on patient outcomes. Additionally, contributions addressing the socioeconomic impact of drug resistance, public health interventions, and strategies for infection prevention and control are welcome. Articles on the development of rapid diagnostics and stewardship programs that promote responsible antibiotic use will also be prioritized.

Preferred article types for this Collection are original research, reviews, guidelines, expert opinions, commentary and clinical studies in all areas of infection and drug resistance that provide insights into emerging trends and innovative solutions in the fight against multidrug-resistant infections.

By featuring groundbreaking studies from various disciplines, we aim to provide a thorough overview that enriches future research and clinical practice. We invite researchers worldwide to submit their manuscripts that explore new trends, emerging patterns, and potential solutions for combating multidrug-resistant infections. This is a vital opportunity to contribute to a critical dialogue aimed at improving global health outcomes in an era where resistance threatens to outpace available treatments. Join us in this essential conversation and share your findings with the broader scientific community.

Keywords

• Multidrug Resistance
• Antibiotic Stewardship
• Infection Control
• Novel Therapies
• Epidemiology

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 31 December 2025.

Please submit your manuscript on our website, quoting the promo code KTNFZ for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Zhiyuan Zhang at [email protected] with any queries regarding this Article Collection.

Guest advisor

Muhammad A. Halwani, Al Baha University, Faculty of Medicine, Saudi Arabia

[email protected]

Dr. Muhammad A Halwani a distinguished professor and consultant specializing in infection control, boasting over 21 years of extensive experience in this vital field. His expertise spans infection control, hospital epidemiology, and clinical microbiology, making him a leading figure in advancing research and practice. As the editor of this special issue, Dr. Halwani warmly invites researchers to contribute their innovative findings and insights, fostering a collaborative environment for sharing knowledge and advancing the field.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Helicobacter pylori Infection and Antibiotic Resistance" in Infection and Drug Resistance.

One of the most pressing challenges in managing Helicobacter pylori infections today is the alarming rise in antibiotic-resistant strains. Resistance rates to commonly used antibiotics such as clarithromycin, metronidazole, and levofloxacin range between 15% and 50% worldwide, with even higher rates reported in Asian regions. This increase in resistance significantly complicates the treatment of infections, making standard therapies less effective and necessitating the development of more precise, personalized approaches. Comparative analyses of global and local antibiotic resistance profiles are essential for understanding regional differences in resistance, particularly in countries with high prevalence rates. Accurate and timely data on these resistance profiles will help clinicians adapt their treatment strategies to combat resistant strains more effectively, preventing further complications from untreated infections.

Rapidly and accurately diagnosing H. pylori infections and determining antibiotic resistance profiles are critical to controlling the spread of resistant strains and ensuring effective treatment. Novel methods for detecting H. pylori infection and antibiotic resistance are increasingly becoming a focus of research, with innovations such as molecular diagnostic tools showing promise for quicker and more accurate detection.

The rising prevalence of antibiotic-resistant H. pylori strains demands the development of novel treatment strategies aimed at precise eradication of the infection. Alternative treatment strategies such as quadruple therapy, sequential therapy, and bismuth-containing regimens are being explored. Precision medicine approaches offer the potential for more tailored treatment plans. This approach may also reduce the likelihood of further resistance developing by minimizing unnecessary antibiotic use.

Comparative analysis of H. pylori genomes has revealed significant genetic variability among strains, which can influence their pathogenicity, virulence, and resistance to antibiotics. Understanding these genetic differences is key to developing targeted therapies and vaccines that are effective against a broad range of H. pylori strains. Moreover, genomic studies can provide insights into the evolutionary mechanisms driving antibiotic resistance, helping researchers identify potential targets for new drugs or treatment strategies that can circumvent resistance.

This Article Collection seeks contributions that address the following key areas in the field of H. pylori research.

• Global and local infection rates and antibiotic resistance profiles
• Diagnostic methods with a focus on identifying the most effective techniques for detecting H. pylori infections and assessing antibiotic resistance
• Development of novel methods for detection and innovative treatment strategies
• Comparative genomic analyses of H. pylori strains and studies investigating the links between H. pylori infection and gastric diseases

These research efforts will help inform more effective management of H. pylori infections and contribute to the development of precision medicine approaches that can combat the growing problem of antibiotic resistance.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 15 August 2025.

Please submit your manuscript on our website, quoting the promo code MAQCV for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Zhiyuan Zhang at [email protected] with any queries regarding this Article Collection.

Guest advisor

Liang Wang, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, China

[email protected]

Prof. Liang Wang is currently working as a chief scientist, principal investigator, and group leader at the Department of Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, China. He is also an adjunct research fellow at the University of Queensland and the University of Western Australia and an adjunct associate professor at Edith Cowan University. His current research interests include but not limited to microbial physiology and metabolism, rapid diagnosis of bacterial pathogens, microbial informatics, and glycogen structure and functions. Prof. Wang has edited seven books and published more than 130 peer-reviewed articles in international journals such as Lancet Microbe, ISME, and Emerging Infectious Diseases, etc.

View all papers in this article collection

Dove Medical Press is pleased to announce a new Article Collection in Infection and Drug Resistance, dedicated to the game-changing role of personalised antimicrobial strategies in managing infectious disease.

In contrast to the standard “one-size-fits-all" approach to prescribing antibiotics, personalized antimicrobial strategies involve using advanced diagnostics and data-driven approaches to determine the best course of treatment for an individual patient. Bringing a precision medicine approach to infectious disease management improves patient outcomes and promotes antimicrobial stewardship.

In light of the growing importance of personalized antimicrobial techniques, Infection and Drug Resistance invites submissions of original research articles, reviews, and perspectives that advance our understanding and use of these strategies.

The Collection, Edited by Editor-In-Chief Professor Oliver Planz, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

While the call is open to receive manuscripts across the broad spectrum of personalized antimicrobial strategies, the Editors are particularly interested in manuscripts relating to the following areas:

• Molecular diagnostics
• Microbiome analysis
• Resistance profiling
• Clinical implementation & therapeutic drug monitoring
• Personalized therapy in specific populations, including pregnancy.
• Economics and cost-effectiveness
• Ethical and regulatory considerations
• Patient education and engagement

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 1 January 2026.

Please submit your manuscript on our website, quoting the promo code LTMAV for a 20% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Zhiyuan Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

Guest Advisor

Oliver Planz, University of Tübingen, Germany

View all papers in this article collection

Respiratory Syncytial Virus (RSV) can lead to symptoms akin to the common cold or winter flu, runny nose, cough, fever and so on. While the body can conquer the infection by itself, there are serious implications to being infected with RSV, as it is a common cause of pneumonia or bronchitis in infants aged under one year of age. Vulnerable patients, including the elderly and immunocompromised, may also be put at risk of further harm from an RSV infection.

During the COVID-19 pandemic, a dip in RSV infections was noted in the United States, meaning the pandemic could have influenced the transmission of RSV during this period. This Thematic Series will consider how infection rates prior to the pandemic differ from to those from 2020 onwards. Questions we’ll be asking include the factors leading to these changes, how does COVID-19 infection affect RSV, or mortality rates. The body’s immunity response will also have a vital role in this Thematic Series, to provide further understanding on where the dangers of RSV lie.

Considering these topics, we hope the submissions will culminate into a fount of knowledge about RSV. This includes efforts to find successful treatments and preventions for RSV, such as antiviral drugs and vaccinations. What sort of treatment should drug developers be looking for? Do we need to take consideration of special populations? These facets of a complicated infection – such as RSV – will be accounted for in this crucial Thematic Series.

The journal is seeking original submissions and review articles on the following topics related to RSV:

• Infection rates before and since the COVID-19 pandemic
• Driving factors behind the infection changes
• Immunity cell responses to RSV and the role of antiviral inhibitors
• RSV interactions with cell receptors
• Infant mortality rates from RSV
• Pneumonia deaths originating from RSV infection
• Interaction between COVID-19 and RSV infections
• Different vaccination types currently in development (e.g., Live attenuated, mRNA, polyvalent etc.)

The deadline for submissions is 31 May 2025.

Please submit your manuscript on our website, quoting the promo code PUYAG to indicate that your submission is for consideration in this Article Collection.

View all papers in this thematic series

Dove Medical Press is pleased to announce a new Article Collection in Infection and Drug Resistance, dedicated to the role of artificial intelligence (AI) in the prediction of drug resistance.

AI has the potential to revolutionize patient care, offering significant benefits in predicting drug response and resistance and improving antibiotic stewardship. Given the importance of AI in this setting, we are pleased to invite submissions of original research articles, reviews, and perspectives on the topic.

The Collection, edited by Editor-In-Chief Professor Oliver Planz, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of AI in predicting drug resistance, the Editors are particularly interested in manuscripts relating to the following areas:

• The performance of AI/machine learning techniques in combating antimicrobial resistance
• Studies relating to emerging resistance patterns and potential hotspots
• Design and evaluation of user-friendly machine learning decision support systems
• Challenges and opportunities for practical implementation
• Topics relating to ethics, data privacy, and algorithmic bias

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 1 January 2026.

Please submit your manuscript on our website, quoting the promo code AOWGL for a 20% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Zhiyuan Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

Guest Advisor

Oliver Planz, University of Tübingen, Germany

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Biomechanical Advancements in COPD" in the International Journal of Chronic Obstructive Pulmonary Disease.

Extra-pulmonary functional decline is common in patients with chronic obstructive pulmonary disease (COPD). These include but are not limited to muscle fatigue, muscle weakness, falls, slower gait speed, and decreased physical activity. Biomechanics, the study of forces and how they act upon a body, can contribute greatly to our understanding of mechanisms leading to dysfunction. Biomechanical studies have provided insight into changes in balance, gait, muscle mechanics, and breathing mechanics to name a few. The use of biomechanical tools such as motion capture has been used to develop optoelectronic plethysmography allowing for study of lung volume contributions to breathing mechanics. Despite the uses of biomechanics in studying COPD, there remains a need to investigate functional outcomes, rehabilitation strategies, and preventative interventions.

Major extra-pulmonary patient concerns include increased fear of falling, increased falls, muscle fatigue, and/or muscle weakness, to name a few. Physiological mechanisms to these functional outcomes has been studied in considerable detail, and these studies have provided advancements in treatment. Extra-pulmonary functional decline that progresses with disease severity may be independent of a decline in lung function. It is important to intervene early and precisely to slow the progression of extra-pulmonary functional decline. Rehabilitation strategies are needed to restore or maintain levels of function. Further, there may be functional outcomes that decline in patients with COPD that have been considered part of the aging process, yet are tied to the pathophysiology of the disease. Biomechanical studies may complement mechanistic physiological investigations. Further, biomechanical assessments in clinic may provide an additional dimension of disease severity.

This Collection will bring together articles focused on extra-pulmonary functional outcomes associated with COPD, with special emphasis on biomechanics-based approaches. Articles may include investigations into mechanisms, both physiological and psychological, driving functional decline; advances in rehabilitation and treatment strategies to restore or maintain function; advancements in early identification of functional decline; precision medicine and treatments to slow the progression of functional decline; and similarly related topics. Preferred article types include original research, reviews, short report, and methodology. Other article types may be considered.

Keywords

• Balance and falls
• Gait and locomotion
• Physical therapy and pulmonary rehabilitation
• Muscle fatigue and weakness
• Extra-pulmonary function including exercise capacity

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 31 January 2026.

Please submit your manuscript on our website, quoting the promo code XEVGI for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Zhiyuan Zhang at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Stephan I Rennard, University of Nebraska Medical Center, USA

[email protected]

Professor Rennard trained in pulmonary medicine at the NIH, joined University of Nebraska Medical Center as Chief, Pulmonary Medicine in 1984 where he remains Professor of Medicine. He has conducted basic and clinical investigations focusing on chronic obstructive pulmonary disease. He was a member of the original GOLD guidelines committee and has served on the Board of Directors of the American Thoracic Society, the American Lung Association, the COPD Foundation and the Alpha 1 Foundation. Currently he serves as the Medical Director for the Alpha 1 Foundation Therapeutic Development Network.

Jennifer Yentes, Texas A&M University, USA

[email protected]

Dr. Yentes' research focuses on functional resiliency and reserve in older adults, and in patients with COPD. Dr. Yentes’ group highlighted biomechanical changes in gait in persons with chronic obstructive pulmonary disease. She has also explored the clinical utility of locomotor respiratory coupling in this population. Her research has shown that non-varying coupling is related to energy expenditure.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "COPD and infection: new understanding of interactions, crossover and impacts" in the International Journal of Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition characterized by persistent respiratory symptoms and airflow limitation. Infections, both bacterial and viral, play a significant role in exacerbating COPD and contributing to its morbidity and mortality. This Article Collection aims to explore the intricate relationship between COPD and infections, highlighting recent advances, ongoing challenges, and potential therapeutic strategies.

The Article Collection aims to provide a comprehensive overview of the current state of knowledge regarding COPD and its interaction with infections. By bringing together experts from various fields, this issue hopes to foster interdisciplinary collaboration and drive forward research and clinical practices that can improve outcomes for COPD patients globally.

Subtopics include but are not limited to:

• Pathophysiology of COPD and Susceptibility to Infections
• Epidemiology of Infections in COPD Patients
• Impact of Viral Infections on COPD Progression
• Bacterial Colonization in COPD
• The Role of the Microbiome in COPD Exacerbations
• Antibiotic Resistance in COPD-Related Infections
• New Antibiotics and COPD
• Immunomodulatory Treatments to Prevent COPD Exacerbations
• Unusual Infectious Agents in COPD Patients
• Innovative Approaches to Managing COPD and Infections
• Future Directions in COPD and Infection Research

This Article Collection will accept a variety of article types. Here are the specific types of articles that are encouraged:

• Original Research Articles
• Review Articles
• Case Studies
• Methodological Papers
• Short Communications

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 30 June 2025.

Please submit your manuscript on our website, quoting the promo code AIHQZ for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisor

Ahmad Riyad Alsayed, Applied Science Private University, Jordon

[email protected]

The main aims of Dr. Alsayed's practice and research are to promote evidence-based medication use to improve disease outcomes and health-related quality of life of patients with internal medicine-related disorders. Dr. Alsayed’s research interests are clinical pharmacy, evidence-based medicine, clinical trials of effectiveness and safety, quality of life and pharmaceutical care research, with a special interest in infectious, respiratory, diabetes, and cardiovascular diseases.​

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Non-Pharmacological Interventions for Improving Physiological, Physical, and Psychological Health Outcomes in Individuals with COPD" in the International Journal of Chronic Obstructive Pulmonary Disease.

Optimal management of COPD includes non-pharmacological interventions including pulmonary rehabilitation, smoking cessation, disease self-management, medication adherence, routine vaccinations, oxygen therapy and ventilatory support, and physical activity promotion. This Article Collection highlights new and innovative non-pharmacological interventions for improving physiological, physical, and psychological outcomes in individuals with COPD.

COPD is a leading cause of morbidity, disability, and mortality worldwide. The disease affects the whole person impacting physiological (e.g., lung function), physical (e.g., physical activity, exercise capacity), and psychological (i.e., depression) outcomes. Non-pharmacological interventions are part of guideline-based care for COPD. Yet, gaps in the management of COPD exist. Many non-pharmacological interventions are underutilized and/or benefits dwindle over time. For example, while pulmonary rehabilitation remains the gold-standard for improving an array of health outcomes, it remains severely underused and benefits begin to wane after 12 months. New and novel non-pharmacological intervention can supplement existing non-pharmacological interventions for individuals with COPD with the potential to improve physiological, physical, and psychological outcomes.

This Article Collection seeks articles focused on intervention development and testing (from preliminary/pilot to effectiveness, implementation and dissemination studies) of interventions targeting improvement in physiological, physical, and/or psychological outcomes. We welcome original research articles, short reports, and systematic reviews. Study protocols of highly innovative non-pharmacological interventions will also be considered. Interventions may include a single component (e.g., balance training) or multiple components (e.g., complex behavioral interventions). Interventions that include chronic pain management, treatment of sleep disturbances, integrative therapies such as mind-body interventions, and psychotherapies (i.e., cognitive behavioral therapy) are salient to this Article Collection. Outcomes should broadly fall within the categories of: physiological, physical, and psychological domains and may include primary and/or secondary outcomes, as well as secondary analysis of completed trials. Moderator and/or mediation analyses of completed trials asking how and for whom interventions work are also welcomed.

Keywords

• Non-pharmacological interventions
• Physiological
• Physical
• Psychological
• Outcomes

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 2 April 2026.

Please submit your manuscript on our website, quoting the promo code 15402 for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Zhiyuan Zhang at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Patricia M. Bamonti, VA Boston Healthcare System, Harvard Medical School, USA

[email protected]

Patricia M. Bamonti, PhD, ABPP, Assistant Professor of Psychology, Department of Psychiatry, Harvard Medical School, is a Staff Psychologist at VA Boston Healthcare System. Dr. Bamonti studies the impact of depression and anxiety symptoms on health outcomes in the context of pulmonary rehabilitation and physical activity interventions. She is currently developing and testing an integrated physical activity intervention with cognitive behavioural therapy for individuals with COPD and comorbid depression and/or anxiety.

Marilyn L. Moy, VA Boston Healthcare System, Harvard Medical School, Boston University Chobanian & Avedisian School of Medicine, USA

[email protected]

Marilyn L. Moy, M.D., M.Sc., Associate Professor of Medicine, Harvard Medical School, is a Staff Pulmonary Physician at VA Boston Healthcare System. She is Medical Director of the Pulmonary Rehabilitation Program, accredited by the American Association of Cardiovascular and Pulmonary Rehabilitation. Dr. Moy studies the role of physical activity in the risk stratification of COPD, technology-based interventions to promote PA, and the biological mechanisms underlying the beneficial effects of PA on COPD outcomes.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Bridging the Digital Gap: Leveraging Metaverse Telehealth to Achieve Fair Access to Healthcare" in the International Journal of General Medicine.

In the rapidly changing digital landscape, telehealth is a beacon of innovation, poised to revolutionize healthcare delivery, particularly for remote and underserved regions. However, digital inequality's looming threat could widen the healthcare access gap, underscoring the urgent need for innovative solutions. This series delves into the transformative potential of emerging metaverse technology to democratize healthcare access. By intricately blending metaverse technologies with the principles of telehealth, we can forge inclusive, universally accessible healthcare experiences, effectively overcoming traditional hurdles such as geographic isolation, socioeconomic disparities, and limited resources. We invite experts from diverse backgrounds to contribute their insights, research findings, and practical experiences regarding integrating metaverse-enhanced telehealth, its profound influence on expanding healthcare reachability, and its pivotal role in bridging the alarming digital divide. The overarching goal is to thoroughly explore how the metaverse can redefine the future of telehealth, presenting innovative strategies to ensure equitable healthcare access for all and significantly improve health outcomes across various communities. Contributors are fervently urged to share their pioneering work on the implementation and impacts of metaverse telehealth, highlighting how it can help narrow the digital chasm and bolster healthcare equity for future generations.

Addressing the digital divide in healthcare is essential for tackling inequalities that adversely affect health outcomes, especially in underserved and hard-to-reach areas. Despite telehealth advancements, a significant gap remains, leaving countless individuals without the means to access digital health solutions. Introducing the metaverse into telehealth presents an innovative solution to these challenges. It offers immersive, interactive healthcare services that can extend to those overlooked by conventional telehealth, including people in remote locations, those with restricted access to technology, and socioeconomically disadvantaged groups. By incorporating metaverse technologies, we can close the gap between patients and healthcare providers, improving care delivery to make it more equitable and inclusive. This breakthrough enhances access and improves health outcomes through personalized, engaging, and comprehensive healthcare interventions. Therefore, embracing metaverse-based telehealth is crucial for fostering a fairer healthcare system, ensuring quality care is accessible to all, irrespective of their geographical or social situation.

• The Collection “Bridging the Digital Gap: Leveraging Metaverse Telehealth to Achieve Fair Access to Healthcare” explores how metaverse technology can be a game-changer in delivering equitable healthcare through telehealth services. The focus is on several compelling aspects, including:
• The use of Metaverse in Telehealth delves into enhancing patient care through virtual realities, offering a futuristic approach to healthcare provision.
• A critical look at enhancing accessibility, questioning the effectiveness of metaverse technologies in making healthcare services more obtainable for those in marginalized and remote communities, thereby addressing geographical and socioeconomic disparities.
• The importance of equity and inclusion, scrutinizing the metaverse's capacity to bridge the health access divide across different demographic groups to ensure fair healthcare for all.
• The hurdles of implementing metaverse telehealth, discussing the technical and regulatory barriers that must be overcome for successful adoption.
• Showcasing real-life successes where metaverse applications in telehealth have made significant positive impacts, illustrating the practical benefits of this technological integration.

This Collection illuminates the metaverse's transformative potential in making healthcare more accessible and equitable, addressing the opportunities and challenges inherent in integrating these technologies.

Keywords

• Telehealth
• Digital Equity
• Metaverse
• Virtual reality
• Health disparities
• Healthcare accessibility

Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 11 August 2025.

Please submit your manuscript on our website, quoting the promo code CCEYI for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Francis Straw at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Radhika Ranganathan, RV University, Bengaluru, India

[email protected]

Radhika Ranganathan is a distinguished researcher with a background in digital health and telemedicine, backed by an MPhil and MSPH in Epidemiology, alongside 16 years in clinical and public health sectors. Currently advancing her education with a PhD in Business (Health Analytics), she specializes in merging metaverse technology with telemedicine to reduce health disparities and improve access to healthcare. With a solid history in healthcare data analysis, Ms. Ranganathan excels in crafting innovative solutions that positively impact global health outcomes.

Subhashree Natarajan, RV University, Bengaluru, India

[email protected]

Dr. Subhashree Natarajan is an esteemed expert in business analytics with over 25 years of experience. She has expanded her research to include health analytics, applying advanced data-driven approaches to improve healthcare delivery. Dr. Natarajan’s research on the innovative application of metaverse technology to enhance mental wellness is poised to impact global health practices significantly. Her commitment to leveraging technology to address critical health challenges exemplifies her dedication to contributing to a healthier, more equitable future worldwide.

S. Vidhusha, Shiv Nadar University, Chennai, India

[email protected]

Dr. S. Vidhusha is an Assistant Professor in the Department of Computer Science and Engineering at Shiv Nadar University Chennai. She has a teaching experience of 12+ years in the Academia. She has over 7 years of research experience in cognitive neuroscience, brain disorder studies, and medical image processing. She had opportunities to visit countries like Australia & USA. During her visit to the United States, she visited Drexel University, Philadelphia, to explore collaborative research prospects. She is an expert member of the International Panel of VR (Virtual Reality) Experts at the Software Sustainable Institute, UK.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Comprehensive Guide for Procedure-Oriented Therapies for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia" in the International Journal of General Medicine.

Benign Prostatic Hyperplasia (BPH) is a common condition in aging men, characterized by the enlargement of the prostate gland which leads to significant lower urinary tract symptoms (LUTS). Symptoms such as urinary frequency, urgency, incontinence, and nocturia can dramatically reduce quality of life. With an aging global population, the prevalence of BPH is anticipated to increase, highlighting the necessity for innovative and effective therapeutic approaches. This Article Collection focuses on procedure-oriented therapies for managing LUTS associated with BPH. It will cover a range of minimally invasive treatments that promise to improve efficacy and minimize side effects compared to conventional surgical methods. Designed to inform and guide ongoing research, this announcement invites contributions that discuss advances and insights in procedural therapies, aiming to enrich clinicians’ and researchers' understanding and management of LUTS due to BPH. 

The importance of advancing therapies for BPH cannot be understated, given its impact on the quality of life and the health economics of aging populations worldwide. Innovative procedure-oriented therapies offer the potential to reduce the invasiveness of treatments while maintaining or enhancing efficacy. Such advancements are crucial as they could lead to shorter recovery times and lower complication rates, which are significant considerations for the elderly demographic most affected by BPH. Furthermore, the development of these therapies aligns with the broader goal of personalized medicine, allowing treatments to be tailored to individual patient profiles and specific symptomatology. This approach not only improves patient outcomes but also optimizes healthcare resources by potentially reducing the need for repeated interventions and long-term medication use. In response to these critical developments, this special issue aims to provide a comprehensive collection of cutting-edge research. It will serve a broad audience of clinicians managing LUTS due to BPH across various disease stages and practice settings, enriching the dialogue and enhancing clinical practice through shared insights and innovations. 

For this Article Collection, we seek to explore the spectrum of procedure-oriented therapies for managing LUTS due to BPH. We welcome submissions that discuss traditional surgical procedures, innovative minimally invasive techniques, and the latest advancements in therapeutic approaches. This issue aims to showcase research that addresses current challenges, measures outcomes and predicts future trends in the treatment of BPH. Submissions can include original research articles, comprehensive reviews, case reports, and clinical studies that contribute to understanding the effectiveness, safety, and patient outcomes associated with these therapies. By compiling these works, this collection seeks to provide valuable insights and practical guidance to physicians, and researchers dedicated to advancing the management of BPH.

Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 18 August 2025.

Please submit your manuscript on our website, quoting the promo code FIHEZ for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Francis Straw at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Dr. Akhil Das, Professor of Clinical Urology in the Department of Urology, University of California Irvine

Dr. Narmina Khanmammadova, Research Coordinator in the Department of Urology, University of California Irvine

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Glioblastoma Pathophysiology" in the International Journal of General Medicine.

Glioblastoma is one of the most aggressive and lethal forms of brain cancer, characterized by its rapid proliferation and pronounced invasiveness. Despite significant advancements in therapeutic interventions, the prognosis for patients with glioblastoma remains dismal, underscoring the urgent need for a more profound understanding of the disease’s pathophysiology. Glioblastoma remains resistant to conventional therapies, leading to a median survival time of only 12-15 months for most patients. 

Understanding the complex biological mechanisms that drive glioblastoma will enable identification of novel therapeutic targets and more effective treatment strategies. This Collection seeks to showcase the latest research on glioblastoma pathophysiology, with particular interest in uncovering the intricate interactions within the tumor microenvironment, the role of immune infiltration, and the impact of neuroinflammation and tumor metabolism. Additionally, exploring neuroimmune interactions and applying single-cell approaches can reveal the cellular heterogeneity and molecular underpinnings of glioblastoma. Advancing our understanding in these areas is vital for overcoming therapeutic resistance, improving patient outcomes, and ultimately paving the way toward personalized medicine in glioblastoma treatment. 

We welcome manuscripts on key aspects of the pathophysiology of glioblastoma, including but not limited to:

• The tumor microenvironment and its role in tumor growth and resistance.
• Immune infiltration and neuroinflammation
• Tumor metabolism
• Neuroimmune interactions
• Advances in immunotherapy
• Single-cell approaches to uncovering cellular heterogeneity and novel therapeutic targets within glioblastoma

Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 1 September 2025.

Please submit your manuscript on our website, quoting the promo code RGODM for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Francis Straw at [email protected] with any queries regarding this Article Collection.

Guest Advisor

Dr. Vinay Kumar, Pennsylvania State University Hershey Medical Center

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Pathophysiological Understanding of Rheumatic Fever and Rheumatic Heart Disease" in the International Journal of General Medicine.

RHD is an acquired heart valve disease, triggered by cross reactivity of anti-Group A streptococcal (GAS) antibodies with host proteins, whose protein epitopes mimic GAS antigenic epitopes. Anti-GAS antibodies have been experimentally cross reacted with myocardial sarcolemma proteins such as myosin, tropomyosin, intermediate filament vimentin and extracellular matrix (ECM) proteins, laminin which mimics the sequence of the N-Acetyl glucosamine, and group M peptide epitopes of GAS. Because myosin and tropomyosin proteins are embedded within intracellular sarcolemma and are only exposed to external immune reactions following myocardial injury, some studies argue the involvement of these proteins is not in the initial Acute Rheumatic fever (ARF) reactions but rather in the subsequent reactions driving RHD progression. Meanwhile, few studies have found myocardial involvement which later heals in the initial stages.

Despite longstanding recognition of autoimmune cross-reactivity to host proteins to drive RHD, factors involved in differential phenotypic presentations and disease progression rates remain elusive. Moreover, for over five decades it has been known that the initial injury is mostly mitral regurgitation during ARF, followed by aortic valvular involvement in later years of the disease. However, recent studies found severe multiple valvular involvement and mixed phenotypes on the same valve in young people and adolescents in some low- and middle-income countries (LMICs). Whether this is due to improvement in diagnosis, or understanding of RF and RHD, or other associated factors remains unanswered. Moreover, while RHD is almost eradicated in most high-income countries (HIC), its remains along the poverty line in HICs, and endemic in LMICS. It thus leaves questions about how specific factors prevalent in poor socio-economic environment drive RHD progression.

As a vaccine has been hard to obtain, the World Heart Federation and World Health Organisation recommend early diagnosis, primary, and secondary prevention as management strategies to delay progression to allow for improved quality of life of those with RF or RHD. Moreover, there has been constant improvement by the World Heart Federation in the training of cardiothoracic surgeons and cardiologist in the care of patients with RF and RHD in LIMCs. In 2023, a workshop at the National Institutes of Health USA re-emphasized priorities to reduce the burden of RHD. This Collection will help pool together updated evidence and guide further research as per the NIH recommendations to eradicate RF and RHD.

This Collection seeks pathophysiological understanding of RHD, including epidemiology, prevention and pathogenetic mechanisms genetics, and epigenetic mechanisms, immune responses, climate change and new knowledge on diagnosis including both imaging and new disease biomarkers and management of rheumatic heart disease. Moreover, comorbidities that enhance progression of RHD, social implications of disease (quality of life with rheumatic heart disease) and interventions to improve quality of life for RHD patients will be considered. Research articles in any of these areas will go through rigorous peer review of the standard editorial process and if accepted will be published gold open access for accessibility to everyone. Systematic review addressing important gaps of this area will be considered for peer review while traditional review formats will only be commissioned.

Keywords

• Rheumatic fever/rheumatic heart disease
• Pathogenesis
• Diagnosis (biomarkers, imaging, clinical)
• Management outcomes (Secondary prevention, cardiothoracic surgery)
• Epidemiology

Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 8 September 2025.

Please submit your manuscript on our website, quoting the promo code XKRLF to indicate that your submission is for consideration in this Article Collection.

Please contact Francis Straw at [email protected] with any queries and discount codes regarding this Article Collection.

Guest Advisor

Evelyn Lumngwena, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand

[email protected]

A researcher at the School of Clinical Medicine, University of the Witwatersrand, who holds a PhD in Biomedical sciences and postdoctoral experience in cardiovascular translational research. My current research aims to understand the pathogenesis of rheumatic heart disease.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Microbiome and Metabolome: Emerging Windows into Human Health and Disease" in the International Journal of General Medicine.

Advances in multiple now foundational technologies, such as high throughput DNA sequencing and ultra-high resolution liquid chromatography and tandem mass spectrometry, have enabled biologists to generate enormous datasets that comprehensively capture the hundreds to thousands of microbes and small molecules present in biological matrices. At the same time, advances in computational technologies and methods have enabled biologists and bioinformaticians to explore these large omics datasets and identify novel associations between resident microbes, molecules, and human health. Studies using these technologies have also revealed how incomplete our understanding of human biology remains, as investigators continue to identify uncharacterized microbes highly prevalent in human microbiomes across populations and have revealed that the vast majority of molecules in biologically important matrices, such as human blood, remain unannotated. In other words, these technologies are enabling scientists to interrogate the “dark matter” of biology, and in doing so allow us to more fully understand the metabolic and genomic diversity that exists with the human super-organism and how these microbes and metabolites impact human health.

This study of microbes and molecules that comprise the human superorganism has already yielded meaningful insights into diseases of public health concern. Faecal microbiota transplantation has emerged as an effective treatment for infection by Clostridioides difficile, and investigators are also working to develop tests for colon cancer based on the gut microbiome. Tests have also been developed that use high throughput sequencing to detect microbial DNA in human blood in order to diagnose a myriad of infectious diseases. Finally, there is evidence that alterations in our microbiomes may be implicated in the rapid rise of metabolic diseases, such as obesity, and autoimmune diseases, such as inflammatory bowel disease, over the past several decades.

This Article Collection aims to investigate how these emerging aspects of human biology, our microbiomes and metabolomes, might be implicated in the risk for or pathogenesis of diseases whose causes have up to this point evaded our understanding. Given this aim, we are calling for a wide range of contributions from investigators with various backgrounds. Example areas of focus include, but are certainly not limited to, the following:
• The microbiome and cancer
• The gut microbiome’s role in the brain-gut axis
• Microbial metabolites in gastrointestinal diseases
• The reproductive tract microbiome, maternal health, and neonatal outcomes
• The gut microbiome, metabolic disease, and obesity
• The respiratory microbiome and pulmonary disease

Keywords

• Microbiome
• Metabolomics
• Metagenomics
• Bioinformatics
• Systems Biology

Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 22 September 2025.

Please submit your manuscript on our website, quoting the promo code JCZHM for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Francis Straw at [email protected] with any queries regarding this Article Collection.

Guest Advisor

William Kindschuh, Columbia University

[email protected]

William Kindschuh received his PhD in Systems Biology from Columbia University (New York, NY), where he is working towards completion of his MD. During his PhD, Dr. Kindschuh investigated the reproductive tract microbiome and metabolome in adverse pregnancy outcomes. Prior to pursuing his PhD, Dr. Kindschuh studied Biomedical Computation at Stanford University (Palo Alto, CA).

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Role of Sleep in the Prevention and Management of Cardiometabolic Disease" in the International Journal of General Medicine.

Cardiometabolic diseases, a group of interrelated conditions that include cardiovascular disease, type 2 diabetes, and metabolic syndrome, are among the leading causes of morbidity and mortality globally. While traditional risk factors such as unhealthy diet, physical inactivity, and obesity have long been associated with cardiometabolic disease, sleep has emerged as a major factor in both the prevention and management of cardiometabolic health. Inadequate sleep adversely affects glucose metabolism, contributing to insulin resistance, a key factor in the development of type 2 diabetes. Other mechanisms through which sleep insufficiency contribute to increased risk of cardiometabolic disease include heightened activation of the sympathetic nervous system, endothelial dysfunction, increased oxidative stress and inflammation, and alterations in hormonal regulation, among others. Sleep disorders, particularly obstructive sleep apnea (OSA), are linked to significant negative metabolic effects, including increased insulin resistance, heightened sympathetic activation, oxidative stress and hormonal imbalances, such as elevated cortisol and ghrelin levels. 

The growing body of evidence linking sleep to cardiometabolic health highlights the importance of incorporating sleep into the prevention and management of cardiometabolic diseases. Interventions aimed at optimizing sleep, whether through lifestyle changes, behavioral therapies, or treatment of sleep disorders, can improve clinical outcomes in patients with cardiometabolic conditions. For instance, continuous positive airway pressure (CPAP) therapy in patients with OSA has been shown to reduce blood pressure, improve glycemic control, reduce proinflammatory markers, and lower the risk of cardiovascular disease. Addressing sleep disorders, improving sleep quality, and ensuring adequate sleep duration should be prioritized in both public health initiatives and clinical practice. By doing so, the burden of cardiometabolic disease, and related conditions can be significantly reduced. 

The aim of this Article Collection is to showcase articles that report on the relationship between sleep and cardiometabolic health.

Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 25 August 2025.

Please submit your manuscript on our website, quoting the promo code RHCLM for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Francis Straw at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Everlyne G Ogugu, Postdoctoral research fellow, Betty Irene Moore School of Nursing, University of California Davis, California, USA

Vinay Kumar, Heart and Vascular Institute, Pennsylvania State University, Hershey Medical Center, Hershey, PA, USA

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Today in Pulmonary Medicine from the Bench to Bedside and Beyond" in the International Journal of General Medicine.

The International Journal of General Medicine seeks to publish innovations in clinical, translational, and basic science that improve our knowledge and management of pulmonary diseases. Although the scope of pulmonary medicine is vast, we seek impactful contributions that use state-of-the-art approaches to promote lung health in the areas of obstructive airways disease, fibrosis, pulmonary hypertension, sleep, neural control of breathing, environmental medicine, and population health. Topics may also include new therapeutics, biomarkers, diagnostics, devices, and new research methodology.

Lung diseases represent one of the most widespread and severe categories of medical conditions globally. In the United States alone, tens of millions of people are affected by various forms of lung disease, ranging from mild respiratory issues to life-threatening conditions. These diseases include chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and lung cancer, among others. The primary causes of lung disease are well established: tobacco smoke—both firsthand and secondhand exposure—remains the leading risk factor. In addition, respiratory infections such as pneumonia and influenza can significantly damage lung function, particularly in vulnerable populations. Genetic factors also play a critical role, with inherited conditions like cystic fibrosis contributing to chronic respiratory problems. Environmental pollutants, occupational exposures, and lifestyle factors further compound the risk, making lung health a critical area of public health concern.

Article types such as Original Research, Reviews and Commentaries are welcomed. Case reports/series are not sought; any submitted to the International Journal of General Medicine will be diverted to the International Medical Case Reports Journal.

Topics of interest include but are not limited to:
Innovative pulmonary therapeutics

• Chronic obstructive pulmonary disease (COPD)
• Pulmonary hypertension
• Pulmonary fibrosis
• Genetic factors of pulmonary health
• Environmental and lifestyle factors affecting pulmonary health

Keywords

1 Respiratory
2. Lung
3. Airways
4. Fibrosis
5. Population health

All manuscripts submitted to the Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code 5E564  to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is March 16 2026.

Guest Advisor

Professor Reynold A. Panettieri, Jr., MD, Rutgers University, New Brunswick, NJ USA

[email protected]

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Tumor Microenvironment, Pathogenesis, and Novel Therapeutic Approaches for Solid Tumors and Metastasis" in the International Journal of General Medicine.

The tumor microenvironment (TME) plays a pivotal role in the initiation, progression, and metastasis of solid tumors. Comprised of a dynamic network of immune cells, stromal fibroblasts, blood vessels, extracellular matrix components, and signaling molecules, the TME forms a supportive ecosystem that sustains tumor growth while shielding it from immune surveillance. This complex microenvironment influences tumor behavior, promoting angiogenesis, immune evasion, and therapeutic resistance. Furthermore, the interaction between tumor cells and the TME modulates critical pathways involved in metastasis, from local invasion through lymphovascular channels to colonization at distant sites.

In recent years, advances in immunotherapy and targeted therapies have transformed cancer treatment paradigms. These therapies, by modulating the tumor immune microenvironment, reprogram key metabolic and immune pathways, stimulating anti-tumor immune responses and creating an immune-permissive environment. Immunotherapies, particularly immune checkpoint inhibitors (ICIs), have emerged as central components of cancer treatment. Simultaneously, targeted therapies that disrupt specific oncogenic signaling pathways have further improved patient outcomes.

Despite these successes, not all patients benefit equally. Resistance to immunotherapy and targeted therapy, as well as the adaptive changes within the TME, remain significant challenges. The mechanisms underlying therapeutic resistance, including immune evasion and alterations in TME composition, are still poorly understood, underscoring the need for further research.

This Article Collection will explore the latest advances in anti-tumor therapies and their impact on the TME. We invite contributions that elucidate molecular mechanisms, identify novel therapeutic targets, and highlight innovative combination strategies involving chemotherapy, immunotherapy, targeted agents, and other emerging modalities. By advancing our understanding of TME dynamics and therapeutic resistance, we aim to foster the development of more effective strategies for overcoming treatment resistance and improving clinical outcomes across diverse tumor types.

Submissions are welcomed from researchers in molecular biology, pathology, pharmacology, and clinical oncology. Our goal is to assemble a comprehensive body of work that enhances the therapeutic landscape for solid tumors and metastasis, ultimately guiding future research and improving patient outcomes.

Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 1 August 2025.

Please submit your manuscript on our website, quoting the promo code JVYGG for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Francis Straw at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Dr. Weijie Ma, Dartmouth Health

Dr. Jiannan Li, Washington University in St. Louis

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Understanding the Biological Mechanisms of Aging Diseases through Integrating Multiomics Data" in the International Journal of General Medicine.

The biological mechanisms of aging-related diseases, such as Alzheimer’s disease, osteoporosis, cardiovascular disorders, etc., remain complex. Advancements in multiomics technologies—such as genomics, transcriptomics, metabolomics, and spatial and single-cell omics—are providing unprecedented insights into these mechanisms. By integrating data from various molecular layers and resolutions, researchers can uncover the intricate networks that contribute to the onset and progression of aging and associated diseases, enabling a holistic view of the molecular changes occurring across different biological systems.

Aging-related diseases are among the leading causes of morbidity and mortality worldwide. Understanding the molecular mechanisms that underlie these diseases could lead to more effective therapeutic interventions, early detection biomarkers, and personalized treatment strategies. By leveraging multiomics data—including bulk, single-cell and spatial omics data—researchers can explore the complex mechanisms at multiple biological scales. This integrated approach is essential for identifying key molecular drivers of aging, deciphering pathways that lead to disease, and discovering novel targets for intervention.

This Article Collection welcomes original research papers that address the integration of multiomics data to uncover the biological mechanisms of age-related diseases. Subtopics may include, but are not limited to, 1) multiomics data integration, 2) identification of biomarkers, pathways, networks and therapeutic targets, and 3) novel computational tools for multiomics analyses. We encourage submissions that apply machine learning, artificial intelligence, and advanced statistical techniques to analyze large-scale multiomics datasets. This collection aims to bring together researchers from diverse fields to contribute toward a deeper understanding of aging and disease through cutting-edge multiomics research.

Please review the journal scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 25 August 2025.

Please submit your manuscript on our website, quoting the promo code NVKEK for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Francis Straw at [email protected] with any queries regarding this Article Collection.

Guest Advisor

Dr. Anqi Liu, Tulane University

Dr. Anqi Liu is an instructor at Tulane University with a strong foundation in biomedical informatics, biostatistics, and medicine. Her research leverages her medical background and statistical expertise to interpret complex data, particularly in whole genome sequencing (WGS), transcriptome-wide association studies (TWAS), multi-omics data integration, single-cell sequencing data, and spatial transcriptomics. She focuses on constructing influential models using machine learning, artificial intelligence, and advanced deep learning techniques. Her current research primarily aims to discover significant biomarkers and causal mechanisms underlying complex human diseases, especially those related to aging, such as osteoporosis and Alzheimer's disease. Additionally, she is working on developing innovative methods in biomedical informatics that are crucial for omics imputation and subsequent analyses.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Advancements in Nanomedicine: Transforming Dental Care", organized by Guest Advisor Dr. Rodrigo França (University of Manitoba, Canada).

Nanomedicine is at the forefront of revolutionizing the field of dentistry, offering innovative solutions that promise to enhance patient outcomes and redefine dental care practices. This burgeoning field leverages the unique properties of nanomaterials to address complex dental challenges, ranging from preventive care to therapeutic interventions. As the integration of nanotechnology into dental applications continues to evolve, it opens new avenues for research and clinical practice, making it an exciting area of exploration for both scientists and practitioners.

The importance of nanomedicine in dentistry cannot be overstated. With the increasing prevalence of dental diseases and the demand for more effective and less invasive treatments, nanotechnology provides a powerful toolkit for addressing these needs. The precision and versatility of nanomaterials enable targeted drug delivery, improved diagnostic techniques, and enhanced material properties for dental restorations. These advancements not only improve the efficacy and safety of dental treatments but also contribute to better patient experiences and long-term oral health outcomes. By transforming the landscape of dental care, nanomedicine holds the potential to significantly impact public health on a global scale.

This Article Collection seeks to gather cutting-edge research and reviews that explore the multifaceted applications of nanomedicine in dentistry. We invite submissions that delve into topics such as nanoparticle-based drug delivery systems, nanocomposite materials for dental restorations, nanoscale diagnostics, and the role of nanotechnology in regenerative dentistry. The collection welcomes original research articles, comprehensive reviews, and case studies that highlight innovative methodologies and applications within the scope of the International Journal of Nanomedicine. Through this collection, we aim to foster a deeper understanding of how nanomedicine is transforming dental care and to inspire future research and collaboration in this dynamic field.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code PFMNI for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

The manuscript submission deadline is 31 July 2025.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest advisor

Dr. Rodrigo França, University of Manitoba

[email protected]

Dr. França has devoted his time to develop new dental biomaterials to provide clinical solutions for patients. Also, he is interested in understanding issues like: surface analyses of dental biomaterials, dental adhesion, the adhesion of endotoxin on dental surfaces, and to developing new magnetic nano-devices to treat chronic diseases.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advances in Polymeric Carriers for Oral Drug Delivery", organized by Dr. Wing-Fu Lai (University of Leeds, UK) in the International Journal of Nanomedicine.

Nanomedicine has emerged as a transformative field, revolutionizing various aspects of drug delivery, particularly in the realm of oral administration. Oral drug delivery continues to be the most preferred route due to its convenience, patient compliance, and cost-effectiveness. Nonetheless, numerous therapeutic agents face significant challenges such as poor solubility, stability, and bioavailability, which severely restrict their clinical efficacy when administered orally.

In recent years, nanomedicine-based approaches, especially the use of polymeric carriers, have gained considerable attention as promising solutions. These polymeric carriers, often operating at the nanoscale level, can effectively protect drugs from the harsh gastrointestinal conditions encountered during oral delivery. Moreover, they possess tunable physicochemical properties that can be precisely engineered to enhance mucosal adhesion and drug absorption, which are crucial for improving the overall bioavailability and therapeutic outcome.

The integration of computational modeling and advanced characterization techniques has further propelled the rational design of polymer-based nanosystems for oral drug delivery. These cutting-edge tools enable researchers to predict and optimize the behavior of polymeric carriers in complex biological environments, ensuring improved efficacy and safety profiles.

This Article Collection aims to provide a comprehensive platform for showcasing the latest research findings and critical reviews on the development, characterization, and application of polymeric carriers within the context of nanomedicine-driven oral drug delivery. We welcome original research articles and review papers covering, but not limited to:

• Design and synthesis of novel polymeric carriers with nanoscale precision for enhanced oral drug delivery.
• Mechanistic studies on drug-polymer interactions and release kinetics within the gastrointestinal environment.
• Advances in bioadhesive, mucoadhesive, and stimuli-responsive polymer systems designed for oral drug administration.
• The application of computational and machine learning approaches in the realm of polymer-mediated oral drug delivery, particularly in predicting nanoparticle behavior, optimizing formulations, and identifying potential candidates for further development in nanomedicine.
• In vitro and in vivo evaluation of polymeric carriers for oral therapeutics.

By gathering contributions from experts across materials science, pharmaceutical technology, and nanomedicine, this Article Collection aims to highlight the current progress and future directions in the field of nanomedicine-based oral drug delivery. It seeks to foster interdisciplinary collaboration and innovation, driving the development of more effective and safe oral drug delivery systems that can overcome the existing challenges and unlock new therapeutic possibilities.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code JBKQL for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

The manuscript submission deadline is 31 December 2025.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest advisor

Dr. Wing-Fu Lai, University of Leeds

[email protected]

Dr. Wing-Fu Lai obtained his MSc degree in Materials Engineering and Nanotechnology from the City University of Hong Kong, and earned his PhD in Chemistry from the University of Hong Kong. He is currently an Associate Professor in School of Food Science and Nutrition at the University of Leeds. His research focus lies in the development and engineering of polymeric materials for food and pharmaceutical applications. He has been ranked among the world's top 2% of scientists by Stanford University.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Cell Penetrating Peptides as Precision Targeting Agents in Nanomedicine", organized by Guest Advisors Dr. Tohru Yamada (University of Illinois at Chicago, USA) and Dr. Duy Binh Tran (University of Illinois at Chicago, USA).

Cell-penetrating peptides (CPPs), also referred to as protein transduction domains (PTDs), are typically short peptides (30 amino acids) that have been widely studied. Since the discovery of the first CPP over 30 years ago, new mechanisms and applications for CPPs have been investigated in preclinical and clinical studies.

The importance of CPPs in nanomedicine cannot be overstated. They offer a unique solution to the challenge of cellular uptake, a critical barrier in the efficacy of many therapeutic agents. By enhancing the delivery of drugs, imaging agents, and therapeutic peptides, CPPs have the potential to improve treatment outcomes for many diseases, including cancer, inflammation, diabetes etc.

This Article Collection seeks to compile the most recent and innovative research on CPPs, focusing on their application as targeted agents in nanomedicine. We aim to provide a comprehensive platform for scholars to share their findings, discuss challenges, and explore future directions in the field. The collection will emphasize the practical applications and biological validation of CPPs, steering clear of purely computational analyses without experimental corroboration.

We invite submissions that address, but are not limited to, the following subtopics:

• Drug Delivery: Studies on the use of CPPs to enhance the cellular uptake of chemotherapeutic agents, gene therapies, and other drugs for treating diseases such as cancer, inflammation, and diabetes.
• Diagnostic Applications: Research on the employment of CPPs to deliver imaging contrast agents for improved visualization of target tissues in diagnostic procedures.
• Therapeutic Peptides and Proteins: Exploration of CPPs as vehicles for therapeutic peptides and proteins, focusing on their ability to facilitate intracellular delivery and enhance therapeutic effects.
• Mechanisms of Action: Investigations into the molecular mechanisms by which CPPs facilitate cell penetration and cargo delivery, including endocytosis, direct translocation, and other pathways.
• Clinical Translation: Reports on the progress of CPP-based therapies in clinical trials, including challenges and successes in translating preclinical findings to patient care.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code DRQZJ for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

The manuscript submission deadline is 30 September 2025.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest advisors

Dr. Tohru Yamada, University of Illinois at Chicago

[email protected]

Dr. Tohru Yamada is an Associate Professor in the Department of Surgery, Division of Surgical Oncology at the University of Illinois, College of Medicine. He was a Post-Doctoral Fellow in the school's Department of Microbiology & Immunology. He received his B.S., M.S. and Ph.D. in Biotechnology from Tokyo Institute of Technology, Japan. His research interests and expertise are the discovery and development of new class of peptide-based anticancer agents and carriers for imaging agent targeting cancers on the basis of molecular biology, protein/peptide chemistry, cell biology and cancer biology. He holds ~25 issued and pending US and international patents, and has authored a number of original research/review/news. Dr. Yamada is currently a member of the Editorial Board of several peer-reviewed scientific journals such as International Journal of Nanomedicine. 

Dr. Duy Binh Tran, University of Illinois at Chicago

[email protected]

Dr. Duy Binh Tran is a Postdoctoral Fellow in the Department of Surgery, Division of Surgical Oncology, at the University of Illinois College of Medicine. Previously, he held postdoctoral positions in the College of Medicine at Inha University, South Korea, and at the Kyoto Institute of Technology, Japan. He earned his B.S. and M.S. in Biotechnology from Can Tho University, Vietnam, and his Ph.D. in Materials Chemistry from the Kyoto Institute of Technology, Japan. Dr. Tran's research focuses on developing potential treatments for breast and ovarian cancers. His work involves using peptide-based carrier agents, bacteria, and recombinant proteins. He has authored several original research articles and review papers.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Shaping the Tumor Microenvironment with Nanomedicine", organized by Guest Advisor Dr. Yong Teng.

The tumor microenvironment (TME) is a unique ecosystem surrounding a tumor, comprising various cells, molecules, and structures that interact with cancer cells. This environment plays a critical role in promoting tumor growth, enabling immune evasion, and driving treatment resistance. Traditional cancer therapies often struggle to penetrate and alter this dynamic ecosystem, making the TME a prime target for innovative therapeutic approaches.

Nanomedicine has emerged as a powerful tool to directly modulate the TME. By designing nanoparticles to deliver drugs, genetic material, or immunomodulatory agents specifically to the tumor site, researchers can precisely target and remodel components of the TME. One notable application is the use of immunostimulatory nanoparticles to enhance T-cell infiltration into the TME to counteract the immunosuppressive conditions established by many tumors. Nanoparticle-based neoantigen vaccines are another promising frontier in cancer treatment, exploiting the specificity of tumor neoantigens to engage the immune system in a targeted and personalized attack on cancer. These innovations hold great potential for more effective and targeted cancer therapies. In addition, recent advances in nanomedicine are enabling responsive nanoparticles that can release their therapeutic payload upon detection of specific signals within the TME, such as a drop in pH or the presence of certain enzymes. While challenges remain - such as ensuring targeted delivery and minimizing off-target effects - ongoing research continues to reveal innovative ways to use nanomedicine to alter the TME and improve therapeutic outcomes. As these technologies evolve, nanomedicine has the potential to reshape the therapeutic landscape by transforming the TME from a cancer-supportive niche to an environment that actively combats tumor growth.

All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code UUQVA for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

The manuscript submission deadline is 30 September 2025.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest advisor

Dr. Yong Teng, Emory University

[email protected]

Dr. Teng’s primary research interests focus on connecting three major themes—tumor microenvironment, tumor metabolism, and metastasis—by studying tumor-immune interactions and developing combination antitumor therapies and treatment strategies. He also has extensive experience in drug discovery, nanomedicine, and biomarker studies. He has published over 160 papers in high-profile journals.

View all papers in this article collection

We are pleased to announce a new Article Collection in the International Journal of Women’s Health, dedicated to the game-changing role of screening in the management of cervical cancer. Since their introduction, cervical cancer screening programs have revolutionized patient care, offering significant benefits in the early detection and prevention of advanced disease. As a cost-effective public health strategy, screening has reduced cervical cancer mortality rates worldwide, particularly in countries with organized screening programs. 

Given its global importance, the International Journal of Women’s Health is welcoming the submission of original research articles, reviews, and perspectives on the topic of cervical cancer screening. 

The collection, edited by the Editor-In-Chief Professor Elie D. Al-Chaer, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, technologies, or protocols that have significantly altered the standard of care.

While the call is open to receive manuscripts across the broad spectrum of screening in cervical cancer, the Editors are particularly interested in manuscripts relating to the following areas:

• Technological advancements in screening methods: HPV-based testing, AI-assisted cytology, and novel biomarkers for early detection.
• Addressing health disparities: strategies to improve screening access in low-resource settings, marginalized communities, and high-risk populations.
• Implementation challenges: cost-effectiveness, national program scalability, and overcoming cultural/behavioral barriers to screening adherence.
• Follow-up and clinical management: protocols for abnormal results, colposcopy, biopsy and treatment of precancerous lesions, balancing overtreatment risks and undertreatment delays
• Emerging paradigms: role of self-sampling, telemedicine, and vaccination-screening synergies in eradicating cervical cancer.

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 1 April 2026.

Please submit your manuscript on our website, quoting the promo code 2341B for a 20% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Current Challenges and Future Directions in Gynecologic Cancer: Epidemiology, Prevention and Emerging Therapies" in the International Journal of Women's Health.

Gynecologic cancers, including malignancies of the uterine cervix, ovary, endometrium, vulva, and vagina, present a significant and growing health burden globally. These cancers are predisposed by a complex interplay of genetic, environmental, and lifestyle factors, with incidence and outcomes varying significantly by geographic region, access to healthcare, and socioeconomic status. Despite advances in early detection, surgical techniques, radiation therapy, and systemic treatments, gynecologic cancers remain a leading cause of cancer-related morbidity and mortality in women. As populations age and new risk factors and disease patterns emerge, we urgently need to grow our understanding of gynecologic cancer epidemiology, refine preventive strategies, and develop more effective therapies with fewer comorbidities. 

This Article Collection aims to bring together cutting-edge research and expert perspectives to address the current challenges and future directions in gynecologic oncology, with a focus on epidemiology, prevention, and emerging therapies. We hope to promote an integrative approach to gynecologic cancer care that crosses prevention, diagnosis, treatment, and survivorship by highlighting the latest advances in basic, translational, and clinical research. 

We envision this Collection to aid as a platform for assorted contributions, including global epidemiologic studies, novel preventive and screening strategies, innovative therapeutic approaches such as immunotherapy and targeted therapy, and insights into disparities in gynecologic cancer care. Additionally, this Collection aims to address critical topics such as the impact of genetic and molecular biomarkers on personalized treatment and the potential of multidisciplinary collaborations to enhance patient outcomes and quality of life. 

Subtopics

• Global epidemiology and disparities in gynecologic cancer
• Advances in preventive and screening strategies
• Novel therapeutics: immunotherapy, targeted therapy, and beyond
• Genetic and molecular biomarkers in gynecologic cancer
• Multidisciplinary approaches to gynecologic cancer care

Preferred article types include original research, systematic reviews, meta-analyses, policy and practice reports and case reports, all in line with the journal’s accepted article types. 

Keywords

Gynecologic oncology; Cancer epidemiology; Prevention strategies; Targeted therapy; Immunotherapy in gynecologic cancers; Biomarkers; Disparities in cancer care; Multidisciplinary cancer treatment

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 30 August 2025.

Please submit your manuscript on our website, quoting the promo code QOQGD for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest advisors

Dr. Ottavia D’oria, San Camillo-Forlanini Hospital, Italy

[email protected]

Prof. Dr. Andrea Giannini, Sapienza University of Rome, Italy

[email protected]

Dr Tullio Golia D’Augè, Sapienza University of Rome, Italy

[email protected]

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Ripple Effects of Breast Cancer Screening: Imaging Advances, Cost-Effectiveness, and Sustainability in Modern Care" in the International Journal of Women's Health.

Breast cancer is the most common cancer among women of all ages, representing a significant challenge not only for the patients directly affected but also for the broader community due to its social, economic, psychological, and environmental implications. Advances in imaging and therapy have improved survival rates, particularly through early diagnosis, enabling more effective and personalized treatments. However, disparities persist, especially for women with dense breasts or those at high risk, where early detection remains a challenge. 

Equally critical is the need to ensure access to preventive measures and early detection for underserved populations, who often face barriers due to geographic, economic, or systemic inequities. The lack of uniform guidelines for breast cancer screening, driven by the diversity in population characteristics worldwide, further complicates the implementation of effective strategies. In this context, artificial intelligence (AI) offers a transformative opportunity, particularly in resource-limited settings, by improving the cost-effectiveness of screening programs. AI enhances the performance of basic tools such as mammography, enabling broader access to early detection initiatives while optimizing resources. 

Innovations in minimally invasive breast biopsy procedures have also significantly advanced the precise identification of prognostic factors, allowing for more tailored therapeutic approaches. These techniques not only improve patient outcomes but also contribute to cost-effective care by avoiding overtreatment and enabling more efficient resource allocation. 

The growing emphasis on sustainability in healthcare highlights the need to integrate environmentally responsible and economically viable practices into every stage of breast cancer management, from diagnostics to treatment. 

This Article Collection aims to explore and discuss all facets of breast cancer management, including innovations in imaging, advances in therapy, the role of AI, cost-effectiveness, and the importance of equitable access to care, while addressing the broader socio-economic and sustainability challenges.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 30 September 2025.

Please submit your manuscript on our website, quoting the promo code SAPWV for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest advisors

Dr. Daniele Ugo Tari, Department of Breast Imaging, District 12, Caserta Local Health Authority

[email protected]

Daniele U. Tari, MD, radiologist, is the Director of the Department of Breast Imaging, District 12, at Caserta Local Health Authority in Italy. He is a member of the Italian College of Senologists and the Italian School of Senology, and he has actively contributed to the development of Italian guidelines for breast cancer diagnosis and management. In his professional endeavours, he explores the latest advancements in breast imaging, emphasizing the importance of specialized training in this specific area and advocating for a multimodality approach to ensure a comprehensive and early diagnosis for patients. His research activity mainly focuses on breast imaging, breast disease, oncology and public health. Dr. Tari has authored over 80 papers published in national and international journals, accumulating more than 500 citations. He has also served as a speaker and moderator at several national and international courses and congresses and assumed editorial responsibilities, serving as an editorial board member for several high-impact international journals. Dr. Tari is affiliated with various scientific and professional organizations, including the European Society of Breast Imaging (EUSOBI), European Society of Radiology (ESR), Italian Society of Medical and Interventional Radiology (SIRM).

Dr. Rosalinda Santonastaso, Department of Economics, University of Campania “Luigi Vanvitelli”

[email protected]

Rosalinda Santonastaso is Lecturer in Accounting at the Department of Economics, University of Campania “Luigi Vanvitelli” in Italy, where she earned her Ph.D. in Entrepreneurship and Innovation. Her research interests focus on Internal Auditing, Sustainability Reporting, and Corporate Governance. Dr. Santonastaso has authored numerous scholarly articles published in esteemed journals, including Corporate Governance, Journal of Management and Governance, Corporate Social Responsibility and Environmental Management, Corporate Ownership and Control, International Journal of Business and Management, and Eurasian Journal of Business and Management. She actively shares her findings at national and international conferences and is an engaged member of prominent scientific organizations, including the European Accounting Association (EAA), the Italian Society of Accounting and Business Economics Professors (SIDREA), and the Italian Academy of Business Economics (AIDEA).

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Understanding Pelvic Floor Dysfunctions: Causes, Treatments, and Advances in Care" in the International Journal of Women's Health.

Pelvic floor dysfunctions (PFD) are common multifactorial heterogeneous conditions mainly due to pelvic floor injury. Otherwise, PFD may be linked to genetic, structural, and/or hormonal variables. PFD symptoms include vaginal, bowel, and lower urinary tract symptoms, as well as sexual impairments. Such symptoms include, among others, urinary and anal incontinence, an overactive bladder, pelvic organ prolapse, and sexual discomfort. 

PFDs are widespread, affecting millions of women globally. In the US, around 25% of women have at least one pelvic floor disorder. PFDs hinders women’s daily activities, inhibits their sexual function, negatively impacts their social and physical functions, and lowers their overall quality of life. However, because many women do not seek medical assistance and some are even reluctant to discuss PFD symptoms with their caregivers, it is still challenging to ascertain the actual prevalence of PFD. 

We are pleased to invite researchers, clinicians, and experts in the field to contribute to an Article Collection of papers on pelvic floor disorders for the International Journal of Women’s Health. This Collection aims to highlight recent advancements, novel treatments, and emerging research on the prevention, diagnosis, and management of pelvic floor conditions. 

We welcome original research, clinical studies, reviews, and expert perspectives that explore a wide range of topics related to pelvic floor health. Your contribution will play a crucial role in advancing knowledge and improving patient care.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 31 August 2025.

Please submit your manuscript on our website, quoting the promo code EVOMO for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest advisors

Dr. Matteo Frigerio, Milano-Bicocca University, Italy

[email protected]

Dr. Maurizio Leone, Pelvic Floor Clinic in Ospedale Policlinico San Martino di Genova, Italy

[email protected]

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Medical Case Reports Journal on “Advancing Oncology through Clinical Case Reports: Insights, Challenges, and Future Directions”, organized by our Associate Editors-in-Chief Prof. Xudong Zhu from University of Kentucky, USA, and Prof. Jiawen Bu from Shengjing Hospital of China Medical University, China.

Clinical case reports in oncology provide critical insights into rare malignancies, atypical treatment responses, and novel therapeutic approaches. These reports bridge the gap between theoretical research and real-world clinical practice, offering clinicians and researchers actionable knowledge to improve patient outcomes.

This Article Collection aims to compile high-quality case studies that highlight diagnostic dilemmas, innovative therapies, and multidisciplinary management strategies in oncology.

Oncology is a rapidly evolving field where individualized patient care is paramount. Case reports serve as foundational tools for identifying emerging trends, unexpected side effects, and therapeutic breakthroughs. By documenting unique clinical scenarios, this collection will foster a deeper understanding of tumor biology, resistance mechanisms, and personalized treatment paradigms. Such knowledge is vital for advancing global cancer care and informing future clinical trials.

We invite submissions of case reports, case series, and clinical vignettes that address the following subtopics:

• Rare or underreported malignancies
• Unusual presentations or complications of common cancers
• Innovative uses of targeted therapies, immunotherapies, or combination regimens
• Ethical and logistical challenges in oncological care
• Long-term survivorship and quality-of-life considerations

All submissions must align with the journal's scope of translational and clinical research.

Please submit your manuscript on our website, using the promo code FB6C1 for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Advancing Oncology through Clinical Case Reports: Insights, Challenges, and Future Directions” Collection. We will be welcoming relevant papers up until the 30th June 2026.

Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Diagnostic Dilemmas and Therapeutic Insights in Cardiovascular Case Reports", in the International Medical Case Reports Journal, organized by our Associate Editors-in-Chief Dr. Vinay Kumar from Pennsylvania State University Hershey Medical Center, USA, and Ms. Anuradha Tyagi from Institute of Nuclear Medicine & Allied Sciences, India.

Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide, spanning a broad spectrum of presentations, complexities, and therapeutic challenges. Case reports play a unique and indispensable role in cardiology by capturing novel presentations, rare complications, unexpected treatment responses, and innovative diagnostic approaches. This Article Collection aims to highlight clinically significant case reports that enhance our understanding of cardiovascular and vascular conditions and inform frontline clinical decision-making.

Despite rapid advances in cardiovascular medicine, clinicians continue to encounter unexpected or atypical patient scenarios. Case reports serve as valuable educational tools, offering real-world insights beyond the confines of large trials and guidelines. They often provide the first glimpse of emerging diseases, drug side effects, procedural innovations, and complex comorbidities. By systematically gathering high-quality case reports, we create a platform that promotes shared clinical learning and fosters global dialogue on rare and instructive cardiovascular phenomena.

This Article Collection invites submissions that align with the scope of Case Reports in Cardiology, focusing on all aspects of heart and vascular health. Subtopics may include - but are not limited to - ischemic heart disease, structural heart defects, electrophysiological disorders, valvular diseases, cardiomyopathies, vascular anomalies, endovascular interventions, and cardio-oncology. We welcome classical case reports, case series, clinical images, and brief communications that offer new insights, challenge existing paradigms, or prompt further investigation. Submissions should clearly articulate the educational value and clinical relevance of the case, ideally supported by imaging, histopathology, or procedural documentation where applicable.

Please submit your manuscript on our website, using the promo code 71858 for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Diagnostic Dilemmas and Therapeutic Insights in Cardiovascular Case Reports” Collection. We will be welcoming relevant papers up until the 31st May 2026. 

Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Targeted Personalized Biologic Therapies: Changing the Game in Asthma Treatment” in the Journal of Asthma and Allergy.

This Collection, edited by the Editor-In-Chief Dr. Amrita Dosanjh, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, and technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

Asthma is a chronic inflammatory lung condition that results in airway obstruction and difficulty breathing. Left untreated, severe asthma flares can lead to hospitalization and even death. Typical front-line treatments of asthma include corticosteroids (which cause immunosuppression with long-term use) and bronchodilators (such as albuterol inhalers). While biologic therapy is relatively new in asthma treatment, Global Initiative For Asthma (GINA) guidelines include biologics as therapeutic options. There are several biologics currently available and in development for the treatment of asthma.

While the call is open to receive manuscripts across the broad spectrum of asthma-modulating biologics, the Editors are particularly interested in manuscripts relating to the following areas:

• Signaling pathways and cellular targets
• Novel mechanisms of action of new candidate biologics
• Anti IL-4 and IL-13 combination biologics and monoclonal antibodies
• Treatment and dosing strategies based on asthma typing
• Biologic switching and combination therapy
• Long-term efficacy and safety studies

Submitting authors are eligible for a 20% discount on the Article Publishing charge by applying the following code at the point of submission SRNMA. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Ashley Ambros at [email protected].

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

Please submit your manuscript on our website. The deadline for submitting manuscripts is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Addressing Global Differences in HCC Risk Factors and Management Strategies" in the Journal of Hepatocellular Carcinoma.

The Journal of Hepatocellular Carcinoma solicits papers addressing global diversity in HCC risk factors and their effect on outcomes. Although significant advances have been made in multidisciplinary and individualized screening and treatments for HCC, such sophisticated methods are relatively expensive and therefore remain beyond the reach of many patients in less economically developed countries where local resources and healthcare budget are limited. To address the global differences in treatment provision, the journal Editors are seeking to publish multidisciplinary clinical and translational studies, cost-effective screening and treatment strategies and consensus statements, including those which consider available local resources. 

Please contact Cassie Houtz at [email protected] with any queries.

Please view the journal Aims and Scope and author submission guidelines. The deadline for submissions is 1 December 2025.

Please submit your manuscript on our website, quoting the promo code UIPMT for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

The Journal of Hepatocellular Carcinoma is pleased to announce an upcoming Article Collection dedicated to the transformative role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.

Immune checkpoint inhibitors targeting PD-1 and PD-L1 have significantly impacted the treatment landscape for HCC. By blocking the signals that prevent T-cells from attacking cancer cells, these inhibitors enhance the immune system's ability to combat tumors. These therapies have shown potential in improving survival rates, reducing tumor burden, and providing durable responses in patients who previously had few effective options.

Given the impact and continued role of immune checkpoint inhibitors in treating HCC, we welcome submissions of original research articles, reviews, and perspectives that contribute to the understanding and advancement of these therapies. Of particular interest would be:

1. Papers focusing on peri-operative immunotherapy approaches in early-stage HCC to improve resectability, induce pathologic responses at time of surgery, and/or reduce rate of recurrence after resection.
2. Papers related to the intermediate/advanced HCC setting focusing on potential mechanisms of:

• Resistance to immunotherapy in advanced HCC based on different risk factor, e.g. viral vs. non-viral related HCC and MASH-related HCC.
• Synergy between immunotherapy and targeted and other systemic therapies.
• Synergy between immunotherapy and localized therapy approaches to improve response rates and survival outcomes.

This Article Collection will be included in a wider Game Changer Series focused on breakthrough therapies across medicine. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor & Francis and Dove Medical Press, increasing the discoverability and visibility of your research.

Please view the journal Aims and Scope and author submission guidelines. The deadline for submissions is 1 April 2026.

Please submit your manuscript on our website. Submitting authors are eligible for a 20% discount on the Article Publishing Charge. To apply this discount, enter the code SDSZG when prompted during submission.

Please contact Commissioning Editor Cassie Houtz at [email protected] with any questions.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation", in the Journal of Inflammation Research.

This Collection, edited by the Editor-In-Chief Prof. Ning Quan, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, and technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

Chronic inflammation is the hallmark of many diseases. These conditions can be crippling to patients. Traditional anti-inflammatory drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, are non-specific, causing further systemic problems with continued use. By contrast, biologic therapies harness the specificity necessary to relieve inflammation while also reducing off-target and non-specific effects.

While this call is open to receive manuscripts highlighting all anti-inflammatory biologics, the Editors are particularly interested in manuscripts relating to the following areas:

• Tumor necrosis factor inhibitors
• Interleukin inhibitors
• Monoclonal antibody specificity studies
• Novel mechanisms of action of new candidate biologics
• The role of biosimilars in treating inflammatory disease
• Indications and contraindications
• Cell-based therapies to quell inflammation

Submitting authors are eligible for a 20% discount on the Article Publishing charge by applying the following code at the point of submission: OTIPZ. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Ashley Ambros ([email protected]). Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript. Please submit your manuscript on our website. The deadline for submitting a manuscript is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Cellular and Molecular Drivers of Lung Inflammation in Respiratory Diseases", in the Journal of Inflammation Research.

Lung inflammation is a hallmark characteristic feature of many respiratory diseases, from asthma and chronic obstructive pulmonary disease (COPD) to pulmonary fibrosis and acute respiratory distress syndrome (ARDS). While inflammation serves as a protective role in response to infection or injury, dysregulated or persistent inflammatory responses can lead to progressive lung damage and impaired respiratory structure and function. Understanding the cellular and molecular drivers behind lung inflammation is crucial for developing targeted therapies that can modulate these pathways without compromising host defense. This topic explores the intricate network of immune and structural cells, signaling pathways, and other cofounding factors that orchestrate inflammatory responses in the lung. This study will offer valuable insight into both disease mechanisms and potential intervention points.

This topic is important because it establishes the foundational understanding of lung inflammation, a key driver of the onset, progression, and severity of numerous respiratory diseases that together pose a significant global health burden.
Studying this topic also matters as it provides following additional advantages:
• Better Understanding of Disease Mechanisms
• Development of Targeted Therapies
• Early Diagnosis and Biomarkers tools
• Understanding Environmental and Infectious Triggering agent

The subject of this Collection, "Cellular and Molecular Drivers of Lung Inflammation in Respiratory Diseases," explores the complex cellular and molecular processes that drive and regulate lung inflammation. It covers key subtopics including immune cell activation, structural cells dysfunction, cytokine and chemokine signaling, and the impact of environmental and infectious triggers on pulmonary inflammation. Special attention will also be given to emerging therapeutic targets and biomarker discovery. This scope is well-aligned with the Journal of Inflammation Research, which emphasizes cutting-edge studies on inflammation-related processes. The ail of this collection will be to encourage the submission of original research articles, comprehensive reviews, and brief reports that will provide new insights into the cellular and molecular understanding of lung inflammation in both acute and chronic respiratory diseases.

Keywords

1. Lung inflammation
2. Respiratory diseases
3. Immune cell signaling
4. Cytokines and chemokines
5. Biomarkers of lung disease

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, using the promo code 5DF61 to indicate that the manuscript is intended for this Article Collection. The deadline for submitting a manuscript is 2 March 2026.

Guest Advisors

Dr. Ashish Kumar, North Dakota State University

[email protected]

I am a Doctoral Graduate Research Assistant in pharmaceutical sciences, specializing in the pathophysiology of asthma. My research explores the dynamic relationship between lung physiology and hormonal influences in disease conditions, aiming to advance respiratory pharmacology and personalized medicine.

Dr. Nilesh Sudhakar Ambhore,University of Minnesota

[email protected]

I am a dedicated and self-motivated research scientist with over 8 years of extensive experience in pharmacology, molecular biology, small molecule drug discovery, and target validation. My proven expertise encompasses the entire preclinical drug development process, including development of in vivo disease models, mechanism of action investigation, endpoint analysis, and disease modelling.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Integrating Artificial Intelligence into Inflammation and Cancer Immunology: From Biomarkers Discovery and Mechanistic Insights to Precision Therapeutics", in the Journal of Inflammation Research.

Inflammation exerts a complex and context-dependent influence on both oncogenesis and the efficacy of cancer therapies. Acute inflammatory responses may enhance anti-tumor immunity; however, chronic inflammation is more commonly implicated in tumor initiation, progression, and the facilitation of immune evasion. Persistent inflammatory signaling contributes to the development of an immunosuppressive tumor microenvironment (TME) by promoting the infiltration of immunoregulatory cell populations, including regulatory T cells, myeloid-derived suppressor cells, and M2-polarized macrophages. This immunosuppressive milieu hinders the therapeutic effectiveness of immune checkpoint inhibitors and adoptive cell therapies such as chimeric antigen receptor T cells. Inflammatory cytokines such as IL-6, IFN-, and TNF-α also play dual roles, with context-dependent capacities to either promote immune resistance or augment immune activation.

Consequently, the modulation of inflammatory pathways holds promise for the development of patient-specific therapeutic strategies aimed at enhancing responses to anti-cancer treatments. For example, the combination of anti-inflammatory agents with immune checkpoint inhibitors may be particularly beneficial in patients exhibiting elevated baseline levels of inflammation. Among the most promising anti-inflammatory approaches is the use of epigenetic inhibitors, including histone deacetylase (HDAC) inhibitors and DNA methyltransferase (DNMT) inhibitors, which have demonstrated synergistic potential when used in combination with immunotherapies to overcome resistance mechanisms. Importantly, the identification of inflammation-associated biomarkers is essential for effective patient stratification. Such biomarkers would enable the rational design of combinatorial treatment regimens and improve the predictive capacity for therapeutic responses in the context of cancer immunotherapy.

The complex regulatory networks that control inflammation within TME are pivotal to the rational design of combinatorial strategies. Recent advances in artificial intelligence (AI), multi-omics technologies, and computational biology now offer powerful tools for the identification and validation of inflammation-associated biomarkers, as well as for elucidating the epigenetic alterations that drive their activation. These insights can be leveraged to inform the development of targeted therapeutic approaches, thereby facilitating the identification of individuals most likely to benefit from specific immunoepigenetic interventions.

This Article Collection seeks interdisciplinary research that investigate the role and underlying mechanisms of epigenetic alterations in the regulation of inflammation and tumor immunity. We welcome original research articles, reviews, clinical trial studies, and case reports. Submissions are also encouraged that examine the application of AI in predicting therapeutic responses and guiding precision immuno-oncology strategies.

Keywords

1. Inflammation and Tumor Immunity
2. Epigenetic Modulation
3. Artificial Intelligence in Oncology
4. Tumor Microenvironment and Metabolism
5. Diagnostic and Prognostic Biomarkers

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, using the promo code 34582 to indicate that the manuscript is intended for this Article Collection. The deadline for submitting a manuscript is 15 April 2026.

Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Neutrophils in a New Light: Emerging Roles in Inflammation", in the Journal of Inflammation Research.

Neutrophils are among the most abundant and evolutionarily conserved components of the innate immune system, long recognized for their frontline role in microbial defense and acute inflammation. However, our understanding of these cells has significantly evolved. Beyond their classical functions, neutrophils are now appreciated as highly plastic and multifunctional cells with the capacity to influence a wide range of immune responses, including those involved in chronic and sterile inflammation, tissue repair, autoimmunity, and even cancer.

This proposed Article Collection of the Journal of Inflammation Research aims to highlight the growing complexity of neutrophil biology and its implications for understanding and treating inflammatory diseases. By assembling a focused collection of high-quality original research articles, reviews, and short communications, this issue will provide readers with a comprehensive and up-to-date overview of the novel roles of neutrophils across diverse inflammatory contexts.

The field of neutrophil research is currently undergoing a paradigm shift. Advances in single-cell RNA sequencing, in vivo imaging, and functional assays have revealed striking heterogeneity among neutrophil populations, suggesting that they are far from being a homogenous cell type. Moreover, their ability to engage in crosstalk with other immune cells, influence adaptive responses, shedding neutrophil extracellular traps (NETs), and contribute to chronic inflammatory states has far-reaching implications for disease progression and therapy.

Despite this, neutrophils remain understudied compared to other immune cells, particularly in chronic disease settings where their roles are less obvious but no less critical. A dedicated special issue in the Journal of Inflammation Research would provide a much-needed platform for consolidating recent discoveries, showcasing state-of-the-art methodologies, and highlighting clinical relevance. Such an issue is well aligned with the journal’s mission to advance understanding of inflammatory mechanisms and foster translational insights into inflammation-related disorders.

This Article Collection will explore the evolving landscape of neutrophil biology with particular emphasis on novel and disease-relevant functions. The field in which submissions are welcomed address the following (but not limited to) subtopics:
1) Neutrophil heterogeneity and plasticity: Insights from single-cell and spatial profiling.
2) Neutrophil roles in chronic inflammation and autoimmunity: Contributions to diseases such as lupus, rheumatoid arthritis, and vasculitis.
3) NETs in inflammation: Molecular mechanisms, regulation, and pathological consequences.
4) Tissue-specific neutrophil behavior: Adaptation and function in lungs, liver, gut, CNS, and tumors.
5) Neutrophil interactions with adaptive immunity: Mechanisms of T cell modulation and antigen presentation.
6) Neutrophils in infection and viral inflammation: Including roles in COVID-19, sepsis, and chronic infections.

This Article Collection will serve as a comprehensive reference for scientists and clinicians working across immunology, inflammation, infectious disease, and translational medicine. By focusing on neutrophils, a cell type once considered simple but now recognized as highly influential, this issue aims to stimulate further research and innovation in the field of inflammation.

Keywords

1. Neutrophils Biology
2. Innate Immunity
3. Inflammation Resolution
4. Neutrophil Heterogeneity
5. Neutrophil Extracellular Traps (NETs)

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, using the promo code 5480B to indicate that the manuscript is intended for this Article Collection. The deadline for submitting a manuscript is 2 March 2026.

Guest Advisor

Dr. Tomasz W Kaminski, Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, WI

[email protected]

Tomasz W. Kaminski earned his doctoral degree from the Medical University of Bialystok, Poland. During his PhD training, he focused on studying hemostasis disturbances in chronic kidney disease. He joined the Sundd Lab as a postdoctoral associate in 2019. Dr. Kaminski’s research centers on innate immune mechanisms in platelets and neutrophils, as well as the pathophysiology of thrombo-inflammation. He employs state-of-the-art intravital microscopy techniques to capture real-time interactions between neutrophils and platelets during the initial phases of immune system activation. His work exhibits a truly interdisciplinary nature, as he investigates the neutrophil and platelet biology in hemophilic arthropathy, sickle cell disease and influenza. Dr. Kaminski has been recognized with numerous awards from both national and international societies and institutions. Furthermore, his research endeavors receive support from external funding sources.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Omics, Microbiome, and Artificial Intelligence: Novel Insights into Human Disease-Associated Inflammatory Responses", in the Journal of Inflammation Research, with Guest Advisors Dr. Swarna Kanchan and Dr. Minu Kesheri.

Understanding the integrative boost powered by omics technologies, human microbiota, and artificial intelligence is transforming our approach to various human diseases. Omics technologies such as epigenomics, genomics, transcriptomics, proteomics, and metabolomics provide comprehensive molecular insights for both host and microbial factors inducing inflammation, especially the dysregulated and chronic inflammation leading to various human diseases. The gut microbiota plays a pivotal role in modulating the immune system often linked to the onset and progression of various inflammatory and autoimmune diseases and maintaining homeostasis. Recent advances in multi-omics integration, powered by artificial intelligence, are enabling researchers to unravel complex host-microbe interactions, identify disease-associated molecular signatures such as driver genes and molecular pathways, and predict patient-specific responses to various therapies advancing precision medicine by facilitating earlier diagnosis, personalized treatment strategies, and improved outcomes for individuals affected by inflammatory conditions.

This topic is important because it addresses the growing need for comprehensive strategies to tackle inflammatory diseases responsible for one of the major causes of morbidity and mortality worldwide. By integrating multi-omics data, understanding the role of the microbiota, and leveraging the capabilities of artificial intelligence, researchers can gain exceptional insights into the complex mechanisms driving inflammatory responses. A comprehensive understanding of the molecular mechanisms, microbial influences, and individual variations is essential for developing effective therapies. This interdisciplinary approach has the potential to identify unique biomarkers, new therapeutic targets to develop novel and personalized medicines, and improve patient outcomes in a wide range of conditions, including inflammatory, autoimmune disorders, metabolic diseases, and cancer. Ultimately, a deeper understanding of these interactions will lead to more effective and targeted treatments, reducing the burden of inflammatory diseases on individuals and healthcare systems.

This Article Collection delves into how multi-omics approaches, gut microbiota dynamics, and artificial intelligence (AI) synergize to provide novel insights into inflammatory responses and mechanisms. The journal welcomes original research manuscripts, reviews, hypothesis formation, expert opinions, etc., relating to all aspects of inflammation.

Potential Subtopics
• Multi-Omics Profiling of Inflammatory Diseases: Integrating epigenomics, genomics, transcriptomics, proteomics, and metabolomics to identify key molecular signatures associated with different inflammatory conditions leading to various diseases.
• Microbiota's Role in Inflammation: Investigating how gut microbiota composition and function influence inflammation (dysregulated and chronic), including various metagenomics studies on dysbiosis, and host-microbe interactions.
• AI-Driven Analysis of Inflammatory Data: Applying machine learning and bioinformatics to analyze complex omics and clinical data, predict disease biomarkers, identify potential therapeutic targets, develop diagnostic personalized therapies, and improve patient management
• Novel Therapeutic Strategies Targeting Inflammation: Exploring new treatments, including precision medicine approaches, that modulate inflammatory responses by targeting specific molecular pathways or the gut microbiota.

Keywords

1. Multi-Omics
2. Microbiome
3. Machine learning
4. Precision Health
5. Inflammatory Diseases

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, using the promo code 08045 to indicate that the manuscript is intended for this Article Collection. The deadline for submitting a manuscript is 15 November 2025.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Targeting the IL-4/IL-13 Axis in the Treatment of Type 2 Inflammation", in the Journal of Inflammation Research.

This Collection, edited by the Editor-In-Chief Prof. Ning Quan, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, and technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

Type 2 inflammation occurs when immune cells, including eosinophils and mast cells, are activated, producing the cytokine IL-4 and Il-13. These cytokines are responsible for signaling the production of eosinophils, mast cells, and IgE antibodies, that lead to the release of more pro-inflammatory cytokines. Type 2 inflammatory conditions affect 10-30% of the global population, and include common conditions such as allergy, asthma, eczema, and eosinophilic esophagitis. By targeting IL-4 and IL-13, overactive immune systems can be regulated, and many patients will see a better quality of life.

While this call is open to receive manuscripts highlighting all aspects of drugs targeting the IL-4/Il-13 axis, the Editors are particularly interested in manuscripts relating to the following areas:

• Clinical studies on the efficacy and safety of IL-4 and/or IL-13 inhibitors
• Novel drug mechanistic actions
• Biologics directed against cells or pathways involved in the IL-4/IL-13 axis
• New drug candidates directed against IL-4 and/or IL-13
• Tailoring treatment in individuals with multiple Type 2 inflammatory conditions
• Drugs to treat non-allergic type 2 inflammation, such as nasal polyps
• Treatment strategies and potential side effects

Submitting authors are eligible for a 20% discount on the Article Publishing charge by applying the following code at the point of submission: YXVCF. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Ashley Ambros ([email protected]). Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript. 

Please submit your manuscript on our website. The deadline for submitting a manuscript is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Translation of Discovery: Cutting Edge Research to Study Airway Inflammation", in the Journal of Inflammation Research, with Guest Advisors Dr. Reynold Panettieri and Dr. Cynthia Koziol-White.

All currently-approved pharmaceuticals have had the same humble beginnings – a hypothesis and experiment in a laboratory. Translational research is a crucial component in drug discovery, though results obtained using in vivo animal models such as mice do not always translate well from bench to bedside. Moreover, technological advancements have made it possible to study aspects of inflammatory processes we never thought possible.

The field of translational immunology allows researchers to learn more about inflammatory processes contributing to airway disorders such as asthma and allergy. These inflammatory airway disorders are found in over 25 million individuals worldwide, and severe inflammatory responses can lead to hospitalization and even death. Preclinical and clinical research have led to the identification and production of drugs with new therapeutic targets, such as interleukin-4, interleukin-1, interleukin-33 and thymic stromal lymphopoietin.

The Guest Advisors welcome relevant clinical Original Research, Reviews, Reports, Hypothesis Formation, Commentaries, and Expert Opinions. These articles may pertain broadly to translational immunology of asthma and allergy, though special attention will be given to the following subareas:

1. Novel in vitro, in vivo, and ex vivo models to study airway inflammation such as organoids

2. New therapeutic targets

3. Genome-wide CRISPR screening for drug discovery

4. Translational information derived from Single-cell RNA seq

5. Whole tissue dynamics using spatial transcriptomics

6. Exome sequencing

7. Immunological synapses between immune cells and structural/mesenchymal cells

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, using the promo code 79538 for a 10% discount on the Article Processing Charge. The deadline for submitting a manuscript is 31 March 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advanced Technologies for Improving the Screening, Diagnosis, and Treatment of Sleep", in the Journal of Multidisciplinary Healthcare.

Sleep disorders, including insomnia, obstructive sleep apnea, restless leg syndrome, and circadian rhythm disturbances, affect millions of individuals worldwide and are increasingly recognized as critical public health concerns. Recent years have seen a surge in research and development focused on applying emerging technologies to improve the detection, understanding, and management of these disorders. From advanced biosignal acquisition to intelligent pattern recognition, technology is playing an ever-expanding role in transforming the sleep health landscape. 

Sleep disorders not only impair daily functioning but also contribute to the development of chronic conditions such as cardiovascular disease, metabolic disorders, and neurodegeneration. However, traditional sleep evaluation tools, such as polysomnography, remain resource-intensive and often inaccessible to the broader population. The integration of artificial intelligence, machine learning, and Internet of Things (IoT)-based wearables offers new possibilities for scalable, cost-effective, and continuous sleep monitoring. These advancements open the door to early detection, remote diagnosis, personalized interventions, and real-time treatment optimization—ultimately enhancing clinical outcomes and patient well-being. 

The goal of this Collection is to showcase cutting-edge work that advances the science and practice of sleep medicine through innovation. We seek high-quality original research articles, reviews, and perspectives focused on the development and application of advanced technologies for sleep disorder research and management. Submissions addressing multidisciplinary collaborations and translational research that bridge clinical, engineering, and data science domains are especially encouraged. 

Topics of interest include but are not limited to: 

• AI-driven sleep staging algorithms
• IoT-enabled wearable and non-contact sensors
• Digital biomarkers for sleep health
• Home-based diagnostic platforms
• Remote therapeutic monitoring
• Smart CPAP or MAD devices

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 31 January 2026.

Please submit your manuscript on our website, quoting the promo code D065F for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors

Dr. Cheng-Yu Tsai, Taipei Medical University, Taiwan

Prof. Wen-Te Liu, Taipei Medical University, Taiwan

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advancing Dental Healthcare: Multidisciplinary Approaches, Biomaterials, and Clinical Innovations", in the Journal of Multidisciplinary Healthcare.

Dental healthcare is rapidly evolving, driven by advances in biomaterials, innovative clinical techniques, and interdisciplinary collaborations. From restorative and regenerative solutions to digital dentistry and precision medicine, the field is embracing cutting-edge approaches to redefine diagnostics, treatment planning, and patient care. This Article Collection aims to explore the latest developments in dental research, with a focus on novel biomaterials, emerging technologies, and multidisciplinary approaches that shape the future of oral healthcare. 

Addressing the growing complexity of dental diseases and patient needs requires a comprehensive approach that extends beyond traditional dentistry. The integration of biocompatible materials, minimally invasive procedures, and artificial intelligence in diagnostics is transforming clinical practice. Furthermore, collaborative efforts between dental professionals, researchers, and specialists in other medical fields contribute to more effective treatments and enhanced patient experiences. Advancements in these areas impact oral and systemic health equally, underscoring the significance of cutting-edge research in the dental field. 

This Article Collection invites original research articles and reviews that examine the development and clinical application of novel biomaterials, tissue engineering in dentistry, digital and AI-driven diagnostics, interdisciplinary treatment planning, and personalized dental care. We welcome contributions from researchers and practitioners across multiple disciplines, aiming to bridge the gap between scientific discovery and clinical practice.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 15 December 2025.

Please submit your manuscript on our website, quoting the promo code IMCZX for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisor

Dr. Eman Allam, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advancing Pharmacogenetics in Limited Resources Countries: Affordable Testing Methods, Genetic Variability, and Clinical Implications", in the Journal of Multidisciplinary Healthcare.

One of the current prominent topics in treatment individualization is pharmacogenetics, a method for tailoring drug selection and dosages based on an individual's genetic profile. Although pharmacogenetic testing is prevalent in developed countries, developing countries are behind in this area due to resource constraints. 

This Article Collection aims to address the critical need for advancing pharmacogenetics research and implementation within developing countries. These regions often face unique challenges related to healthcare infrastructure, economic constraints, and significant genetic diversity, all of which profoundly impact drug response and efficacy. 

Topics of interest include: 

• Development and validation of low-cost pharmacogenetic testing methodologies.
• Application of innovative technologies for pharmacogenetic analysis in resource-limited settings.
• Studies on the genetic variability of drug-metabolizing enzymes and drug targets in diverse populations within developing countries.
• Investigation of gene-environment interactions influencing drug response in these populations.
• Clinical utility and cost-effectiveness analyses of pharmacogenetic testing in specific disease areas relevant to developing countries
• Strategies for the implementation of pharmacogenetics in routine clinical practice, including education and training of healthcare professionals.
• Ethical, legal, and social implications of pharmacogenetic testing in diverse cultural contexts.
• Policy recommendations for the integration of pharmacogenetics into healthcare systems in developing countries.
• Studies and pilot projects demonstrating the successful application of pharmacogenetics in improving patient care.

We believe this Collection will serve as a valuable resource for researchers, clinicians, policymakers, and stakeholders committed to advancing pharmacogenetics and achieving equitable healthcare outcomes in developing countries.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 15 February 2026.

Please submit your manuscript on our website, quoting the promo code D14E0 to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors

Dr. Harri Hardi, Universitas Indonesia

Dr. Mohamed Nagy, Children’s Cancer Hospital, Egypt

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advancing Women’s Health Through Digital Health and Artificial Intelligence in Global Contexts", in the Journal of Multidisciplinary Healthcare.

Women’s experiences with healthcare are worthy of dedicated exploration. Across global contexts, women often face distinct and multifactorial challenges in accessing and navigating healthcare systems. These challenges may arise from complex healthcare needs, socioeconomic and cultural influences that sometimes dismiss or devalue women’s health concerns, and political or legal constraints that limit access to essential care. 

In parallel, the rapid evolution of digital health and artificial intelligence is reshaping how healthcare is delivered, offering new possibilities to enhance personalization, accessibility, and system efficiency. 

The integration of digital technologies into women’s healthcare requires collaboration across a wide range of professional disciplines including clinicians, nurses, public health professionals, technologists, and healthcare managers. Equally essential is the presence of women in leadership roles where they guide strategic priorities, influence system level decisions, and ensure that digital solutions are designed and implemented with gender equity in mind. Although the contribution of women to digital health leadership is increasingly recognized, research exploring how women lead, manage, and shape digital transformation within healthcare institutions remains underdeveloped. 

This Article Collection explores the intersection of women’s health, leadership and management, and digital innovation with a particular focus on multidisciplinary approaches that contribute to more equitable and responsive health systems. We welcome original research articles and reviews (though not meta analyses) focused on the use of digital health and artificial intelligence in the delivery of women’s healthcare by multidisciplinary teams. 

• Relevant topics include, but are not limited to: 
• AI applications in reproductive and maternal health
• Digital mental health interventions
• Mobile health platforms for underserved populations
• Ethical and regulatory considerations in algorithmic design
• Strategies to reduce bias in women’s health technologies

Submissions that address women’s roles in digital health leadership and management such as organizational change, governance models, capacity building, or the impact of women leaders on innovation outcomes are especially encouraged. Contributions from diverse disciplines and global perspectives are welcome to advance a more inclusive and effective digital health future for women.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 31 December 2025.

Please submit your manuscript on our website, quoting the promo code 4B8A6 to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors

Prof. Raniah N. Aldekhyyel, King Saud University, Saudi Arabia

Prof. Ruaim Muaygil, King Saud University, Saudi Arabia

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Allied Health Matters: Showcasing Value, Driving Impact", in the Journal of Multidisciplinary Healthcare.

The term “allied” refers to being joined or associated with others for a common goal. It implies a supportive relationship between individuals and groups, characterized by cooperation, collaboration, and mutual support. Allied health professionals exemplify this concept and are at the heart of healthcare delivery, making significant contributions to patient outcomes, organizational efficiencies, and driving system-wide innovation. This Article Collection aims to highlight and celebrate the essential value that allied health services bring to individuals and communities, emphasizing the profound and lasting impact these professionals have on both healthcare systems and the lives of those they serve. 

We welcome submissions that showcase the transformative impact of allied health practices through cutting-edge research, evidence-based practices, end-user-centered approaches, innovative clinical models and workforce solutions, interdisciplinary collaboration, policy advancements, and technological integration. 

Topics of interest include, but are not limited to: 

• Innovative models of care and interventions: Highlighting new and emerging practices, as well as workforce solutions, that improve patient care and outcomes
• Interdisciplinary collaboration: Exploring the value of teamwork across healthcare professions and its positive impact on care delivery
• Educational Advancements: Demonstrating innovative teaching strategies and curriculum developments that enhance allied health training and professional development
• Technological integration: Exploring how technology and digital health tools are transforming allied health practices and patient engagement
• Cultural Competency and Equity: Examining practices that promote inclusivity, cultural sensitivity, and health equity within allied health services
• Consumer Experiences and Perspectives: Showcasing research on how allied health services impact patients' lived experiences, satisfaction, and engagement in care
• Policy and Advocacy: Addressing how allied health professionals influence healthcare policy, access to services, and advocacy for underserved populations.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 15 January 2026.

Please submit your manuscript on our website, quoting the promo code RNTHT for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors

Prof. Saravana Kumar, University of South Australia

Ms. Esther Jie Tian, University of South Australia

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Big Data and AI in Immune-Mediated Conditions: Bridging Systems Biology and Clinical Practice", in the Journal of Multidisciplinary Healthcare.

Immune-mediated conditions, spanning panvascular diseases and metabolic disease, are driven by dysregulated immune mechanisms that challenge diagnosis and therapeutic precision. The integration of artificial intelligence (AI) and big data analytics has emerged as a transformative force in immunology and system biology. These datasets—rich in longitudinal health records, multi-omics profiles, and sociodemographic variables—provide unparalleled opportunities to uncover disease patterns and predict outcomes. This Article Collections highlights how AI-driven analyses of real-world and population-level data—from global cohorts to clinical registries—are redefining research and care in immune-mediated conditions. 

The importance of leveraging these resources lies in addressing the heterogeneity of immune-mediated diseases, where patient-specific factors, environmental influences, and genetic variability complicate traditional research paradigms. For instance, AI models trained on integrated datasets can identify biomarkers for early detection, stratify autoimmune disease risk in diverse populations, or predict infection outcomes by combining immunological, nutritional, and lifestyle data. However, challenges persist in harmonizing fragmented data sources, ensuring algorithmic generalizability across populations, and maintaining ethical standards in data usage—issues this Collection seeks to explore. 

This Article Collection invites contributions that demonstrate innovative applications of AI and big data in immune-mediated conditions, emphasizing both methodological advances and translational impact. Topics include, but are not limited to: 

• AI-driven analysis of multi-source datasets to unravel immune-disease associations
• Machine learning for predictive modeling of comorbidities and treatment responses in autoimmune and inflammatory conditions
• Ethical AI deployment in global health contexts

Article types such as Original Research, Reviews, and Methods papers are welcomed, particularly those bridging gaps between computational innovation, systems biology, and clinical practice. By uniting cutting-edge analytics with scalable health data, this issue aims to catalyze breakthroughs in understanding and managing immune-mediated conditions worldwide.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 15 February 2026.

Please submit your manuscript on our website, quoting the promo code ED93F to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors

Dr. Jian Chen, Shanghai TCM-Integrated Hospital, China 

Dr. Krit Pongpirul, Chulalongkorn University, Thailand

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Children with Disabilities and Chronic Diseases: Perspectives, Challenges, and Opportunities", in the Journal of Multidisciplinary Healthcare.

Children with disabilities represent a diverse population with unique strengths, needs, and challenges. Their experiences are shaped by various factors, including healthcare access, inclusive education, family support, social policies, and community engagement. 

This Article Collection seeks to explore multidisciplinary perspectives on the well-being, rights, and development of children with disabilities, highlighting both systemic barriers and innovative solutions that promote inclusivity and equity. 

Potential topics include, but are not limited to: 

• Early intervention and access to healthcare
• Inclusive education strategies and policies
• Assistive technologies and accessibility innovations
• Family and caregiver perspectives
• Social inclusion and community participation
• Mental health and emotional well-being
• Legal frameworks and advocacy efforts 

We welcome submissions from researchers, clinicians, educators, policymakers, and advocates working in fields such as disability studies, special education, pediatric healthcare, rehabilitation, psychology, and social work. Institutions, advocacy organizations, and multidisciplinary teams working on disability-related initiatives are also encouraged to submit.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 1 January 2026.

Please submit your manuscript on our website, quoting the promo code MQUOM for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisor

Prof. Sawsan Abuhammad, University of Sharjah, UAE

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Cybersecurity in Healthcare: Ensuring Patient Safety and Data Privacy", in the Journal of Multidisciplinary Healthcare.

All computer systems are vulnerable to cyberattacks, but healthcare systems are especially at risk due to the pervasive use of interconnected digital health systems for service delivery, insurance billing, pharmaceutical ordering, diagnostics test reporting, and telehealth. Medical device usage, remote patient monitoring, patient portals, and the increasing number of connected smart devices provide multiple entry points for cyber actors. Moreover, healthcare targets are ten times more valuable than financial targets because they can enable fraudulent billing. 

Healthcare security specialists may wish for a universal application to scan computer systems and detect all cyber threats, but that app does not exist. The reason is that cybersecurity issues are intricate and multifaceted, involving human factors, system vulnerabilities, technological vulnerabilities, physical access issues, and legal compliance challenges. 

Information sharing and remote access make healthcare systems more susceptible to viruses and phishing. Cyberattacks in one system can have a domino effect, resulting in issues in multiple connected internal and external systems. As an illustration, the February 2024 ransomware data breach at Change Healthcare, a company that supplied revenue cycle and payment management services to over 900,000 healthcare providers and 5,500 hospitals, significantly impacted healthcare systems in several states. This breach, the largest ever reported, affected approximately 190 million individuals, and resulted in revenue losses due to delays in processing clinical, financial, and operational transactions. 

At a minimum, cyberattacks in healthcare can delay care due to healthcare databases being held for ransom. The worst-case scenario is when the Internet of Medical Things is hijacked and causes malfunction. Disruptions to healthcare systems harm the financial stability of the affected healthcare facility and pose serious risks to patient safety and data privacy. This was a concern as far back as 2000 when the U.S. Secret Service disabled the Wi-Fi capabilities of the pacemaker in Vice President Dick Cheney’s chest. 

During cyberattacks, patient information can be compromised, lost, stolen, or held for ransom, endangering the ability to diagnose and treat the patient efficiently and safely. The Department of Health and Human Services Office for Civil Rights' analysis of healthcare data breaches revealed a substantial increase in the number and severity of data breaches over the last fourteen years, and the average cost is higher than data breach costs for other industries. 

This Article Collection welcomes original research articles and systematic reviews. Topics of interest include, but are not limited to: 

• Empirical studies exploring topics related to healthcare patients, systems, and data privacy and security.
• Comprehensive reviews summarizing the current state of healthcare cybersecurity.
• Comparing blockchain and active Artificial Intelligence to more traditional intrusion detection mechanisms.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 1 January 2026.

Please submit your manuscript on our website, quoting the promo code JJGXV for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors

Prof. Diane Dolezel, Texas State University, USA

Prof. Scott Kruse, Texas State University, USA

Prof. Rohit Pradhan, Texas State University, USA

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Empowering Public Health through Advancements in Telehealth", in the Journal of Multidisciplinary Healthcare.

Telehealth has indeed seen rapid adoption and expansion in recent years, especially due to the COVID-19 pandemic. The convenience, accessibility, and efficiency it provides have proven to be game changers for both patients and healthcare providers. It allows healthcare professionals to reach patients in remote or underserved areas, alleviating the burden of travel and time constraints for both parties. Additionally, telehealth enables quicker and more efficient management of chronic conditions, routine follow-ups, mental health services, and urgent care needs, all of which contribute to better overall healthcare delivery. Another significant advantage of telehealth is its role in reducing healthcare costs. By minimizing the need for in-person visits, healthcare systems can reduce overhead costs associated with clinics and hospital visits. Furthermore, telehealth can facilitate better coordination of care, reducing the likelihood of medical errors and improving patient outcomes. The rapid uptake of telehealth also led to the development of regulations and technologies that support secure and reliable communication, such as encrypted video calls and electronic health records. These advancements help maintain patient confidentiality and ensure compliance with health standards like HIPAA in the U.S. Given the rise in patient demand and the efficiency benefits to healthcare providers, telehealth is likely to continue playing a central role in modern healthcare systems, especially as technologies evolve and integrate with other digital health tools, like remote monitoring devices, and become more seamless. 

However, some challenges remain, including technological barriers for certain populations, reimbursement models, and varying regulations across regions. Several important trends are anticipated to impact the expansion of telehealth care delivery including advancements in the consumer technology market, ongoing progress in electronic health records and clinical decision support systems, shortages in the health professional workforce, restructuring in the delivery and financing of medical care, and consumerism. Healthcare professionals must integrate new technologies into their workflows while ensuring they improve patient care. Both patients and clinicians may struggle with adoption, and reimbursement models remain complex due to varying policies. Interoperability between electronic health record (EHR) systems is crucial, but smaller facilities may lack the infrastructure for bandwidth-intensive telehealth. Regulatory barriers, including varying accreditation and insurance policies, add to the complexity. Additionally, concerns about technical reliability, privacy, and accountability in telehealth need to be addressed for successful integration. 

This Article Collection highlights key trends in telehealth adoption, examines the current state of telehealth evidence, and discusses the challenges in promoting its implementation. It also aims to guide healthcare professionals and researchers in identifying critical priorities for telehealth research. Such research is essential for maximizing telehealth’s potential to improve patient experience, advance population health, reduce healthcare costs, and enhance the delivery of care. Papers submitted for this Article Collection should concentrate on the general theme of telehealth service delivery, addressing the following subtopics or research priorities: 

• Healthcare professionals’ leadership: Leadership among healthcare professionals is essential to improve telehealth care delivery by collaborating with telehealth technology and service providers, while also contributing to the evidence base through comparisons of telehealth outcomes with traditional care.
• Reimbursement: Research on reimbursement in fee-for-service contexts and the impact of alternative payment models that use bundled telehealth services to calculate buyer returns on investment could be made easier by the current procedural terminology codes.
• Licensure: The needed licensing requirement, which may be bolstered by continuing research on potential quality-of-care concerns.
• Liability: Evidence to enhance understanding of any quality and safety risks that may distinguish telehealth service delivery from traditional in-person care.
• Human factors: Investigating user-centered design to enhance the incorporation of telehealth into clinical workflows and improve patient engagement
• Device interoperability and data integration: Exploring evidence-based best practices and standards that facilitate the optimal integration of devices and data streams from physician and patient telehealth engagement.
• Privacy and security: Establishing evidence-based standardized norms to facilitate adequate safeguards and regulatory control.
• Performance measurement: Improved evidence to fill deficiencies in current telehealth-related clinical performance metrics and augment those presently available.
• Patient engagement: Evidence-based recommendations to assist health professionals in counseling and engaging with patients and caregivers over the entire range of telehealth services and technologies.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 15 February 2026.

Please submit your manuscript on our website, quoting the promo code 3A08C to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected]. 

Guest Advisors 

Dr. Salah Alshagrawi, The Saudi Electronic University, Saudi Arabia

Dr. Krzysztof Laudanski, Mayo Clinic, USA

View all papers in this article collection

The Journal of Multidisciplinary Healthcare invites submissions for an Article Collection addressing the emerging and multifaceted relationship between internet addiction and pain syndromes. As digital technology becomes increasingly integral to daily life, excessive internet use is being recognized not only as a behavioral health issue but also as a potential contributor to a range of physical and psychological pain conditions.

Recent studies suggest that internet addiction may exacerbate or even precipitate pain syndromes through a variety of mechanisms, including:

● Increased Pain Perception: Continuous digital engagement may interfere with the body's natural pain regulation systems, such as those affected by sleep disruption and heightened stress responses.

● Chronic Pain and Comorbid Mental Health Conditions: Anxiety and depression—often comorbid with internet addiction—are known to amplify chronic pain, creating a complex interplay between emotional and physical health.

● Musculoskeletal Strain: Sedentary behaviors, poor ergonomics, and prolonged device use are contributing factors to neck, back, and wrist pain, as well as digital eye strain.

● Sleep Disturbances: Irregular sleep patterns linked to excessive screen time may impair the body’s ability to manage and recover from pain.

● Pain as a Coping Mechanism: Individuals experiencing chronic pain may turn to the internet for distraction or relief, potentially reinforcing maladaptive behaviors and worsening both emotional and physical outcomes.

● Neurological and Inflammatory Pathways: Emerging evidence suggests that chronic internet use may affect neural activity and immune function, potentially increasing systemic inflammation and contributing to conditions such as arthritis or migraines.

We welcome original research articles, reviews, hypotheses, and commentaries from all relevant disciplines—including psychology, pain medicine, psychiatry, neurology, rehabilitation, digital health, and public health—that explore:

● Mechanisms linking internet use with pain perception

● The role of digital behavior in chronic pain management

● Interventions for individuals with co-occurring internet addiction and pain disorders

● Prevention strategies and public health implications

● Interdisciplinary approaches to diagnosis and treatment

All submissions will undergo rigorous peer review and must align with the journal’s mission to promote integrated, patient-centered care through cross-disciplinary collaboration.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 1 March 2026.

Please submit your manuscript on our website, quoting the promo code 10AED to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisor

Prof. Gergely Feher, University of Pécs, Hungary

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Female Sexual Function and Functioning Across the Life Cycle: Multidisciplinary Perspectives in Healthcare", in the Journal of Multidisciplinary Healthcare.

Female sexual function and functioning across the life cycle are fundamental aspects of women's health and quality of life. These aspects are influenced by multiple biological, psychological, and sociocultural factors that interact in various ways from adolescence to senescence. Understanding these interactions is essential for promoting multidisciplinary healthcare approaches grounded in scientific evidence. 

The study of female sexual function still faces significant challenges, including persistent taboos, knowledge gaps, and the need for individualized approaches. Additionally, functioning, recognized as the third key indicator of health conditions, requires further investigation throughout the female life cycle. Women’s functioning may be affected by events such as pregnancy, postpartum, menopause, and various clinical conditions. Thus, research on these aspects is crucial for developing effective health promotion strategies and preventive measures tailored to the female population. 

This Article Collection aims to bring together original research, systematic reviews, and clinical studies addressing the interrelationship between female sexual function and functioning in different contexts. Studies exploring healthcare interventions, biopsychosocial factors, the use of the International Classification of Functioning, Disability, and Health (ICF), the impact of chronic diseases, and multidisciplinary approaches to women's health promotion are welcome.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 15 January 2026.

Please submit your manuscript on our website, quoting the promo code TYHOK for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisor

Prof. Vanessa Patrícia Soares de Sousa, Federal University of Rio Grande do Norte, Brazil

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Harnessing Database Mining for Advancing Clinical Practice: From Insights to Therapeutic Innovation", in the Journal of Multidisciplinary Healthcare.

The integration of advanced database mining techniques into clinical practice is reshaping how healthcare professionals diagnose, treat, and manage diseases. Modern clinical databases - encompassing electronic health records (EHRs), genomic profiles, treatment outcome registries, and real-time patient monitoring data - hold immense, untapped potential to uncover actionable insights that directly improve patient care. This Article Collection focuses on cutting-edge methodologies and applications of database mining to bridge the gap between data-driven discoveries and their practical implementation in therapeutic decision-making, ultimately enhancing precision, efficacy, and equity in clinical practice. 

The urgency of leveraging database mining in clinical settings lies in its capacity to address critical healthcare challenges. Traditional approaches to treatment optimization often rely on generalized protocols, which may fail to account for individual patient variability, comorbidities, or emerging patterns in population health. By systematically analyzing large-scale clinical datasets, researchers and practitioners can identify novel biomarkers, predict treatment responses, and tailor interventions to specific patient subgroups. For example, mining oncology databases may reveal correlations between genetic mutations and drug efficacy, enabling personalized cancer therapies, while analyzing longitudinal EHR data could uncover early warning signs of treatment complications. Furthermore, in resource-limited settings, database-driven insights can guide cost-effective, evidence-based care. Despite this potential, challenges such as data heterogeneity, ethical constraints, and the translation of mined patterns into clinical workflows remain significant barriers to widespread adoption. 

This Article Collection invites submissions that explore the transformative role of database mining in advancing therapeutic strategies and clinical outcomes. Key subtopics include, but are not limited to: 

• Multidisciplinary Literature Informatics: Cross-disciplinary approaches such as bibliometric analyses to map trends in disease research, therapeutic innovations, and knowledge gaps across fields like pharmacology, genomics, and public health.
• Mining Large-Scale Biomedical Databases: Methodological advances and applications leveraging datasets such as NHANES (nutrition and health trends), GBD (global disease burden), UK Biobank (genomic and health data), TriNetX (real-world clinical data), and other repositories to uncover disease mechanisms, treatment patterns, and population health insights.
• Data-Driven Discovery of Disease and Therapeutic Targets: Computational strategies including network pharmacology, bioinformatics analyses, and multi-omics integration to identify novel drug candidates, repurpose existing therapies, or elucidate disease pathways.
• Machine Learning for Precision Therapeutics: Predictive models to forecast individual patient responses to treatments (e.g., chemotherapy efficacy, adverse drug reactions) or stratify high-risk populations (e.g., early detection of sepsis, cardiovascular events) using clinical, genomic, and demographic data.
• Ethical and Technical Challenges in Clinical Data Mining: Addressing biases in heterogeneous datasets, ensuring interoperability across platforms, and balancing data utility with patient privacy in global health contexts.

We welcome original research articles, method and methodology papers, and reviews that demonstrate rigorous data mining approaches with clear clinical relevance. Submissions should emphasize scalable solutions, reproducibility, and direct implications for improving therapeutic decision-making, aligning with the journal’s commitment to fostering innovation at the intersection of data science and clinical care.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 1 January 2026.

Please submit your manuscript on our website, quoting the promo code MFNEB for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors

Prof. Qingwen Tao, China-Japan Friendship Hospital, Beijing, China

Dr. Guangyao Chen, China-Japan Friendship Hospital, Beijing, China

Dr. Caixian Qiu, Beijing University of Chinese Medicine, China

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Targeting Non-Alcoholic Fatty Liver Disease: Lifestyle, Pharmacotherapy, and Beyond", in the Journal of Multidisciplinary Healthcare.

Non-alcoholic fatty liver disease (NAFLD) has rapidly become one of the most significant liver disorders globally, affecting nearly a quarter of the world’s population. It encompasses a spectrum of liver conditions, starting with simple steatosis (fat accumulation in hepatocytes) and progressing in some individuals to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and even hepatocellular carcinoma (HCC). Unlike other liver diseases, NAFLD is not driven by alcohol abuse or viral infections but is closely linked to metabolic dysfunction, including obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). 

Despite its high prevalence, NAFLD remains underdiagnosed and undertreated, partly due to its asymptomatic nature in early stages and the lack of universally approved pharmacotherapies. Current management primarily relies on lifestyle modifications, such as weight loss and exercise, while emerging drugs target specific molecular pathways involved in disease progression. However, the heterogeneity of NAFLD poses challenges in developing one-size-fits-all treatments, necessitating a deeper understanding of individualized therapeutic approaches. 

This Article Collection, "Targeting NAFLD: Lifestyle, Pharmacotherapy, and Beyond," aims to explore the latest advancements in NAFLD management, from foundational lifestyle interventions to cutting-edge pharmacological and non-pharmacological strategies. By compiling high-quality research and reviews, we seek to provide a comprehensive resource for researchers, clinicians, and policymakers working to combat this growing epidemic. 

The importance of addressing NAFLD cannot be overstated, given its substantial and expanding global burden. As the hepatic manifestation of metabolic syndrome, NAFLD is not just a liver-specific disease but a multisystem condition associated with increased risks of cardiovascular disease (CVD), chronic kidney disease (CKD), and extrahepatic cancers. With the rising prevalence of obesity and diabetes, NAFLD is projected to become the leading cause of liver-related morbidity and mortality worldwide, surpassing even viral hepatitis and alcoholic liver disease. 

One of the most pressing challenges in NAFLD management is the absence of universally approved drug therapies. While lifestyle interventions (diet, exercise, and weight loss) remain first-line treatments, long-term adherence is often poor, and not all patients achieve sufficient metabolic improvement to reverse liver damage. Additionally, the progression from simple steatosis to NASH and fibrosis varies among individuals, highlighting the need for personalized treatment strategies. 

Beyond lifestyle and pharmacotherapy, novel approaches—such as microbiome modulation, gene therapy, and artificial intelligence (AI)-driven diagnostics—are opening new frontiers in NAFLD research. Understanding these emerging strategies is crucial for developing effective, targeted therapies that can halt or reverse disease progression. This Article Collection will serve as a platform to discuss these innovations, bridging the gap between preclinical research and clinical application. 

We welcome original research articles, systematic reviews, clinical trials, and perspective pieces that advance the understanding of NAFLD treatment strategies. We encourage submissions that explore, but are not limited to, the following key themes: 

• The role of dietary modifications (Mediterranean diet, low-carbohydrate diets, intermittent fasting)
• Impact of physical activity and structured exercise programs
• Behavioral strategies to improve long-term adherence
• Bariatric surgery and metabolic interventions in NAFLD/NASH
• Emerging drug targets (FXR agonists, PPAR modulators, GLP-1 receptor agonists, etc.)
• Repurposing existing medications (e.g., SGLT2 inhibitors, statins) for NAFLD
• Challenges in clinical trial design and endpoints for NAFLD therapies
• Personalized medicine approaches based on genetic and metabolic profiling
• Gut microbiome modulation (probiotics, prebiotics, fecal microbiota transplantation)
• Gene therapy and RNA-based interventions
• The role of digital health and AI in NAFLD diagnosis and monitoring
• Integrative medicine and alternative therapeutic strategies
• Screening and early detection strategies in high-risk populations
• Economic burden and healthcare policies for NAFLD management
• Global disparities in NAFLD prevalence and treatment access

By compiling diverse perspectives on NAFLD management, this Article Collection aims to foster interdisciplinary collaboration and accelerate the translation of research into clinical practice. We invite contributions from hepatologists, endocrinologists, nutritionists, pharmacologists, and public health experts to provide a holistic view of current and future directions in NAFLD therapy. 

Through this Collection, we hope to inspire innovative solutions that will ultimately reduce the global impact of NAFLD and improve patient outcomes.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 2 February 2026.

Please submit your manuscript on our website, quoting the promo code 878F6 for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors

Dr. Asghar Ali, Jamia Hamdard, New Delhi, India

Dr. Mohan Kamthan, Jamia Hamdard, New Delhi, India

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Unraveling AI: The Use of Interactive AI, Conversational AI, and Generative AI in Teaching and Learning or Health and Care", in the Journal of Multidisciplinary Healthcare.

The concept of artificial intelligence (AI) has a long history. Due to the growing availability of data, its relevance in research and application has steadily increased. Three terms dominate the actual research landscape: interactive AI (iAI), conversational AI (cAI) and generative AI (genAI).

This call for papers is dedicated to the aforementioned terms with respect to the following two application areas:

1. Learning Environments

Chatbots get increasing attention as learning assistants. They support individual, social, or metacognitive learning, offering feedback and guidance. They serve as mentors or assistants, providing motivation, cues, and instant feedback to enhance learning. In informal learning or care settings, and for individual health questions, empirical insights into chatbot-mediated learning are required.

With the growing use of chatbots, it's crucial to ask in which contexts they lead to which learning outcomes. Contributions can refer to the following or related questions:

• Teachers' perspective: how do teachers in different educational contexts integrate Chatbots in teaching strategies? what are facilitating or hindering factors of a teacher-chatbot co-creation?
• Learners: what kind of learning outcomes do they achieve by what kind of interaction with chatbots?
• Informal, self-paced health learning: How do chatbots support health literacy? Which target groups, outcomes, context-specific features can be identified?

2. Health

iAI, cAI and genAI in healthcare have the potential to ensure and, ideally, increase the effectiveness and efficiency of healthcare in the future. This call for papers explicitly welcomes contributions from the entire spectrum of healthcare, i.e. prevention, diagnostics, therapy, rehabilitation and care.

Example iAI: The proportion of people with at least one chronic disease is constantly growing. Such conditions require lifelong support and care. Solutions from the field of iAI can support such people in the form of a virtual coach and bring together various care situations (medication, appointments, etc.).

The type of research must be clearly recognizable e.g. systematic literature review, qualitative study or observational studies. Submissions must rigorously refer to established reporting guidelines, such as PRISMA, COREQ, STROBE and similar.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 15 January 2026.

Please submit your manuscript on our website, quoting the promo code C4247 for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors

Prof. Dr. Daniela Schmitz, Witten/Herdecke University, Germany

Prof. Dr. Sven Meister, Witten/Herdecke University, Germany

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advancing Inclusion in Pediatric Pain Research, Training, and Practice", in the Journal of Pain Research.

Much of our current understanding of pediatric pain mechanisms and interventions is informed by an evidence base that does not adequately reflect the broader population of youth living with acute and chronic pain. Individuals who are marginalized due to sociocultural characteristics including (but not limited to) racialized identity, ethnicity, indigeneity, age, sex, gender identity, disability status, educational attainment, socioeconomic position, immigration and refugee status, and geographic location are underrepresented in pain research. These same groups are also at highest risk for experiencing profound inequities in pain care and outcomes. 

Numerous calls to action have been made to improve inclusion in the design, conduct, reporting, and dissemination of pain research. Alongside efforts to meaningfully engage communities in research and recruit and retain diverse study participants, these calls highlight the importance of diversifying the research environment itself to accelerate translation of findings to real-world efforts to alleviate pain for all youth. Additionally, culturally aware mentoring resources and training for providers in culturally attuned, evidence-based pain care are imperative to foster the talents of trainees from diverse backgrounds and adequately prepare the next generation of pain scientists and clinicians. Ultimately, inclusive pediatric pain research, training, and practice seeks to ensure that innovations in pain science and care meet the needs of all youth with pain and their families. 

This Article Collection seeks to advance this cause by highlighting inclusive approaches to pediatric pain research, training, and practice. Articles that focus on underrepresented groups (e.g., infants, young adults, indigenous populations, people of color, people with disabilities, LGBTQ2A+), biopsychosocial risk and resilience factors associated with chronic primary or secondary pain in young people, use of innovative methodologies or technologies to improve the quality and equity of pediatric pain care, projects that exemplify community engagement in knowledge production and/or mobilization, and approaches to enhancing diversity and inclusion within pediatric pain research and clinical workforce are especially welcome.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submitting manuscripts is 15 January 2026.

Please submit your manuscript on our website, quoting the promo code KQQFZ for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

Guest Advisors 

Aimee Hildenbrand, Nemours Children’s Health, USA

Shreela Palit, Nemours Children’s Health, USA

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “The Future of Pain Medicine: Emerging Technologies, Treatments, and Education” organized by Guest Advisors Dr. Giuliano Lo Bianco, Dr. Christopher Robinson, Dr. Ryan S D'Souza, Dr. Robert Jason Yong, and Dr. Tess Veuthey in the Journal of Pain Research.

"Emerging Technologies, Treatments, and Education" is an in-depth examination of how cutting-edge technologies are revolutionizing pain medicine and education for chronic pain providers and trainees. This Collection explores the transformative impact of emerging technologies such as artificial intelligence, virtual reality, cloud-based technologies, wearables, and novel roles for neuromodulation. By integrating these technologies, pain management and training can be enhanced and patient outcomes improved. Authors are encouraged to contribute their expertise and research findings to advance our understanding of these technologies' role in shaping the future of pain management and education. Whether you are an established researcher or an emerging scholar, this Collection provides a unique opportunity to contribute to the evolving narrative of pain medicine. Join us in exploring the frontiers of technology-driven advancements that promise to transform how we perceive, diagnose, and alleviate pain.

Traditional approaches to pain management face challenges in providing personalized and effective interventions. The integration of artificial intelligence allows for data-driven precision medicine, enabling tailored treatment plans based on individual patient characteristics. Virtual reality offers innovative therapeutic interventions, providing patients an immersive environment to alleviate pain and improve well-being. Cloud-based technologies facilitate seamless data sharing, fostering collaboration among healthcare professionals and researchers globally. Wearables provide real-time monitoring and feedback, enhancing the understanding of pain patterns and enabling timely interventions. Neuromodulation continues to expand its applicability, treating even more conditions than previously considered. Furthermore, pain education must continually evolve to meet the growing arsenal of tools that providers can utilize in their practice. This Collection aims to showcase the significance of these advancements, encouraging researchers to contribute to the ongoing dialogue and propel the field toward a future where technology serves as a powerful ally in the fight against pain.

The Collection invites contributions that span a spectrum of subjects aligned with the scope of our journal.

Subtopics include, but are not limited to:

• Application of artificial intelligence, virtual reality, wearables, and cloud-based technologies in collaboration, monitoring, diagnosis, management, and outcomes.
• Novel applications of neuromodulation such as sensory, motor, or functional restoration.
• Exploration of psychedelics for the management of chronic pain.
• Education reform to accommodate a more efficient and comprehensive training process that equips trainees with the necessary skills to start practice.

Preferred article types for this Collection include original research articles, scoping reviews, systematic reviews and/or meta-analyses, editorials, and perspectives that contribute to the scholarly discourse and foster a deeper understanding of the intersection between emerging technologies and pain management.

Through this diverse array of contributions, we aim to assemble a Collection that not only informs but also sparks dialogue and innovation in the field.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 30 September 2025.

Please submit your manuscript on our website, quoting the promo code RVCEK for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisors

Dr. Giuliano Lo Bianco, MD, PhD, FIPP, EDPM, is a distinguished expert in Anesthesia and Pain Therapy, specializing in percutaneous fluoro/ultrasound-guided interventions. With a commitment to advancing pain therapy, he collaborates with leading experts globally and holds key positions at Fondazione G. Giglio di Cefalù since 2020, serving as the Head of the Operational Unit for Analgesia and Percutaneous Surgery. Dr. Lo Bianco is an esteemed educator, sharing his expertise through lectures at the University of Palermo and the University of Pavia, contributing to the development of pain therapy programs. His dedication to advancing pain medicine and research makes a lasting impact on healthcare and well-being.

Dr. Christopher Robinson, MD, PhD is a resident physician-scientist at Harvard Medical School-BIDMC and will be doing his chronic pain fellowship at Brigham and Women's Hospital. Dr. Robinson did his MD, PhD in stem cell biology in the lab of Dr. Shuibing Chen at the Weill Cornell Medicine/Rockefeller University/Sloan-Kettering Tri-Institutional MD-PhD Program. His team leadership experience from running a startup during his PhD allowed him and his PhD team including the 2020 Nobel Prize winner in medicine, Dr. Charles Rice, to discover a new anti-viral drug targeting Zika virus during the epidemic. Prior to his MD/PhD, he completed his undergraduate studies at Georgetown University in Washington DC. Now, his chronic pain research team, consisting of members across the globe, work together to accomplish science and medicine in a whole different way utilizing everyone's skillsets across all specialties from machine learners (artificial intelligence developers) to physician-scientists to ethicists to bring education and research to all while keeping the patient at the center.

Dr. Ryan S D’Souza is an interventional pain physician and anesthesiologist in Mayo Clinic. He was ranked in the top 1% of physicians in the country based on national clinical knowledge testing required to graduate from residency and fellowship. Dr. D'Souza is currently an Associate Professor of Anesthesiology and Perioperative Medicine at Mayo Clinic (Rochester). His clinical and research interests include spinal cord stimulation, peripheral nerve stimulation, fibromyalgia, evidence appraisal, and education. He has lectured both national and internationally and has published extensively in neuromodulation and chronic pain.

Dr. Robert Jason Yong earned his medical degree and Master of Business Administration at Baylor College of Medicine in Houston. He completed his internship in General Surgery at Beth Israel Deaconess Medical Center in Boston and completed his residency in Anesthesiology at Brigham and Women’s Hospital in Boston, where he was named Chief Resident, an FAER Scholar and a Distinguished Resident. Dr. Young completed his fellowship in Pain Medicine at Brigham and Women’s Hospital in Boston. He completed his Bachelor of Arts in Biology at the University of Texas at Austin.

Dr. Tess Veuthey MD/PhD is a neurology resident at Stanford interested in neural engineering, chronic pain, psychedelics, and health disparities. Her PhD examined neural representations of behavior in rodents learning motor skills and brain-machine interface tasks. She is looking to bring tools from those fields into the study of chronic pain and its treatment. Dr. Veuthey aims to integrate neuromodulation and psychedelics to collaboratively develop safe, effective treatments for neuropsychiatric conditions both within and outside of formal medical contexts. She has been supported by a Fulbright Fellowship, National Defense Science and Engineering Graduate Fellowship (NDSEG), North American Neuromodulation Society Diversity and Outreach Committee Pipeline Fellowship Grant, and NINDS R25.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Nanotechnology, Science and Applications on "Advances in Green Synthesized Nanomaterials".

Nanotechnology has revolutionized various fields, including medicine, electronics, and environmental science. However, traditional methods of synthesizing nanomaterials often involve toxic chemicals and high energy consumption, leading to significant environmental and health concerns. In response, green synthesis methods have emerged as a sustainable alternative, utilizing natural biological systems such as plants, bacteria, and fungi to produce nanomaterials. These methods not only reduce the environmental footprint but also offer unique properties and functionalities to the synthesized nanomaterials.

As the world faces the challenges of climate change and environmental degradation, the need for sustainable and eco-friendly technologies has become increasingly important. Green synthesis methods align with the principles of green chemistry, aiming to minimize waste, reduce energy consumption, and use non-toxic reagents. These methods hold the potential to revolutionize various industries by providing safer and more sustainable alternatives to conventional nanomaterials.

To help raise the profile of this important area of research, Nanotechnology, Science and Applications is publishing a timely Article Collection on green synthesized nanomaterials.

Potential topics include, but are not limited to, the following:

• Biological Methods for Nanomaterial Green Synthesis
• Characterization of Green Synthesized Nanomaterials
• Green Synthesized Nanomaterials in Medicine
• Environmental Applications of Green Synthesized Nanomaterials
• Green Synthesized Nanomaterials in Energy and Electronics
• Sustainability and Lifecycle Analysis of Green Synthesized Nanomaterials

The Collection is led by the Editor in Chief, Professor Kattesh Katti, who is globally recognized as the 'Father of Green Nanotechnology'.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 31 August 2025.

Please submit your manuscript on our website, using the promo code MDEXJ for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Advances in Green Synthesized Nanomaterials” Collection. We will welcome relevant Original Research, Reviews and Editorials. 

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Nanotechnology, Science and Applications on "Advancing Novel Nanozymes: Preparation, Performance Analysis, and Functional Application Design", organized by Dr. Amin Zhang (Shanghai Jiao Tong University, China), Dr. Qian Zhang (Shanghai Jiao Tong University, China) and Dr. Jin Cheng (Wuxi Center for Disease Control and Prevention, China).

Nanozymes, a class of nanomaterials with enzyme-like catalytic properties, have emerged as a ground-breaking innovation in the fields of nanotechnology and biotechnology. These artificial enzymes replicate the catalytic activities of natural enzymes while offering enhanced stability, cost-efficiency, and remarkable potential for multifunctional design. Since their discovery, nanozymes have garnered significant attention due to their versatility, enabling diverse applications in catalysis, biosensing, medicine, and environmental remediation.

The significance of nanozymes lies in their ability to overcome the inherent limitations of natural enzymes, such as their susceptibility to denaturation and high production costs. These challenges are particularly pressing in industries that require robust and reusable catalytic agents, including industrial processing, clinical diagnostics, and therapeutic applications. Moreover, the rapid evolution of nanozyme technologies has paved the way for ground-breaking innovations, such as combating antimicrobial resistance, engineering targeted cancer therapies, and fostering sustainable environmental solutions. By focusing on the preparation, performance optimization, and functional application design of novel nanozymes, this research not only enhances foundational scientific understanding but also delivers practical benefits across a broad spectrum of scientific and industrial domains.

This Article Collection aims to highlight the latest advancements in nanozyme research, covering their preparation, performance evaluation, and innovative applications. The scope includes, but is not limited to:

• Synthetic Strategies: Development of cutting-edge methodologies for nanozyme synthesis, including green and bio-inspired approaches.
• Mechanistic Insights: Elucidation of catalytic mechanisms and exploration of structure-property relationships.
• Biomedical Applications: Deployment of nanozymes in diagnostics, therapeutic interventions, and targeted drug delivery systems.
• Environmental Applications: Applications of nanozymes in pollutant degradation, waste management, and sustainable catalysis.
• Integration in Multifunctional Systems: Design and incorporation of nanozymes into hybrid materials and advanced devices.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 31 December 2025.

Please submit your manuscript on our website, using the promo code ZKKJU for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Advancing Novel Nanozymes: Preparation, Performance Analysis, and Functional Application Design” Collection. 

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Dr. Amin Zhang, Shanghai Jiao Tong University

[email protected]

Dr. Amin Zhang graduated from Shanghai Jiao Tong University in 2020 with a Ph.D. in Instrument Science and Technology (Biomedical and Engineering track), she finished postdoctoral research there and became an Assistant Researcher at the School of Agriculture and Biology in March 2024. Her research focuses on developing nanozyme sensing technologies and designing functional active component delivery systems. She has published over 30 papers in top international journals, such as Advanced Materials, Biosensors and Bioelectronics, Nano Research, Theranostics, and Sensors and Actuators B: Chemical. 

Dr. Qian Zhang, Shanghai Jiao Tong University

[email protected]

Dr. Qian Zhang graduated in 2015 with a Ph.D. in Science from Philipps-Universität Marburg, Germany, under the supervision of Professor Wolfgang J. Parak. From 2016 to 2017, conducted postdoctoral research in Professor Da-Xiang Cui's research group at the School of Electronics. Served as an Assistant Researcher at the same institution from 2018 to 2022 and was promoted to Associate Researcher in 2023. In recent years, she focuses primarily on the controlled synthesis and performance studies of various inorganic nanomaterials and the development of nanodrug delivery systems to achieve multimodal tumor therapy under MRI/NIR guidance. She has published over 50 SCI papers, including 17 as the first or corresponding author, with 3 ESI Highly Cited Papers. These works have been cited more than 3,200 times, with an H-index of 29. Additionally, the applicant has contributed to two books (in both Chinese and English) and holds three authorized patents. 

Dr. Jin Cheng, Wuxi Center for Disease Control and Prevention

[email protected]

Dr. Jin Cheng graduated from Shanghai Jiao Tong University in 2021 with a Ph.D. in Instrument Science and Technology (Biomedical and Engineering track). Since July 2021, serves as an Assistant Researcher at the Wuxi Center for Disease Control and Prevention. His research focuses on DNA nanotechnology, tumor therapy, and disease diagnosis and detection. He has published over 20 papers in top international journals like Angewandte Chemie International Edition, Nature Communications, and Nanoscale.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Bridging Bench to Bedside and Beyond: Advancing Sleep and Circadian Science for Precision Health Across All Ages", organized by Guest Advisors Dr. Azizi Seixas, Dr. Carolina Scaramutti and Dr. Mairead Moloney in Nature and Science of Sleep.

Sleep and circadian rhythms are fundamental to human health and well-being, influencing cognitive function, metabolic regulation, cardiovascular health, mental health, and immune function. Disruptions in sleep and circadian biology have been linked to a wide range of diseases, from neurodegenerative disorders and cardiometabolic conditions to mood disorders and impaired developmental trajectories in children. Yet, sleep and circadian health remain underutilized as modifiable targets in preventive medicine, clinical care, and public health initiatives. 

This Article Collection will focus on translational sleep and circadian health across the lifespan, highlighting research that spans developmental, clinical, and population health perspectives. We seek contributions that integrate basic science, clinical applications, and public health strategies to address sleep and circadian disruptions from infancy through older adulthood. The goal is to foster a lifespan approach to sleep health, identifying key windows for intervention, personalized treatment strategies, and innovative translational solutions that bridge laboratory research with real-world applications. 

From molecular insights into circadian rhythms to population-level interventions for sleep equity, this issue will showcase groundbreaking research that leverages multi-disciplinary methodologies, digital health tools, and precision medicine approaches to tackle sleep-related challenges at every stage of life. 

Understanding translational sleep and circadian health across the lifespan is critical for advancing precision medicine, public health, and clinical care. Sleep and circadian rhythms are foundational to nearly every aspect of human health—affecting brain function, cardiovascular health, metabolic regulation, immune response, and mental well-being. However, sleep remains underrecognized as a modifiable risk factor and is often excluded from mainstream healthcare strategies. 

This Article Collection will bridge the gap between basic science, clinical applications, and public health interventions, bringing together experts across neurology, psychiatry, cardiology, and digital health to explore novel, data-driven, technology-enhanced solutions for sleep-related disorders. By integrating AI, digital biomarkers, and multi-modal precision health approaches, this research will redefine sleep medicine and improve health outcomes across diverse populations and life stages. Ultimately, addressing sleep and circadian health inequities can lead to more effective, scalable, and personalized interventions, making healthcare more proactive, equitable, and transformative. 

Sleep and circadian health are critical yet underappreciated determinants of overall well-being, influencing neurodevelopment, cognitive aging, cardiometabolic health, mental health, and disease resilience across the lifespan. Advances in translational sleep research now offer unprecedented opportunities to integrate basic science, clinical medicine, public health, and digital health technologies to improve sleep-related outcomes for diverse populations. 

This Article Collection seeks cutting-edge contributions that bridge multiple disciplines, highlighting collaborative and interdisciplinary approaches to advancing sleep health. We encourage original research, systematic reviews, meta-analyses, and methodological papers exploring topics such as:

• Novel biomarkers & digital health tools for sleep and circadian rhythm assessment
• AI-driven and precision medicine approaches to sleep health interventions
• Cross-disciplinary research networks integrating neurology, psychiatry, cardiology, and public health
• Sleep inequities & social determinants of health in marginalized communities

By bringing together leading experts, this collection will advance the field toward equitable, scalable, and personalized sleep health solutions that can transform clinical and public health practices worldwide.

Keywords

• Translational Sleep Science
• Circadian Health
• Precision Sleep Medicine
• Interdisciplinary Sleep Research
• Digital and AI-Driven Sleep Technologies

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal's Aims and Scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript through the Dovepress website. During submission, enter the promo code B71DF to indicate that your article should be considered for this Collection. Standard article publishing charges apply.

The manuscript submission deadline is 31 December 2025.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Antipsychotic Treatments - Transforming Schizophrenia Management in the Modern Era" in Neuropsychiatric Disease and Treatment.

We are pleased to announce a new Article Collection in Neuropsychiatric Disease and Treatment, dedicated to the game-changing role of antipsychotic treatments in the management of schizophrenia.

Since their clinical introduction, antipsychotic treatments have revolutionized care for patients with schizophrenia, offering benefits in reducing psychotic symptoms, stabilizing mood and emotions, improving cognitive and occupational functioning, and suicide prevention.

Given their global importance, Neuropsychiatric Disease and Treatment invites submissions of original research articles, reviews, and perspectives exploring the mechanisms of action, clinical efficacy, safety, and real-world application of antipsychotics in the management of schizophrenia.

The Collection, edited by the Editor-In-Chief Dr. Roger Pinder, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

While the call is open to receive manuscripts across the broad spectrum of antipsychotic treatment in schizophrenia, the Editors are particularly interested in manuscripts relating to the following areas, including but not limited to:

• Novel antipsychotic drug mechanisms, pharmacology, and targets
• Clinical effectiveness of antipsychotic drugs on reduction of psychotic symptoms and emotional regulation
• Impact of antipsychotic treatments on cognition, functional recovery, and neurobiological changes
• Efficacy and safety of antipsychotics for optimizing treatment and minimizing side effects
• Long-acting injectable (LAI) antipsychotic drugs for improving treatment adherence and patient outcomes
• Innovations and technologies in personalized antipsychotic treatment

Please submit your manuscript on our website. Submitting authors will be eligible for a 20% discount of the Article Publishing Charge by applying the following code at the point of submission TQYVE. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Sam Zhang at [email protected].

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submissions is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Artificial Intelligence and Machine Learning in Neuropsychiatric Disease Diagnosis, Prognosis, and Treatment" in Neuropsychiatric Disease and Treatment.

Artificial intelligence (AI), machine learning (ML), and data mining (DM) have become pivotal tools in revolutionizing the diagnosis, treatment, and management of neuropsychiatric diseases. These technologies, capable of handling vast amounts of complex data, offer innovative solutions to traditional clinical approaches. The intersection of AI, ML, and neuropsychiatry is expanding rapidly, bringing about groundbreaking advancements in understanding conditions such as Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Anxiety and Depressive Disorders, Schizophrenia, and other cognitive disorders. By leveraging data-driven techniques, it is now possible to detect patterns in patient data that were previously difficult to identify, enabling early detection, personalized treatment, and improved patient outcomes. This Article Collection will explore how AI, ML, and DM are being applied to neuropsychiatric diseases, highlighting recent research and methodologies.

The importance of this topic lies in its potential to address some of the most pressing challenges in neuropsychiatric healthcare. Traditional diagnostic methods, based on clinical judgment and limited patient data, often fail to capture the complexity of brain disorders. The integration of AI and ML techniques, such as neural networks, deep learning, and reinforcement learning, promises to enhance diagnostic accuracy, predict disease progression, and optimize treatment strategies. Additionally, the ability of AI and ML to analyze multimodal data, including genetic, neuroimaging, and behavioral data, could lead to the discovery of novel biomarkers and personalized therapeutic interventions. As these technologies become more refined, they hold the potential to revolutionize how neuropsychiatric conditions are understood and treated.

This Article Collection will focus on the cutting-edge applications of AI, ML, and DM in the field of neuropsychiatry. We welcome original research, survey papers, meta-analyses, and review articles that explore the following subtopics including but not limited to:

• AI/ML in Neuropsychiatric Disease Diagnosis and Prognosis: Studies on how AI models, including deep learning and reinforcement learning, can be used to predict disease onset, progression, and therapeutic response.
• AI/ML Models for Biomarker Discovery: Utilizing machine learning algorithms to identify novel biomarkers for neuropsychiatric conditions, focusing on genetic, neuroimaging, and clinical data integration.
• Personalized Treatment through AI/ML: Exploration of AI-driven approaches in tailoring treatments for patients based on their unique genetic, clinical, and environmental factors.
• Data Mining Techniques in Cognitive Disorder Management: Application of advanced data mining algorithms to clinical datasets for the early detection and monitoring of conditions like schizophrenia, bipolar disorder, and depression.
• Neuroimaging and Neuroinformatics in AI/ML: Development of AI/ML algorithms to analyze neuroimaging data (e.g., MRI, PET scans) for better understanding of brain structures associated with neuropsychiatric disorders.
• Challenges and Ethical Considerations in AI/ML in Neuropsychiatry: Addressing issues related to data privacy, ethical implications, and bias in AI/ML models when applied to sensitive health data.

This Article Collection will appeal to researchers, clinicians, and technologists interested in how AI and ML can improve the diagnosis, treatment, and management of neuropsychiatric diseases.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 31 January 2026.

Please submit your manuscript on our website, quoting the promo code HXCWA for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisors

Dr Sathishkumar V Easwaramoorthy, Sunway University

[email protected]

Professor Vetriselvan Subramaniyan, Sunway University

[email protected]

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Autism, Autonomy, and Policy: Approaches to Enhancing Choice and Long-Term Cost Savings Across ASD Communities" in Neuropsychiatric Disease and Treatment.

Individuals with Autism Spectrum Disorder (ASD) and/or Intellectual Development Disorder (IDD) face significant barriers to autonomy in key areas such as healthcare, education, employment, therapy modalities, housing, and daily living. Policy frameworks often prioritize standardized interventions rather than individualized support, limiting choice and self-determination. This Article Collection explores how policy-driven, data-informed approaches may enhance autonomy for individuals with ASD and/or IDD and their caregivers, improve well-being, and reduce long-term costs associated with restrictive care models. By integrating perspectives from neuropsychiatry, public health, and social policy, this collection will provide insights into the intersection of ASD/IDD, mental health, and systemic reforms needed to support choice and inclusion.

Autonomy-supportive policies are crucial for improving the quality of life of individuals with ASD or IDD while also reducing economic burdens on healthcare, social services, and government programs. Research has shown that when individuals are given greater control over their care, educational pathways, and employment opportunities, they experience better mental health outcomes, greater social integration, and increased economic productivity. However, disparities exist in access to such opportunities, particularly among racially and ethnically diverse communities. By examining how autonomy-driven policies may enhance self-determination while providing long-term cost savings, this Article Collection will highlight solutions that benefit both individuals and broader societal structures.

This Article Collection will focus on but not limited to the following four key areas:

(1) Supported decision-making models and policy interventions that investigate autonomy in education, healthcare, and employment for individuals with autism spectrum disorder (ASD) and or Intellectual Development Disorder (IDD).

(2) The intersection of ASD/IDD and mood disorders, with a focus on improving mental health outcomes through autonomy-supportive approaches and investigating self-efficacy in ASD or IDD.

(3) Racial and ethnic disparities in ASD or IDD diagnosis and services, highlighting how culturally competent policies and understanding of varying conceptions of autism may bridge gaps in care.

(4) Economic analyses of long-term cost savings associated with autonomy-supportive policies in relation to housing, supportive care and therapy modalities, and education.

We welcome original research, systematic reviews, and case studies that provide data-driven recommendations for understanding the role of autonomy within the scope of neuropsychiatric disease and treatment.

Please submit your manuscript on our website. Submitting authors will be eligible for a 10% discount of the Article Publishing Charge by applying the following code at the point of submission 3C3FF. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Sam Zhang at [email protected].

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submissions is 31 January 2026.

Guest Advisors

Allyson Kristofik, Saint Michael’s College

Independent Researcher

[email protected]

Ms. Kristofik is an autistic self-advocate and researcher with ten years of experience in research-based institutions, the government sector, and leading autism-focused nonprofit organizations. As a co-advisor for the Neuropsychiatric Disease and Treatment Autism Article Collection, she brings a unique perspective that integrates lived experience with scholarly expertise. Her published work focuses on addressing service gaps, policy improvements, and transitional support for autistic individuals and their caregivers. With a background in psychology and neuropsychoanalysis, Ms. Kristofik is committed to advocating for meaningful, evidence-based systemic change.

Katandria Love Johnson, Abilene Christian University

[email protected]

Dr. Katandria Demps is co-founder of KLD Consulting. She is a multi-lingual, nationally certified speech-language pathologist, linguist, certified autism specialist, certified public health researcher and certified in the practice of cognitive rehabilitation, ACA advanced national caregiving and assisted living.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Environmental Factors in Neuropsychiatric Pathophysiology and the Role of Alternative Therapeutic Approaches" in Neuropsychiatric Disease and Treatment.

Neuropsychiatric disorders, including depression, anxiety, schizophrenia, and bipolar disorder, arise from a complex interplay of genetic, neurobiological, and environmental factors. Among these, environmental influences play a pivotal role in shaping brain function and mental health. Exposure to psychological stress, trauma, sleep dysfunction, toxicants, infections, and socioeconomic factors can contribute to neuropsychiatric pathophysiology by altering neurochemical balance, inflammatory pathways, and neuronal signaling and plasticity. While conventional treatments such as pharmacotherapy and psychotherapy remain the cornerstone of management, alternative therapeutic approaches are gaining recognition for their potential to complement traditional treatments. New concepts in nutritional psychiatry, gut microbiome, mindfulness-based therapies, transcranial magnetic stimulation, exercise, and herbal medicine have led to propositions and explorations of alternative interventions for treating mental health disorders based upon their neuroprotective and neuromodulatory effects. This Article Collection aims to explore the intricate relationship between environmental factors and neuropsychiatric disorders, while also evaluating the efficacy and mechanisms of alternative therapeutic approaches for holistic, personalized treatment.

With increased life expectancies coupled with detrimental life-style changes, there has been a tremendous rise in the global burden of neuropsychiatric disorders. They have become a leading cause of disability worldwide, affecting millions of individuals. Environmental influences (e.g., chronic stress, pollution, urbanization, socioeconomic disparities, trauma, sleep issues, poor nutrition, etc.) play a crucial role in both the development and progression of these multifactorial and heterogeneous of neurological conditions. While pharmacotherapy and psychotherapy remain standard treatments, they are not always effective for all patients and may have side effects. Novel alternative treatments are being proposed regularly and are gaining scientific validation for a more comprehensive, patient-centered approach to neuropsychiatric care. Thus, identification of modifiable environmental risk factors and exploring alternative therapies can lead to prevention and early intervention, and more effective, personalized, and holistic treatment strategies.

This Article Collection will explore the complex interaction between environmental exposures and neuropsychiatric pathophysiology while evaluating the potential of alternative treatment approaches. The subtopics include, but are not limited to, (i) environmental factors contributing to neuropsychiatric disorders: chronic stress, trauma, and early-life adversity, influence of pollutants, heavy metals, and endocrine disruptors, urbanization, socioeconomic status, and lifestyle factors, (ii) neurobiological mechanisms linking environmental stressors to psychiatric disorders: neuroendocrine changes, alterations in neurotransmitter (dopamine, serotonin, glutamate) systems and neuroplasticity, oxidative stress, neuroinflammation and gut microbial dyshomeostasis, and (iii) alternative therapeutic approaches for neuropsychiatric disorders: nutritional psychiatry (ketogenic diet, micronutrients, and omega-3 fatty acids, etc.), mindfulness-based interventions and meditation, mental and physical activity, gut microbiome modulation, non-invasive brain simulation (TMS, tDCS, etc.), herbal medicines. Both reviews and original research will be entertained.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 31 January 2026.

Please submit your manuscript on our website, quoting the promo code NRCCP for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisors

Dr. Faraz Ahmad, Vellore Institute of Technology, India

[email protected]

Dr. Faraz Ahmad’s research focusses on understanding the molecular mechanisms of synaptic pathology in a range of neuronal disorders, ranging from early-life stress to ageing-induced cognitive decline. He’s also interested in devising and evaluating phytotherapy-based strategies for neuroprotection.

Dr. Shafiul Haque, Jazan University, Saudi Arabia

[email protected]

Dr. Shafiul Haque has been offering 15+ years of accomplished experience in health sciences/ biomedical sciences /life sciences research, academia, bio-business with flare of research strategy and scientific management, team leadership, design & development of biological research projects/products, research application support and R&D project management.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Neuromodulation in Neuropsychiatric Disorders" in Neuropsychiatric Disease and Treatment.

We are pleased to announce a new Article Collection in Neuropsychiatric Disease and Treatment, dedicated to the game-changing role of neuromodulation therapies in the management of neuropsychiatric disorders.

The collection, edited by the Editor-In-Chief Dr. Roger Pinder, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

While the call is open to receive manuscripts across the broad spectrum of neuromodulation in neuropsychiatric disorders, the Editors are particularly interested in those that are being used within the clinic:

• Transcranial magnetic stimulation (TMS) for depression and obsessive-compulsive disorder (OCD)
• Electroconvulsive therapy (ECT) for depression and other mood disorders
• Vagus nerve stimulation (VNS) for depression and epilepsy
• Deep brain stimulation (DBS) for Parkinson’s disease and OCD
• Cranial electrotherapy stimulation (CES) for depression, anxiety, and insomnia

Submissions on other neuromodulation therapies in treating neuropsychiatric disorders are also welcome. The subtopics of interest include but are not limited to:

• Neurological mechanisms and pathways
• Clinical benefits and long-term outcomes
• Cognitive and emotional effects
• Risks, side effects, and safety considerations
• Technical innovations and personalized approaches

Please submit your manuscript on our website. Submitting authors will be eligible for a 20% discount of the Article Publishing Charge by applying the following code at the point of submission NZIEY. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Sam Zhang at [email protected].

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submissions is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Neuropsychiatric Aspects of Autoimmune Illness and Infectious Disease" in Neuropsychiatric Disease and Treatment.

In the 17th century, Rene Descartes posited that the mind and body are fundamentally distinct, but the boundary between physical and mental health has been challenged by awareness that psychological factors influence physical health. It was in 1818 that the German physician Johann Christian introduced the term “psychosomatic”. Over the past century it has become increasingly apparent that physical disease can cause psychiatric symptoms, or “somatopsychic” illness. While this pattern has long been apparent in conditions such as thyroid disorders, brain tumors and vitamin deficiencies, there is now widespread research documenting the role of neuroinflammation as a cause of neuropsychiatric disorders. Autoimmune illnesses and infections are increasingly recognized as potential contributors to neuropsychiatric illness.

The immune system is tasked with defending the body against pathogens and aberrant cell growth that may lead to malignancies. When the immune response becomes misdirected, the resulting inflammation can attack healthy tissues, including those in the brain. Neuroinflammation can manifest as cognitive changes, depression, anxiety, psychosis, irritability or other neuropsychiatric symptoms. Understanding the capacity of autoimmune conditions and infections to cause a wide range of mental health issues is crucial for accurate diagnosis and treatment, especially when psychiatric symptoms emerge suddenly or atypically, or precede physical complaints.

The intersection of the immune system and brain function has emerged as a crucial frontier in medicine. Autoimmune diseases and infections are increasingly recognized not only for their systemic manifestations but also for their profound neuropsychiatric effects. Conditions such as lupus, multiple sclerosis, post-Covid syndrome, Lyme disease and even common viral illnesses can trigger a wide range of cognitive, emotional, and behavioral symptoms. Understanding these complex interactions is vital for early diagnosis, effective treatment, and improved quality of life for affected individuals. This Article Collection brings together cutting-edge research and expert perspectives on the mechanisms, clinical presentations, and therapeutic approaches to neuropsychiatric complications of autoimmune and infectious diseases. Through a multidisciplinary lens, we aim to highlight the biological underpinnings, diagnostic challenges, and evolving management strategies at this dynamic interface between immunology, neurology, and psychiatry.

Keywords

• Neuropsychiatric disorders
• Autoimmunity
• Infection
• Neuroinflammation
• Mind-body connection

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code 80BEE to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 31st Mar 2026.

Please contact Sam Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

Guest Advisors

Dr. Daniel A. Kinderlehrer, Private practice

[email protected]

Daniel A. Kinderlehrer M.D. is a nationally recognized physician with expertise in the fields of nutrition, allergy, environmental medicine, Lyme disease and the healing of mind-body-spirit as a unified whole. Dr. Kinderlehrer has taught extensively, including practitioner training courses at the Omega Institute, The National Institute of Behavioral Medicine, and the International Lyme and Associated Diseases Society. He is the author of several articles in medical journals, the Lyme Times, and Psychology Today. His integrated medical practice in Denver, Colorado focuses on the diagnosis and treatment of tick-borne disease. Dr. Kinderlehrer is the author of Recovery From Lyme Disease: The Integrative Medicine Guide to the Diagnosis and Treatment of Tick-Borne Illness, which was released in 2020.

Dr. Robert C Bransfield, Hackensack Meridian School of Medicine Rutgers-RWJ School of Medicine

[email protected]

Dr. Robert C. Bransfield, MD, DLFAPA has held a number of administrative positions with hospitals and organizations involved with health, mental health and community related activities and has received multiple awards from the American Psychiatric Association and the International Lyme and Associated Diseases Society. Dr. Bransfield’s clinical activities has focused upon treating patients who are considered to be treatment resistant. Many of these patients were found to have infectious disease contributors to their psychiatric symptoms. As a result, his research has often focused upon the association between infectious disease and mental illness. Dr. Bransfield has authored and co-authored a number of publications in peer-reviewed and other literature and has been active in political advocacy.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advances in Cancer Immunotherapy: Harnessing the Immune System for Cancer Treatment" in OncoTargets and Therapy.

In the last decade, harnessing the immune system with immune checkpoint blockades has achieved remarkable results in solid tumors of different histotypes, enabling durable responses and long-term survival. Despite these unprecedented results, primary or acquired resistance can limit its efficacy; thus, a deeper understanding of the underlying mechanisms of resistance is crucial for the identification of novel therapeutic strategies in several clinical settings (e.g. adjuvant, neo-adjuvant setting, rare tumors, etc.). Immunotherapy research needs to answer some key questions, from mechanistic exploration of lack of response, to biomarker identification, to the development of novel immunotherapeutic modalities and their clinical application. 

We are seeking original research and review article submissions on cancer immunotherapy, including but not limited to the following subtopics:

• Immune-checkpoint blockade for cancer treatment: from biology to clinical results

• Therapeutic Combinations of Immune-Modulating Antibodies

• Immunotherapy of brain metastases and brain primary tumors

• Cancer immunotherapy in ocular melanoma

• Immunotherapy in rare tumors

• Immunotherapy in adjuvant and neoadjuvant setting

• Mechanisms of immune escape and potential strategies to overcame resistance

• Epigenetic immune remodeling to improve efficacy of cancer immunotherapy

• Harnessing T cell metabolism to improve anti-tumor response

• Microbiome and immune-checkpoint blockade therapy

• Beyond immune-checkpoint(s): new targets for cancer immunotherapy

• Imaging challenges of immunotherapy

• Biomarkers of response and toxicity of immunotherapy

• Radiomics and deep learning approach in cancer immunotherapy

The deadline for submissions is 1 August 2025. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code JALHG for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest advisor

Anna Maria Di Giacomo, University Hospital of Siena

Anna Maria Di Giacomo is an Associate Professor of Oncology at the University of Siena, Chair of the Early Phase Clinical Trial Center and Associate Director for the Center for Immuno-Oncology, Department of Oncology at the University Hospital of Siena. She is a member of the Associazione Italiana di Oncologia Medica (AIOM), the Italian Network for Tumour Biotherapy (NIBIT) Foundation, The Italian Melanoma Intergroup (IMI) and ESMO (European Society of Clinical Oncology). She is also a member of the Board of Director of NIBIT Foundation, of IMI and of Federation of Italian Cooperative Oncology Groups (FICOG). She is a member of Steering Committee of ESMO Immuno-oncology. 

Prof. Di Giacomo is currently Principal Investigator and Co-Investigator for more than 150 clinical trials in solid malignancies, investigating bio-chemotherapy, immunotherapeutic agents and molecularly targeted agents. Her clinical and translational research interests include: the immunological and clinical activity of immunotherapeutic agents including the new generation of targeted immunotherapy in the treatment of skin, brain and other solid tumours; epigenetics and epigenetic-immuno-sequencing strategies to improve efficacy of cancer immunotherapy; and identification of biomarkers of efficacy of cancer immunotherapy.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Radiation Therapies for Cancer" in OncoTargets and Therapy.

Radiation therapy remains a cornerstone in the treatment of various cancers. With continuous advancements in technology and a deeper understanding of cancer biology, radiation therapies are becoming more precise and effective. This Article Collection seeks to explore these advancements, including novel radiation techniques, toxicity management, and integration of radiation therapies with other treatment modalities.

We invite papers on topics including but not limited to:

• Innovative radiation techniques, including proton therapy, carbon ion therapy, and stereotactic body radiotherapy (SBRT).
• Technological innovations in radiation oncology, including the development and implementation of technologies such as artificial intelligence, machine learning, and image-guided radiation therapy (IGRT) in clinical practice.
• Radiation therapy and immunotherapy combinations.
• Personalized radiation therapy
• Radiation-induced toxicity management

The deadline for submissions is 1 December 2025. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code MMCTR for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “Advancing Medical Problem-Oriented Approaches in Infectious Disease Management”, organized by Dr. Ahmad Riyad Alsayed, in Patient Preference and Adherence.

Infectious diseases remain a significant global health challenge, with the emergence of new pathogens, the spread of drug-resistant strains, and the ongoing threat of pandemics. In response to these challenges, infectious disease management has continuously evolved, adopting innovative strategies to combat common and emerging infections. This Collection aims to highlight and disseminate cutting-edge research and developments in the field, particularly on problem-oriented approaches.

Scope and Objectives

This Article Collection seeks to provide a comprehensive platform for researchers, clinicians, and public health experts to share their insights and findings related to problem-oriented approaches in infectious disease management. The primary objectives of this Article Collection include:

1. Illuminating the critical issues surrounding drugs and treatment, using classification systems like drug-related problems (DRPs), treatment-related problems, or recently, the medical problems-oriented plan (MPOP), with the ultimate goal of enhancing patient outcomes and the overall quality of care in patients suffering from infectious diseases.
2. Exploring Novel Diagnostic Tools: Papers in this Article Collection will delve into the development and application of innovative diagnostic tools, including molecular techniques, point-of-care devices, and artificial intelligence-driven algorithms, to enhance the rapid and accurate detection of infectious pathogens, considering patient acceptance and adherence.
3. Advancements in Therapeutic Strategies: Researchers are encouraged to present studies on discovering and evaluating new therapeutic agents, vaccines, and treatment modalities for infectious diseases. Emphasis should be placed on personalized and precision medicine approaches.
4. Surveillance and Epidemiological Studies: Contributions that focus on using epidemiological models, big data analytics, and advanced surveillance systems to predict, prevent, and manage infectious disease outbreaks will be featured.
5. Antimicrobial Stewardship: Papers discussing the implementation of antimicrobial stewardship programs in healthcare settings and strategies to combat antimicrobial resistance will be considered for inclusion.

The deadline for submissions is 30 July 2025. Please review the journal’s aims and scope, alongside the author submission instructions prior to completing your submission.

Please submit your manuscript on our website, quoting the promo code WGNSA for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest advisor

Ahmad Riyad Alsayed, Applied Science Private University

[email protected]

The main aims of Dr. Alsayed's practice and research are to promote evidence-based medication use to improve disease outcome and health-related quality of life of patients with internal medicine-related disorders. His current research interests include clinical pharmacy, evidence-based medicine, clinical trials of effectiveness and safety, quality of life, and pharmaceutical care,  with a special interest in infectious, respiratory, diabetes, and cardiovascular diseases.​

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “Comprehensive Management of Chronic Respiratory Diseases” in Patient Preference and Adherence.

Chronic respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and asthma, represent a significant global health burden. Effective management of these conditions requires a multifaceted approach that includes inhalation therapy, pulmonary rehabilitation, biologic therapies, physical activity, and psychological support.

This Article Collection aims to explore these key components in the management of chronic respiratory diseases, with a focus on enhancing treatment adherence and improving patient outcomes. Inhalation therapy is the cornerstone of treatment, but adherence challenges related to device complexity and patient understanding persist. The Collection examines strategies to improve inhaler use, such as patient education and simplified devices. Pulmonary rehabilitation, which combines physical activity, education, and behavioral interventions, is increasingly recognized as an essential aspect of managing respiratory conditions, particularly in COPD.

The Collection will explore how pulmonary rehabilitation programs can improve functional capacity, reduce symptoms, and enhance quality of life. Additionally, the growing role of biologic therapies, particularly in severe asthma and COPD, will be addressed, focusing on their ability to reduce exacerbations and improve long-term control. Psychological support will also be discussed, as mental health conditions like depression and anxiety can significantly impact treatment adherence and overall well-being. By integrating these diverse elements—pharmacological, physical, and psychological care—this Collection offers a comprehensive perspective on optimizing care and outcomes for patients with chronic respiratory diseases.

Key topics appropriate for this Article Collection include, but are not limited, to:
• Inhalation therapy: multiple devices vs. single device, adherence challenges, patient preferences, improving adherence, device usability, and patient education
• Pulmonary rehabilitation: benefits, components, and integration into treatment plans
• Physical activity as part of a holistic management strategy
• The role of biologic therapies in severe asthma and COPD
• Psychological support: addressing mental health issues and enhancing treatment adherence
• Personalizing care through patient preferences and shared decision-making

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and Author Submission Instructions prior to submitting a manuscript.

The deadline for submissions is 31 January 2026.

Please submit your manuscript on our website, quoting the promo code RLZYR for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

If you have any queries regarding this Article Collection, please reach out to the Commissioning Editor, Darcy Hodge ([email protected]).

Guest Advisor

Dr. Alessandra Tomasello, Vanderbilt University Medical Center

[email protected]

Dr. Alessandra Tomasello is currently a Visiting Research Fellow at Vanderbilt University Medical Center, joining the Cahill Group. She attended Comenius University of Bratislava (SK) where she obtained her MD degree. She then attended the School of Respiratory Diseases at the University of Palermo, where she completed her residency in Pulmonology. Her primary research interest is mainly focused on chronic respiratory diseases with particular interest in asthma and COPD: pathophysiological mechanisms, biomarkers, characterization of phenotypes of the disease, evaluation of airway remodeling processes and the effects of treatments and target therapy.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “Digital Healthcare Solutions for Patient Experience and Medication Adherence”, organized by Dr. Krzysztof Laudanski in Patient Preference and Adherence.

The introduction of technology into healthcare has developed from humble beginnings into an essential for many aspects of medicine. Recently, as with many other industries, there has been increased interest in the digital solutions available worldwide. Such solutions include those developed in times of need, such as the introduction of telemedicine during the COVID-19 pandemic, and some have emerged in tandem with developments in other areas, including machine learning and artificial intelligence.

The potential benefits of digital solutions for patients are vast, and as this Article Collection aims to highlight, the application and implementation of digital technologies are crucial to their success in healthcare settings. This is with the end goal of maximizing the patient experience and using technologies to promote good health-related outcomes. One facet of this includes medication adherence, for both communicable and non-communicable diseases, which presents challenges to patient care, recovery and disease maintenance. Certain medical specialties may endure more challenges with medication adherence than others, but it is also crucial to recognize the patient in this process; for example, the reasons behind failure to adhere to medication regimens, side-effects, comorbidities and additional aspects of the patient experience – all of which are important to recognize for their care.

The importance of medication regimens in healthcare cannot be overstated and, therefore, barriers to adherence ought to be overcome. This is with the aim of delivering the best-quality care. Digital healthcare solutions help healthcare professionals embark on a new age of medical care, including the ability to accommodate various preferences and environments. This not only changes the practical aspects of providing care, but indeed how patients may perceive and experience healthcare settings across their lifespan. However, that is not to suggest that digital technologies can provide a ‘one-size-fits-all’ solution for all patients and all conditions. It is paramount to the future of digital healthcare technologies to investigate the specific relationships certain technologies have with multiple factors.

In order to provide effective care, digital healthcare technologies must be sensitive to patients' authentic needs and experiences. This includes assisting with patient care beyond inpatient settings, as the power of preventative medicine and patient self-care continues to be highlighted, particularly in light of overburdened and underfunded global health systems. Knowledge of the digital healthcare technologies in development, and their implementation, is paramount to continuing serving patient needs as effectively as possible.

This Article Collection aims to highlight the value of digital healthcare solutions, such as telemedicine for patient care and experience. It is hoped that by launching this Collection, we will help readers feel better empowered to utilize digital healthcare solutions and to research ways of improving these technologies, with the goal of enhancing the patient experience further. The Collection is open to submissions from all disease areas and all patient groups, but submissions must have a focus on digital healthcare solutions and the patient experience.

Topics of interest may include, but are not limited to:
• Development and implementation of digital healthcare solutions and technologies
• Adaptations and strategies relating to patient groups, disease areas and more
• Relationship between digital healthcare and patient outcomes
• Telehealth, remote monitoring, electronic health records and artificial intelligence in healthcare settings
• Role of technology in diagnoses, medication adherence and overall patient experience

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and Author Submission Instructions prior to submitting a manuscript.

The deadline for submissions is 21 November 2025.

Please submit your manuscript on our website, quoting the promo code NSENH for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisor

Dr. Krzysztof Laudanski, Mayo Clinic: Rochester, Minnesota, US

[email protected]

Dr. Laudanski is a board-certified anesthesiologist and critical care doctor. He holds a Regional Anesthesia Certificate from the American Association of Anesthesiologists. His clinical experience focuses on managing ECMO, VAD, postoperative recovery, sepsis, and senescence secondary to maladaptive allostasis after critical illnesses. Additionally, he has expertise in neuro-critical care and telemedicine. Krzysztof “Kris” Laudanski’s research focuses on the regulation of DNA in critical care illnesses survivors and innovation in healthcare. His passion is providing support to future generations of medical professionals. In these efforts, he creates a tailored plan that fits both the mentee’s and mentor’s interests, goals, and passion.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “Breaking Down the Intricacies of Catabolic Enzymes”, organized by Editor-in-Chief Dr. Martin Bluth in Pharmacogenomics and Personalized Medicine.

Genetic polymorphisms are one way in which people vary from one another. While initial thoughts of "variance" might include a person’s physical features, it is well established that the body’s internal processes are also subject to differ dependent on a multitude of factors. This could include traits that follow them from birth, but also polypharmacy, or even diet.

In line with the advances in modern medicine and genetic testing, research has started to explore the plethora of information linked to catabolic enzyme polymorphisms. This can involve specifying polymorphisms of interest, such as the Cytochrome P450 (CYP) family such as those including the location on the chromosome, possible allelic variations and the impact of these polymorphisms on their parent compound, metabolites or other molecules.

Genetic polymorphisms affect many parts of human function, irrespective of specific health status. This stresses the importance of such polymorphisms further, for both promoting wellbeing in times of health, but to also understand how to approach certain illnesses given the variance in each individual case. This Collection aims to explore the role of catabolic enzyme polymorphisms for a wide variety of disease areas, such as oncology, pulmonology, immunology, psychology, cardiology and more.

The advances in medicine can also leave researchers asking more questions. As more drug compounds reach regulators and medicine agencies, should we be considering how enzyme polymorphisms influence the efficacy and reaction of new medicines? What dangers exist when you inhibit or enhance an enzyme reaction? When considering these possibilities for new medicines, it is also imperative to acknowledge the range of possible reactions and their severity, given that polymorphisms highlight how differences between people should not be underestimated. In turn it is hoped that this Article Collection can promote best practices when prescribing treatments, by placing leading research in this collection.

It is also hoped that research can investigate catabolic enzyme polymorphisms with a wider lens, to understand global trends in such polymorphisms and our understanding of variance on a larger scale. Thus, exploring upcoming topics of interest in this field, such as genomic testing and the use of bioinformatics in predictive technologies, elucidating the intricacies of such interaction are now within reach. These possibilities may provide more control to the individual, their medical practitioners, drug manufacturers by acknowledging human variance stretches beyond what meets the eye. These investigations, questions and early research outcomes highlight the importance of this topic for sustaining our health as a population.

The journal is seeking original submissions and review articles from all disease areas on the following topics related to catabolic enzyme polymorphisms:

• Identifying and understanding polymorphisms (e.g., single-nucleotide polymorphisms)
o All aspects of enzyme metabolism (e.g., catabolism, anabolism)
o Associated mutations, location and allelic compositions
o Functions of interest (e.g., CYPs, steroidogenic enzymes)
• Incidence and variance of poor metabolizers
• Biochemical impact of polymorphisms (e.g., on parent compound, metabolites)
• Impact of polymorphisms on drug reaction symptoms, severity and consequences
o Variance in pro-drug and active drug reactions
• Non-drug consumables (i.e. diet, infectious diseases) and polymorphisms
• How epigenetic and infectious processes affect polymorphism function
• Treatment efficacy and polymorphisms
o Role of polypharmacy on reactions
o Personalized dosages, drug classes and emergency medical care
• Global trends and variation in polymorphisms
• Progress in polymorphism genomic testing and associated benefits and costs
• Use of bioinformatics and modelling systems for predictive testing

All manuscripts submitted to this Article Collection are subject to desk assessment and peer review processes as part of our standard editorial process. We kindly ask all submitting authors to review the Aims and Scope of the journal, alongside the Author Information prior to completing your submission.

The deadline for submissions is 31 May 2024.

Please submit your manuscript on our website, quoting the promo code XSMPT for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

We are pleased to announce a new Article Collection in Psychology Research and Behavior Management, dedicated to the game-changing role of GLP-1 receptor agonists (GLP-1 RAs) in psychological treatment and behavior management. Since their clinical introduction, GLP-1 RAs have revolutionized patient care beyond metabolic and cardiovascular diseases, offering significant benefits in reward regulation, cognitive functions, behaviour control, and mental health for eligible populations.
Given the global importance of GLP-1 RAs in management of psychological disorders, Psychology Research and Behavior Management invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these transformative therapies.

The collection, edited by Editor-In-Chief Dr. Igor Elman, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of GLP-1 Receptor Agonists in mental health, the Editors are particularly interested in manuscripts relating to the following areas:

• Effects of GLP-1 Receptor Agonists on Psychological Factors in Patients with Metabolic Disorders
• Effects of GLP-1 Receptor Agonists on Mental Health Disorders
• Temporal trends in GLP-1 Receptor Agonists’ Effects on Mental Health
• GLP-1 Receptor Agonists’ Effects on Reward Function, Suicidality, Anxiety, or Depression

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website. The deadline for submitting manuscripts is 1 April 2026.

Submitting authors will be eligible for a 20% discount of the Article Publishing Charge by applying the following code at the point of submission 25CF5. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Sam Zhang at [email protected].

View all papers in this article collection

Dove Medical Press is pleased to announce a new Article Collection in Research and Reports in Urology, dedicated to the transformative role of focal therapy in the management of prostate cancer. Since its clinical introduction, focal therapy has revolutionized patient care, offering benefits in preserving urinary and sexual function, minimizing treatment-related morbidity, and enabling targeted cancer control.

Given the importance of focal therapy in managing prostate cancer, Research and Reports in Urology invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these paradigm-shifting therapies. 

This collection, edited by Editor-in-Chief Professor Panagiotis J Vlachostergios, is part of the new Game Changer series of Article Collections, spotlighting breakthrough therapies that redefine standards of care and deliver game-changing improvements in patient outcomes. 

While the call welcomes manuscripts across the broad spectrum of focal therapy in prostate cancer, the Editors are particularly interested in submissions addressing the following priority areas:

• Patient selection and biomarkers: advances in MRI-guided targeting, genomic profiling, and risk stratification for focal therapy candidacy.
• Energy modalities and technologies: comparative outcomes of HIFU, cryotherapy, laser ablation, and irreversible electroporation.
• Long-term oncologic outcomes: disease-free survival, recurrence patterns, and integration with active surveillance protocols.
• Complications and side effects: Short-term (urinary retention, infection) vs. long-term risks (erectile dysfunction), management strategies for adverse events.
• Technological advancements: AI in treatment planning and imaging interpretation, robotics/real-time imaging integration and nanotechnology, combination therapies (e.g., focal ablation + immunotherapy)

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 1 April 2026.

Please submit your manuscript on our website, quoting the promo code BICXO for a 20% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The use of AI in Urology and Urologic Oncology", organized by Guest Advisors Michele Marchioni, Daniele Amparore, and Rossella Cicchetti in Research and Reports in Urology.

The rapid advancement of Artificial Intelligence (AI) technologies offers transformative potential in the field of urology. This Article Collection aims to examine the innovative applications and future prospects of AI within urological practice, highlighting its significant impact on diagnostics, treatment planning, and patient care. 

The primary objective is to showcase cutting-edge research and practical applications of AI in urology. Key topics of interest include machine learning algorithms for diagnosing various urological disorders, AI-enhanced imaging techniques, robotic surgery applications, and predictive analytics that improve clinical decision-making. We also aim to address the ethical considerations surrounding AI implementation in urology and its potential to change patient outcomes. 

The aim is to curate a comprehensive collection of articles focused on "The Use of AI in Urology and Urologic Oncology." This collection is designed to be a valuable resource for publication in prestigious journals specializing in artificial intelligence, urology, and oncology. The subtopics featured within this collection will provide in depth coverage of a wide array of important subjects:

• The application of machine learning algorithms in the diagnosis and identification of various urological disorders. This will include discussions on the latest advancements in algorithmic techniques and their clinical effectiveness in improving diagnostic accuracy.
• Exploration of cutting-edge imaging techniques that have been significantly enhanced through artificial intelligence. These techniques not only improve the quality of imaging but also facilitate more accurate detection and assessment of urological conditions.
• Examination of the role of robotic surgery within urology, highlighting how AI-powered innovations are revolutionizing surgical practices. This will cover both the technological advancements and the clinical benefits associated with robotic-assisted procedures.
• Analysis of predictive analytics tools that leverage AI to support more informed and efficient clinical decision-making processes. These tools have the potential to personalize treatment plans and optimize patient outcomes by predicting disease progression and treatment responses.
• A thorough discussion on the ethical considerations involved in the integration of AI within the field of urology. This will address the potential implications for patient care, data privacy, and the overall impact of AI on healthcare outcomes, ensuring that the adoption of these technologies is both responsible and beneficial.

We encourage submissions from urologists, researchers, data scientists, and healthcare professionals exploring how AI technologies can optimize the management of urological conditions. The Article Collection will serve as a platform to discuss successful case studies, ongoing research, and the challenges associated with integrating AI into clinical practice. 

By fostering collaboration and knowledge exchange, this collection intends to illuminate the current landscape of AI in urology and inspire further innovation in the field.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 12 June 2025.

Please submit your manuscript on our website, quoting the promo code JHIPA for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

Guest Advisers

Michele Marchioni, Università degli studi G. D.Annunzio

[email protected]

Daniele Amparore, Department of Urology, San Luigi Gonzaga Hospital, Orbassano, Turin - Italy

[email protected]

Rossella Cicchetti, Università degli studi G. D’Annunzio

[email protected]

View all papers in this article collection

We are pleased to announce a new Article Collection in Risk Management and Healthcare Policy, dedicated to the game-changing role of Artificial Intelligence (AI) in the management of healthcare risk. Since their clinical introduction, AI technologies have revolutionized patient care, offering significant benefits in early disease detection, optimizing personalized treatments, and enabling real-time risk prediction to support healthcare providers in decision-making.

Given the importance of AI in healthcare risk management, Risk Management and Healthcare Policy invites submissions of original research articles, reviews, and perspectives exploring AI applications in managing risks, and their impacts on the healthcare system.

The Collection, edited by Editor-In-Chief Dr Gulsum Kubra Kaya, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections focused on breakthrough applications or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of AI applications in healthcare risk, the Editors are particularly interested in manuscripts relating to the following areas:

• AI applications in reducing diagnostic errors and adverse events
• AI-driven predictive modeling
• Ethical frameworks and policy implications of AI in clinical decision-making
• AI-driven remote monitoring systems for chronic disease management
• The impact of AI applications or technology on the healthcare system.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submissions is 31 May 2026.

Please submit your manuscript on our website, quoting the promo code 65A27 for a 20% discount on the Article Publishing Charge and to indicate that your submission is for consideration in this Article Collection.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Assessment and Management of Cardiovascular Risk", organized by Guest Advisor Prof. Dr. Yong Peng in Therapeutics and Clinical Risk Management. 

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide, necessitating a comprehensive understanding of cardiovascular risk factors and the development of effective prevention and management strategies. This Article Collection aims to explore the multifaceted nature of cardiovascular risk, encompassing traditional factors such as hypertension, dyslipidemia, and diabetes, alongside emerging risk factors, including inflammatory markers, genetic predispositions, and lifestyle influences. The goal is to highlight innovative approaches to risk assessment, early detection, and tailored therapeutic strategies that can optimize cardiovascular health outcomes. 

Addressing cardiovascular risk is critical due to its profound impact on global health and healthcare systems. Despite advances in pharmacotherapy and clinical guidelines, cardiovascular events remain prevalent, with a substantial proportion occurring in individuals who would not traditionally be classified as high-risk. This gap underscores the importance of refining our current risk stratification methods and integrating novel biomarkers and personalized approaches into clinical practice. By understanding the complexities of cardiovascular risk, healthcare professionals can develop more effective strategies to reduce the burden of CVD, improve patient outcomes, and allocate healthcare resources more efficiently. 

The Collection welcomes original research, comprehensive reviews, and clinical studies that delve into the assessment and management of cardiovascular risk. Potential topics include, but are not limited to, novel risk prediction models, the role of imaging in risk stratification, pharmacological and non-pharmacological interventions, and strategies for managing high-risk populations. Manuscripts discussing the implementation of precision medicine approaches and health policy considerations in cardiovascular risk management are also encouraged. We invite contributions that will contribute to advancing our understanding of cardiovascular risk and provide insights for clinical application. 

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

Keywords

• Cardiovascular Risk Assessment
• Risk Stratification
• Cardiovascular Disease Prevention
• Precision Medicine
• Therapeutic Interventions

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code RMNJP for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

The deadline for submitting manuscripts is 31 July 2025.

Guest Advisor

Prof. Dr. Yong Peng, Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China

[email protected]

Prof. Peng Yong, MD, FESC, is the Senior Consultant Cardiologist and the Vice Director of the Department of Cardiology at West China Hospital, Sichuan University. As an accomplished interventional cardiologist, Prof. Peng’s expertise spans the interventional treatment and prognosis research of coronary artery disease, valvular heart disease interventions, and sympathetic denervation for hypertension. His clinical and research work aims to advance minimally invasive cardiovascular therapies and improve patient outcomes. Prof. Peng is recognized for his contributions to both clinical practice and academic research in cardiovascular medicine.

View all papers in this article collection

We are pleased to announce a new Article Collection in Therapeutics and Clinical Risk Management, dedicated to the role of biologic treatments in the management of allergic disease. Since their clinical introduction, biologic treatments, particularly monoclonal antibodies, have transformed patient care, offering targeted therapies and improved outcomes for conditions including allergic asthma, allergic rhinitis, atopic dermatitis and urticaria.

Given the importance of biologics in managing allergic disease, we are welcoming submissions of original research articles, reviews, and perspectives exploring the mechanisms of action, clinical efficacy, safety, and real-world application of these therapies.

The Collection, edited by the Editor-In-Chief Prof. Garry Walsh, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of biologic treatments in allergic disease, the Editors are particularly interested in manuscripts relating to the following areas:
• Mechanisms of action and biomarkers for personalized treatment
• Clinical efficacy and safety profiles
• Real-world evidence and patient-reported outcomes
• Cost-effectiveness and health economic evaluations
• Reviews, perspectives and editorials discussing emerging therapies and future directions

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code 7A889 to indicate that your submission is for consideration in this Article Collection.

The deadline for submitting manuscripts is 1 April 2026.

If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor, Catherine Teng at [email protected].

View all papers in this article collection

We are pleased to announce a new Article Collection in Vascular Health and Risk Management, dedicated to the role of anti-diabetic drugs in the management of cardiovascular risk.

While anti-diabetic drugs are widely used in clinical practice for blood sugar control and to delay complications of diabetes, several anti-diabetic drugs – including GLP-1 receptor agonists and SGLT2 inhibitors – have also been shown to prevent adverse cardiovascular events and cardiovascular mortality.

Anti-diabetic drugs thus have an important role to play in cardiovascular medicine, with considerable potential for preventing further cardiac events in select populations.

To highlight this important area of research, Vascular Health and Risk Management invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of anti-diabetic therapies in the context of cardiovascular disease (CVD).

The Collection, edited by Editor-In-Chief Professor Roland Asmar, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections that highlight breakthrough therapies, drugs, or technologies that have the potential to lead to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor & Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of antidiabetic drugs in the management of cardiovascular risk, the Editors are particularly interested in papers relating to the following areas:

• Risk factors for diabetes and CVD
• Mechanisms of cardiovascular protection for modern anti-diabetic treatments
• Clinical studies uncovering the efficacy and safety of antidiabetic drugs in CVD
• Epidemiological studies of CVD patients taking anti-diabetic medications

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

Please review the journal scope and author submission instructions prior to submitting a manuscript. Submitting authors are eligible for a 20% discount on the Article Publishing charge. Please use the promo code BWOME when prompted during the submission.

Please submit your manuscript on our website. The deadline for submitting manuscripts is 1 January 2026.

Please contact Zhiyuan Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

Guest Advisor

Roland Asmar, Foundation-Medical Research Institutes (F-MRI), Switzerland

View all papers in this article collection

We are pleased to announce a new Article Collection in Vascular Health and Risk Management, dedicated to the promising role of renal denervation in the treatment of hypertension. Renal denervation offers a new, minimally invasive option for patients with uncontrolled hypertension, effectively lowering blood pressure and potentially reducing the need for, or dosage of, antihypertensive medications.

Given the emerging importance of renal denervation in managing hypertension, Vascular Health and Risk Management invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of this transformative therapy.

The Collection, edited by Editor-In-Chief Professor Roland Asmar, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor & Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of renal denervation in hypertension, the Editors are particularly interested in manuscripts relating to the following areas:

• The physiology of renal denervation in the treatment of hypertension
• Strengths and limitations of current renal denervation technologies
• Identification and evaluation of appropriate patients, including biomarkers and phenotype
• Advances in technologies, including catheter design, ultrasound, and radiofrequency
• Endpoint selection in clinical trials
• Long-term efficacy and safety studies

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

Please review the journal scope and author submission instructions prior to submitting a manuscript. Submitting authors are eligible for a 20% discount on the Article Publishing charge. Please use the promo code OMDLY when prompted during the submission.

Please submit your manuscript on our website. The deadline for submitting manuscripts is 1 January 2026.

Please contact Zhiyuan Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

Guest Advisor

Roland Asmar, Foundation-Medical Research Institutes (F-MRI), Switzerland

View all papers in this article collection

We are pleased to announce a new Article Collection in Vascular Health and Risk Management, dedicated to the game-changing role of pharmacotherapy in the management of heart failure. Since their clinical introduction, heart failure medications have revolutionized patient care, leading to improved survival, reduced hospitalization and improved quality of life in eligible patients, especially in those with reduced ejection fraction.

Given the global importance of pharmacotherapy in managing heart failure, Vascular Health and Risk Management invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these transformative therapies.

The collection, edited by Editor-In-Chief Professor Roland Asmar, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of pharmacotherapy in the management of heart failure, the Editors are particularly interested in papers in the following areas:

• Heart failure pathophysiology as it relates to potential therapeutic targets
• Emerging drugs for acute and chronic heart failure
• Efficacy and safety of heart failure pharmacotherapy, with special attention given to studies on patients with comorbidities
• Papers focused on the implementation of heart failure medications in clinical practice

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

Please review the journal scope and author submission instructions prior to submitting a manuscript. Submitting authors are eligible for a 20% discount on the Article Publishing charge. Please use the promo code VBOLK when prompted during the submission.

Please submit your manuscript on our website. The deadline for submitting manuscripts is 1 January 2026.

Please contact Zhiyuan Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

Guest Advisor

Roland Asmar, Foundation-Medical Research Institutes (F-MRI), Switzerland

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Vascular calcification in health and disease", in Vascular Health and Risk Management.

Calcification plays a significant role in the development and progression of vascular disease. It involves the abnormal deposition of calcium phosphate crystals within the vascular intimal or medial layer. Intimal calcification is commonly associated with atherosclerosis, a condition in which plaque builds up inside the arteries, leading to reduced elasticity and narrowed vessels. Intimal calcification is typically linked with inflammation and plaque rupture, contributing to acute cardiovascular events such as heart attacks. Vascular calcification can also occur in the medial layer of blood vessels. Medial calcification, more common in the ageing population, and in patients suffering from diabetes and chronic kidney disease, leads to arterial stiffening and increased systolic blood pressure. While once considered a passive process, calcification is now recognized as an actively regulated, cell-mediated phenomenon involving osteogenic signaling pathways. Understanding the mechanisms behind vascular calcification is crucial for developing targeted therapies to mitigate its impact on cardiovascular health.

Studying vascular calcification is crucial because it is a key contributor to cardiovascular morbidity and mortality, particularly in ageing populations and patients with chronic conditions like diabetes and chronic kidney disease. Vascular calcification is associated with arterial stiffness, reduced vessel elasticity, and increased risk of hypertension, heart attacks, and stroke. Despite its clinical significance, there are currently no effective therapies that specifically target or reverse vascular calcification. Understanding the underlying molecular and cellular mechanisms, such as the transformation of vascular smooth muscle cells into osteoblast-like cells, can help identify potential therapeutic targets. Additionally, early detection and improved imaging techniques can aid in risk stratification and treatment planning for patients. Given its active, regulated nature, vascular calcification represents a promising area for intervention. Studying it not only deepens our understanding of vascular biology but also has the potential to improve outcomes for millions of patients affected by cardiovascular disease worldwide.

This Article Collection seeks contributions that address the following key areas:

• Genetics of vascular calcification
• Intimal vs medial calcification
• Cell biological and molecular pathways of vascular calcification
• Biomarkers for the detection of vascular calcification
• Detection of vascular calcification by clinical imaging modalities (MSCT, PET/ SPECT)
• Clinical significance of vascular calcification - Is calcification good or bad?
• Pharmacological treatment of vascular calcification
• Nutraceutical intervention of vascular calcification

Keywords

• Calcification
• MGP
• Vitamin K.
• Treatment trials
• Vascular smooth muscle cells

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code 04D4D to indicate that your submission is for consideration in this Article Collection. Please note that normal Article Processing Charges will apply.

The deadline for submitting manuscripts is 28 February 2026.

Please contact Zhiyuan Zhang at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Peter W de Leeuw, Maastricht University Medical Center, The Netherlands

[email protected]

Peter W de Leeuw is emeritus professor of Medicine at Maastricht University and has a life-long history of research in hypertension. He has been a member of the Council of the ISH and has served as an Editorial Board member of several hypertension journals. His present research interest is in vascular calcification and in fibromuscular dysplasia.

Leon Schurgers, Maastricht University, The Netherlands

[email protected]

Leon Schurgers is chair and professor of Biochemistry at Maastricht University and has a life-long history of research in vascular remodeling. His present research interest is in vascular calcification and vascular smooth muscle cell phenotype switching.

View all papers in this article collection